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The mammalian stress response is generated by several integrated neural systems that allow rapid 
adaptation to homeostatic disturbances. This is principally mediated through the hypothalamic-
pituitary-adrenal axis which mobilises energy reserves by adrenal glucocorticoids. This in turn 
accelerates cellular metabolism which consequently increases free radical formation through the 
mitochondrial electron transport chain. Excess generation of free radicals such as reactive oxygen 
and nitrogen species (RNS) may potentially cause damage to fatty acids, proteins, and DNA by 
oxidative and nitrosative stress. Nitric oxide is a ubiquitous signalling molecule belonging to the 
family of RNS and is endogenously synthesised from ʟ-arginine by nitric oxide synthase (NOS). 
Three distinct subtypes of NOS have been identified, with the neuronal and endothelial isoforms 
being constitutively expressed enzymes responsible for synaptic signalling and smooth muscle 
relaxation. The inducible isoform is primarily present in cells of the inflammatory immune system 
where its activity is transcriptionally induced by cytokines and other inflammatory agents and thus, 
is thought to play an important role in immunomodulation. Recently, a number of studies have 
demonstrated that the nitrergic system have significant implications in neuropsychiatric disorders 
including anxiety and depression. Specifically, chronic stress-induced hippocampal neuronal NOS 
upregulation is responsible for glucocorticoid receptor downregulation, a factor linked to the 
development of depressive disorders. Although stress and nitrergic signalling are intrinsically linked 
in pathological states, little is known about the acute physiology between these two systems. 
Therefore, the primary aim of this thesis was to establish the profile of nitrosative changes in 
peripheral blood and brain regions known to be impacted by stress following an acute psychological 
challenge. The observed changes were subsequently investigated by employing a pharmacological 
intervention using a novel stress-alleviating and anti-inflammatory endocannabinoid enhancer.  
To achieve the aims for this thesis, Male Wistar rats aged 5-7 weeks postnatal were maintained 
under control conditions or subjected to acute stress. Blood samples were collected at time-points 
immediately before, during, and following treatment in order to estimate the levels of stress 
hormones and redox parameters including oxidative/nitrosative status, glutathione and glutathione 
disulphide ratio, and lipid peroxidation. Post mortem neural tissue was collected and specific brain 
regions were isolated for the determination of nitrosative status, NOS enzymatic activity, and 
relative gene expression of stress and nitrergic-related genes. Following the establishment of these 
measurements, a separate group of animals was used to examine the effects of endocannabinoid 
modulation on the nitrergic and inflammatory-related indicators following acute stress. 
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We found that exposure to a single episode of psychological stress causes early and marked changes 
to both oxidative and nitrosative status sufficient to induce oxidative damage in peripheral blood. 
Within the hippocampus, there was a rapid increase in levels of nitric oxide due to an initial and 
transient increase in the activity of calcium-dependent constitutive NOS following acute stress. 
Transcriptional activation of inducible NOS following stress resulted in sustained elevations in 
nitric oxide within the hippocampus. In comparison, there was a delayed stress-induced increase in 
striatal nitrosative status which was mainly driven by the inducible isoform. Furthermore, 
preventing endocannabinoid hydrolytic degradation with a fatty acid amide hydrolase inhibitor, PF-
3845, successfully suppressed hippocampal inducible NOS upregulation and the associated 
neuroinflammation following acute stress exposure. 
In conclusion, this thesis has established an acute profile of stress-induced central and peripheral 
nitrergic activation. By demonstrating changes in the oxidative and nitrosative systems, and linking 
these to indices of cellular oxidative damage, it has confirmed the involvement of the nitrergic 
system in the rapid redox response to stress. Short term restraint stress also rapidly increases 
hippocampal nitrergic activity involving both the constitutive and inducible isoforms of NOS while 
striatal nitrosative status following stress is predominately inflammatory-mediated. The 
amelioration of these stress-induced modifications in the hippocampus via central augmentation of 




Declaration by author 
This thesis is composed of my original work, and contains no material previously published or 
written by another person except where due reference has been made in the text. I have clearly 
stated the contribution by others to jointly-authored works that I have included in my thesis. 
 
I have clearly stated the contribution of others to my thesis as a whole, including statistical 
assistance, survey design, data analysis, significant technical procedures, professional editorial 
advice, and any other original research work used or reported in my thesis. The content of my thesis 
is the result of work I have carried out since the commencement of my research higher degree 
candidature and does not include a substantial part of work that has been submitted to qualify for 
the award of any other degree or diploma in any university or other tertiary institution. I have 
clearly stated which parts of my thesis, if any, have been submitted to qualify for another award. 
 
I acknowledge that an electronic copy of my thesis must be lodged with the University Library and, 
subject to the policy and procedures of The University of Queensland, the thesis be made available 
for research and study in accordance with the Copyright Act 1968 unless a period of embargo has 
been approved by the Dean of the Graduate School.  
 
I acknowledge that copyright of all material contained in my thesis resides with the copyright 
holder(s) of that material. Where appropriate I have obtained copyright permission from the 





Publications during candidature 
Peer-reviewed papers  
1. Spiers, J.G., Chen, H.J., Bradley, A.J., Anderson, S.T., Sernia, C., Lavidis, N.A., 2013. Acute 
restraint stress induces rapid and prolonged changes in erythrocyte and hippocampal redox 
status. Psychoneuroendocrinology 38, 2511-2519. 
2. Spiers, J.G., Chen, H.-J.C., Sernia, C., Lavidis, N.A., 2014. A combination of plant-derived 
odors reduces corticosterone and oxidative indicators of stress. Chemical Senses 39(7), 563-
569. 
3. Spiers, J.G., Chen, H.-J.C., Lavidis, N., 2014. Stress alleviating plant-derived ‘green odors’: 
behavioural, neurochemical and neuroendocrine perspectives in laboratory animals. 
Phytochemistry Review, 1-13. doi: 10.1007/s11101-014-9371-3 
4. Chen, H.-J.C., Spiers, J.G., Sernia, C., Anderson, S.T., Lavidis, N.A., 2014. Reactive nitrogen 
species contribute to the rapid onset of redox changes induced by acute immobilisation stress in 
rats. Stress 17(6), 520-527.  
5. Spiers, J.G., Chen, H.-J.C., Sernia, C., Lavidis, N.A., 2014. Activation of the hypothalamic-
pituitary-adrenal stress axis induces cellular oxidative stress. Frontiers in Neuroscience 8(456). 
doi: 10.3389/fnins.2014.00456 
6. Chen, H.-J.C., Spiers, J.G., Sernia, C., Lavidis, N.A., 2015. Response of the nitrergic system 
to activation of the neuroendocrine stress axis. Frontiers in Neuroscience 9(3). doi: 
10.3389/fnins.2015.00003 
7. Chen, H.-J.C., Spiers, J.G., Sernia, C., Lavidis, N.A., 2016. Acute restraint stress induces 
specific changes in nitric oxide production and inflammatory markers in the rat hippocampus 
and striatum. Free Radical Biology and Medicine 90, 219-229. 
8. Spiers, J.G., Chen, H.-J.C., Lee, J.K., Sernia, C., Lavidis, N.A., 2016. Neuronal and inducible 
nitric oxide synthase upregulation in the rat medial prefrontal cortex following acute restraint 
stress: a dataset. Data in Brief 6, 582-586.   
9. Spiers, J.G., Chen, H.-J.C., Cuffe, J.S.M., Sernia, C., Lavidis, N.A., 2016. Acute restraint 
stress induces rapid changes in central redox status and protective antioxidant genes in rats. 








Conferences and Symposiums  
National 
Chen, H.-J.C., Spiers, J.G., Sernia, C., Lavidis, N.A., The role of the nitrergic system in an 
acute stress response. Postgraduate Symposium in Biomedical Sciences, 2013, Brisbane, 
Australia. (Poster presenting author) 
 
Chen, H.-J.C., Spiers, J.G., Sernia, C., Lavidis, N.A., Involvement of the nitrergic system in the 
rapid onset of redox changes induced during acute immobilisation stress. Postgraduate 
Symposium in Biomedical Sciences, 2014, Brisbane, Australia. (Poster presenting author) 
 
Chen, H.-J.C., Spiers, J.G., Sernia, C., Lavidis, N.A., Changes in the hippocampal nitrergic 
system during short term restraint stress. Postgraduate Symposium in Biomedical Sciences, 
2014, Brisbane, Australia. (Session speaker) 
 
Chen, H.-J.C., Spiers, J.G., Sernia, C., Lavidis, N.A., The production of nitric oxide differs in 
the hippocampus and striatum following short term psychological stress. Postgraduate 
Symposium in Biomedical Sciences, 2015, Brisbane, Australia. (Poster presenting author) 
 
International  
Spiers, J.G., Chen, H.-J.C., Bradley, A.J., Sernia, C., Anderson, S.T., and Lavidis, N.A., 
Restraint stress induces rapid changes in blood and brain reactive oxygen species. Society for 
Neuroscience 42
nd
 Annual Meeting, October, 2012, New Orleans, United States. POS-280.16. 
(Poster co-presenting author) 
 
Chen, H.-J.C., Spiers, J.G., Sernia, C., Anderson, S.T., Lavidis, N.A., 2013. Acute 
psychological stress induces rapid changes in both oxidative and nitrosative status. Society for 
Neuroscience 43
rd
 Annual Meeting, November, 2013, San Diego, United States. POS-175.12. 
(Poster presenting author) 
 
Chen, H.-J.C., The upregulation of oxidative and nitrergic systems by short-term 
immobilisation stress in rats. The Otago School of Medical Sciences Poster Evening and 




Spiers, J.G., Chen, H.-J.C., Cuffe, J.S.M., Sernia, C., and Lavidis, N.A., Restraint stress induces 
rapid changes in redox status accompanied by an up-regulation of protective antioxidant genes. 
The Otago School of Medical Sciences Poster Evening and Postgraduate Symposium, March, 
2014, Dunedin, New Zealand. (Poster presenting author) 
 
Chen, H.-J.C., Spiers, J.G., Sernia, C., Lavidis, N.A., Changes in the hippocampal nitrergic 
system during short term restraint stress. 8
th
 International Congress of Neuroendocrinology, 
August, 2014, Sydney, Australia. POS-373. (Poster presenting author)  
 
Chen, H.-J.C., Spiers, J.G., Sernia, C., Lavidis, N.A., Acute nitric oxide production differs in 
the hippocampus and striatum following short term restraint stress. The 45
th
 annual meeting for 
the International Society of Psychoneuroendocrinology, September, 2015, Edinburgh, Scotland. 
POS-10 (Poster presenting author) – received a Young Investigator Award from ISPNE 
 
Chen, H.-J.C., Spiers, J.G., Sernia, C., Lavidis, N.A., An increase in endocannabinoid content 
by inhibition of fatty acid amide hydrolase alleviates nitrergic-related neuroinflammation in the 
hippocampus following acute restraint stress. The 7
th
 joint meeting for the Societies for Free 
Radical Research Australasia and Japan, December, 2015, Christchurch, New Zealand. POS-A10 




International Brain Research Organisation-APRC Associate School: Techniques in Neuroendocrine 
Research Workshop. 9-14
th












Publications included in this thesis 
Chen, H.-J.C., Spiers, J.G., Sernia, C., Anderson, S.T., Lavidis, N.A., 2014. Reactive nitrogen 
species contribute to the rapid onset of redox changes induced by acute immobilisation stress in 







Contributor Statement of contribution 
Hsiao-Jou Cortina Chen  
 
Study design (60%)  
Animal treatment (50%)  
Hormone assay (60%)  
Redox assays (70%)  
Interpretation of results (60%)  
Manuscript preparation (85%)  
Reviewing and editing manuscript (40%)  
Jereme G. Spiers  
 
Study design (20%)  
Animal treatment (50%)  
Hormone assay (30%)  
Redox assays (30%)  
Interpretation of results (15%)  
Manuscript preparation (15%)  
Reviewing and editing manuscript (20%) 
Stephen T. Anderson  
 
Hormone assay (10%)  
Interpretation of results (5%)  
Reviewing and editing manuscript (10%) 
Conrad Sernia  
 
Study design (10%)  
Interpretation of results (10%)  
Reviewing and editing manuscript (15%) 
Nickolas A. Lavidis  
 
Study design (10%)  
Interpretation of results (10%)  
Reviewing and editing manuscript (15%) 
viii 
 
Chen, H.-J.C., Spiers, J.G., Sernia, C., Lavidis, N.A., 2016. Acute restraint stress induces specific 
changes in nitric oxide production and inflammatory markers in the rat hippocampus and striatum. 









Contributor Statement of contribution 
Hsiao-Jou Cortina Chen  
 
Study design (60%)  
Animal treatment (50%)  
Hormone assay (60%)  
Nitrosative assays (70%)  
Real-time PCR (90%) 
Interpretation of results (60%)  
Manuscript preparation (90%)  
Reviewing and editing manuscript (50%)  
Jereme G. Spiers  
 
Study design (20%)  
Animal treatment (50%)  
Hormone assay (40%)  
Nitrosative assays (30%)  
Real-time PCR (10%) 
Interpretation of results (20%)  
Manuscript preparation (10%)  
Reviewing and editing manuscript (20%) 
Conrad Sernia  
 
Study design (10%)  
Interpretation of results (10%)  
Reviewing and editing manuscript (15%) 
Nickolas A. Lavidis  
 
Study design (10%)  
Interpretation of results (10%)  
Reviewing and editing manuscript (15%) 
ix 
 
Contributions by others to the thesis  
 
The majority of the work presented in this thesis was completed by Hsiao-Jou Cortina Chen. The 
project was conceptualised by Hsiao-Jou Cortina Chen, Jereme G. Spiers, Conrad Sernia, and 
Nickolas A. Lavidis. Jereme G. Spiers assisted with animal treatment, redox, nitrosative, hormone, 
and real-time PCR assays and was involved in data interpretation, reviewing and editing of 
manuscripts. Stephen T. Anderson helped with the prolactin and insulin assays in Chapter III. 
Conrad Sernia and Nickolas A. Lavidis assisted in data interpretation and manuscript revisions. 
 







This thesis would not have been possible without the support of many people. I would like to use 
this opportunity to express my eternal gratitude to all of you who made this journey an insightful 
and memorable one.  
 
First and foremost, I wish to express my deepest appreciation to my principle advisor, Dr. Nickolas 
Lavidis, for your invaluable support, guidance, and generosity throughout these years whilst 
allowing me the freedom and space to learn and grow as a research student. With the countless 
space disruptions and every other setback, the effort you put in to create a workable environment 
along with your humour and casual approach has given me the spirit to cross the thesis finishing 
line, for all of which I am extremely grateful. I owe my deepest gratitude towards my co-advisor, 
Associate Professor Conrad Sernia, for always being willing to talk when I needed help. Your 
immense knowledge, insightful comments, and patience for correcting innumerable drafts have 
provided a solid basis throughout my candidature. To both Nick and Conrad, I respectfully say, 
Thank You!  
 
It gives me great pleasure in acknowledging my mentor, labmate, and a dear friend, Dr. Jereme 
Spiers. Words cannot convey how much I appreciated your guidance and support, without them I 
would most assuredly have gone crazy. For the past four years of this project, we built our 
experimental equipment, went through months and months of assay calibration, and sleepless nights 
of redox assays. I thank you deeply and it is an honour for me to work alongside with you. You are 
a brilliant scientist and I have learned so much from you, I wish you every success in the future!  
 
Besides my advisors, I would like to thank my thesis committee members, Dr. Frederik Steyn and 
Dr. Francois Windels, for their time, tough questions, and intellectual contributions to my 
development as a young scientist. My sincere thanks goes to Professor Karen Moritz, who very 
kindly gave me access to her laboratory to perform all the molecular work in this thesis. A big thank 
you goes to Dr. Stephen Anderson for the prolactin and insulin assays. A very special thanks goes 
to my Honours supervisor and mentor, Dr. Adrian Bradley, thank you for your kind encouragement 
throughout my postgraduate education.  
 
To my fellow PhD companions, Kirat Chand, Carlie Cullen, John Lee, Jenny Fung, James Cuffe, 
and Emily Dorey, thank you so much for your friendship and all the fun we have had in the past few 
years, it would not be the same without all of you! I would also like to thank all the other members 
of the Lavidis lab, both past and present, who have assisted me in my project.  
xi 
 
I am indebted to my beloved family, to my dearest Mum and Dad, there is no words to describe 
how much I appreciate your tremendous love, support, patience, and tolerance during years filled 
with stress and anxiety. To Patricia and Leo, my dear sister and brother, thank you for supporting 
and encouraging me with all your best wishes. To Professor Kinsuk, our dear family friend, for your 
kind reward when I got admitted into the PhD program. I also owe my thanks to all my good friends 
outside the University, thank you for tolerating my odd working hours and never asking for reasons 
and explanations when all I wanted was a few laughs. 
 
Last but not least, I acknowledge that myself was supported by a University of Queensland 



























acute stress, corticosterone, endocannabinoids, fatty acid amide hydrolase inhibitor, 
neuroinflammation, nitrergic system, nitric oxide, nitric oxide synthase, oxidative stress, redox 
status. 
 
Australian and New Zealand Standard Research Classifications (ANZSRC) 
ANZSRC code: 111603 Systems Physiology (40%) 
ANZSRC code: 110306, Endocrinology (30%)  
ANZSRC code: 110903 Central Nervous System (30%) 
 
Fields of Research (FoR) Classification 
FoR code: 1116 Medical Physiology (50%) 

















Table of Contents 
Chapter I: Introduction ............................................................................................. 1 
1.0 Thesis Overview ......................................................................................................................... 2 
1.1 Neuroendocrine Responses to Stress............................................................................................ 3 
1.1.1 The stress systems......................................................................................................... 3 
1.1.2 Negative feedback of the hypothalamic-pituitary-adrenocortical axis ............................ 7  
1.1.3 The physiological and pathophysiological effects of glucocorticoids ............................. 9 
1.2 Oxidative and Antioxidative Systems .......................................................................................... 14 
1.2.1 Free radical production ................................................................................................. 14 
1.2.2 The endogenous antioxidant system .............................................................................. 15 
1.2.3 Adrenal glucocorticoids and oxidative stress ................................................................. 17 
1.3 The Nitrergic System................................................................................................................... 23  
1.3.1 Nitric oxide biosynthesis and functions ......................................................................... 23  
1.3.2 Nitric oxide metabolism and clearance .......................................................................... 24 
1.3.3 Reactive nitrogen species and nitrosative stress ............................................................. 25 
1.3.4 Stress-evoked modulation of the nitrergic system .......................................................... 27 
1.4 Thesis Rationale .......................................................................................................................... 31 
1.5 Overall Aim ................................................................................................................................ 32  
Chapter II: General Materials and Methods ............................................................ 33  
2.0 General Methods ......................................................................................................................... 34 
2.1 Ethics Clearance .......................................................................................................................... 34 
2.2 Animal Housing  ......................................................................................................................... 34 
2.3 Habituation and Transportation ................................................................................................... 34 
2.4 Acute Stress ................................................................................................................................ 34 
2.5 PF-3845 Administration .............................................................................................................. 35 
2.6 Experimental Groups ................................................................................................................... 36  
xiv 
 
2.7 Sample Collection ....................................................................................................................... 36 
2.8 Plasma Prolactin .......................................................................................................................... 37 
2.9 Plasma Corticosterone ................................................................................................................. 38 
2.10 Plasma Insulin ........................................................................................................................... 38  
2.11 DAF-FM DA Assay .................................................................................................................. 39 
2.11.1 Plasma assay ............................................................................................................... 39 
2.11.2 Tissue assay ................................................................................................................ 39  
2.12 Total Nitrite and Nitrate Levels ................................................................................................. 40  
2.12.1 Plasma assay ............................................................................................................... 40 
2.12.2 Tissue assay ................................................................................................................ 40 
2.13 Plasma Oxidative Status ............................................................................................................ 40 
2.14 Reduced and Oxidised Glutathione Assay in Erythrocytes ......................................................... 41  
2.15 Plasma Lipid Peroxidation Assay .............................................................................................. 42  
2.16 Nitric Oxide Synthase Activity in Tissue ................................................................................... 42 
2.17 Ribonucleic Acid Extraction and Preparation of cDNA ............................................................. 43 
2.18 mRNA Expression..................................................................................................................... 44 
2.19 Haemoglobin Determination ...................................................................................................... 45  
2.20 Protein Estimation ..................................................................................................................... 45 
2.21 Statistical Analysis .................................................................................................................... 45 
Chapter III: Reactive nitrogen species contribute to the rapid onset of redox 
changes induced by acute immobilisation stress in rats ........................................... 46  
3.1 Abstract  ...................................................................................................................................... 47 
3.2 Introduction ................................................................................................................................. 48 
3.3 Materials and Methods ................................................................................................................ 49  
3.3.1 Experimental animals.................................................................................................... 49 
3.3.2 Acute immobilisation stress .......................................................................................... 49 
3.3.3 Experimental protocol ................................................................................................... 49 
xv 
 
3.3.4 Hormone assays ............................................................................................................ 50 
3.3.5 Nitrosative status .......................................................................................................... 51  
3.3.6 General oxidative status assay ....................................................................................... 51 
3.3.7 Reduced and oxidised glutathione assay ........................................................................ 52 
3.3.8 Lipid peroxidation in plasma ......................................................................................... 52  
3.3.9 Haemoglobin and protein determination........................................................................ 53  
3.3.10 Statistics ..................................................................................................................... 53 
3.4 Results ........................................................................................................................................ 54 
3.4.1 Endocrine and metabolic ............................................................................................... 54 
3.4.2 Nitrosative status .......................................................................................................... 56 
3.4.3 Redox status  ................................................................................................................ 58 
3.4.4 Lipid peroxidation ........................................................................................................ 60 
3.5 Discussion ................................................................................................................................... 61 
3.6 Acknowledgements ..................................................................................................................... 64 
3.7 Conflict of Interest ...................................................................................................................... 64 
3.8 Role of Funding Source ............................................................................................................... 64 
Chapter IV: Acute restraint stress induces specific changes in nitric oxide 
production and inflammatory markers in the rat hippocampus and striatum ....... 65 
4.1 Abstract ....................................................................................................................................... 66 
4.2 Introduction ................................................................................................................................. 67 
4.3 Materials and Methods ................................................................................................................ 68  
4.3.1 Experimental animals.................................................................................................... 68  
4.3.2 Habituation and transportation ...................................................................................... 68  
4.3.3 Acute restraint stress ..................................................................................................... 69 
4.3.4 Treatment protocol and tissue collection ....................................................................... 69  
4.3.5 Plasma corticosterone assay .......................................................................................... 69 
4.3.6 Neural tissue preparation............................................................................................... 69 
xvi 
 
4.3.7 Assay of calcium-independent and dependent nitric oxide synthase activity .................. 70 
4.3.8 Nitric oxide metabolism in neural tissue........................................................................ 70  
4.3.9 Nitric oxide production in neural tissue ......................................................................... 70 
4.3.10 Real-time PCR ............................................................................................................ 71 
4.3.11 Protein estimation ....................................................................................................... 71 
4.3.12 Statistical analysis ....................................................................................................... 71 
4.4 Results ........................................................................................................................................ 72 
4.4.1 Indicators of HPA activity............................................................................................. 72 
4.4.2 Hippocampal nitrergic activity ...................................................................................... 74 
4.4.3 Hippocampal mRNA expression of NOS and inflammatory markers ............................ 77 
4.4.4 Striatal NO production, metabolism, and synthesis........................................................ 80 
4.4.5 Striatal mRNA expression of NOS and inflammatory markers ...................................... 82 
4.5 Discussion ................................................................................................................................... 84 
4.6 Acknowledgements ..................................................................................................................... 88 
4.7 Conflict of Interest ...................................................................................................................... 88 
4.8 Role of Funding Source ............................................................................................................... 88 
Chapter V: Inhibition of fatty acid amide hydrolase by PF-3845 alleviates 
nitrergic-related neuroinflammatory response following acute restraint stress ..... 89 
5.0 Contributions by others ............................................................................................................... 90 
5.1 Abstract ....................................................................................................................................... 91 
5.2 Introduction ................................................................................................................................. 92 
5.3 Materials and Methods ................................................................................................................ 94 
5.3.1 Ethical approval and experimental animals ................................................................... 94  
5.3.2 Experimental protocol ................................................................................................... 94 
5.3.3 Plasma corticosterone assay .......................................................................................... 95 
5.3.4 Real-time PCR .............................................................................................................. 95 
5.3.5 Statistical analysis ......................................................................................................... 95 
xvii 
 
5.4 Results ........................................................................................................................................ 96 
5.4.1 Inhibition of FAAH dampens acute stress-induced corticosterone release ..................... 96 
5.4.2 Acute stress-induced upregulation of inducible nitric oxide synthase was attenuated by 
PF-3845 ........................................................................................................................ 97 
5.4.3 Dampening of HPA activity by PF-3845 prevents TNF downregulation and TACE 
upregulation ................................................................................................................. 98 
5.4.4 Inhibition of FAAH constrains inflammatory cytokines including IL-1β and IL-6 
upregulation following acute stress ............................................................................... 100 
5.4.5 PF-3845 acutely suppressed inflammatory COX-2 mRNA expression in the 
hippocampus   .............................................................................................................. 102 
5.4.6 The FAAH inhibitor reduces the potential of NF-кB transactivation monitored by 
Nfkbia mRNA expression ............................................................................................. 103 
5.5 Discussion ................................................................................................................................... 104 
5.6 Acknowledgements ..................................................................................................................... 107 
5.7 Conflict of Interest ...................................................................................................................... 107 
5.8 Role of Funding Source ............................................................................................................... 107 
Chapter VI: General Discussion ............................................................................................ 108  
6.0 Thesis Summary .......................................................................................................................... 109 
6.1 Acute Psychological Stress and the Endocrine System................................................................. 111 
6.2 Acute Psychological Stress and the Redox Response ................................................................... 114 
6.3 Stress-Induced Activation of the Nitrergic System ....................................................................... 115 
6.3.1 Peripheral tissue ............................................................................................................ 115 
6.3.2 Central tissue ................................................................................................................ 117 
6.4 Acute Psychological Stress and the Inflammatory Response ........................................................ 119 
6.5 Future Directions ......................................................................................................................... 120 
6.6 Conclusions ................................................................................................................................. 121 
References .................................................................................................................................... 122 
Appendix ....................................................................................................................................... 153 
xviii 
 
List of Figures  
Figure 1.1. The three stress systems.................................................................................................. 6 
Figure 1.2. Priming of the neuroinflammatory response following peak glucocorticoid levels within 
the central nervous system ................................................................................................................ 12 
Figure 1.3. Temporal relationship between stress and the onset of oxidative challenge ..................... 18 
Figure 1.4. The oxidation/reduction system ......................................................................................... 22 
Figure 1.5. A schematic representation of the nitrergic system and its downstream effects in 
hippocampal neurons following stress exposure ................................................................................ 26 
Figure 2.1. Levels of anandamide, N-pamitoyl ethanolamine, and N-oleoylethanolamine in brain 
tissue following intraperitoneal injection of fatty acid amide hydrolase inhibitors ............................. 35 
Figure 3.1. The effect of acute immobilisation stress on plasma prolactin, plasma corticosterone, 
blood glucose, and plasma insulin concentrations .............................................................................. 55 
Figure 3.2. The effect of acute immobilisation stress on nitric oxide production measured by the 
benzotriazole derivative of 4-amino-5-methylamino-2’, 7’-difluorofluorescein formation ................. 56 
Figure 3.3. The effect of acute immobilisation stress on total nitrite and nitrate levels ...................... 57 
Figure 3.4. The effect of acute immobilisation stress on the general oxidative status measured by 
dichlorofluorescein formation ........................................................................................................... 58 
Figure 3.5. The effect of acute immobilisation stress on the erythrocytic glutathione to glutathione 
disulfide ratio indicative of oxidative stress ....................................................................................... 59 
Figure 3.6. The effect of acute immobilisation stress on plasma lipid peroxidation measured by 
malondialdehyde-thiobarbituric acid adduct formation ...................................................................... 60 
Figure 4.1. The effect of acute restraint stress on plasma corticosterone and hippocampal 
glucocorticoid and mineralocorticoid receptor mRNA expression ..................................................... 73 
Figure 4.2. The effect of acute restraint stress on total, constitutive, and inducible nitric oxide 
synthase enzymatic activity in the hippocampus ................................................................................ 75 
Figure 4.3. The effect of acute restraint stress on hippocampal total nitrite and nitrate and 
nitrosative status measured by the benzotriazole derivative of 4-amino-5-methylamino-2’, 7’-
difluorofluorescein formation ............................................................................................................ 76 
Figure 4.4. The effect of acute restraint stress on hippocampal Nos1, Nos2, Nfkbia, Il1b, Il6, Mif, 
and Ciita mRNA expression .............................................................................................................. 78 
Figure 4.5. The effect of acute restraint stress on total, constitutive, and inducible nitric oxide 
synthase enzymatic activity in the striatum ........................................................................................ 80 
xix 
 
Figure 4.6. The effect of acute restraint stress on striatal total nitrite and nitrate and nitrosative 
status measured by the benzotriazole derivative of 4-amino-5-methylamino-2’, 7’-
difluorofluorescein formation ............................................................................................................ 81 
Figure 4.7. The effect of acute restraint stress on striatal Nos1, Nos2, Nfkbia, Il1b, Il6, and Mif 
mRNA expression ............................................................................................................................. 83 
Figure 5.1. The effect of the fatty acid amide hydrolase inhibitor, PF-3845, on plasma 
corticosterone levels .......................................................................................................................... 96 
Figure 5.2. The effect of the fatty acid amide hydrolase inhibitor, PF-3845, on hippocampal Nos2 
and Nos1 mRNA expression ............................................................................................................. 97 
Figure 5.3. The effect of the fatty acid amide hydrolase inhibitor, PF-3845, on hippocampal Tnf 
mRNA expression ............................................................................................................................. 98 
Figure 5.4. The effect of the fatty acid amide hydrolase inhibitor, PF-3845, on hippocampal 
Adam17 mRNA expression ............................................................................................................... 99 
Figure 5.5. The effect of the fatty acid amide hydrolase inhibitor, PF-3845, on hippocampal Il1b 
and Il6 mRNA expression ................................................................................................................. 101 
Figure 5.7. The effect of the fatty acid amide hydrolase inhibitor, PF-3845, on hippocampal Ptgs2 
mRNA expression ............................................................................................................................. 102 
Figure 5.6. The effect of the fatty acid amide hydrolase inhibitor, PF-3845, on hippocampal Nfkbia 
mRNA expression ............................................................................................................................. 103 
Figure 6.1. Schematic thesis summary .............................................................................................. 110 
Figure 6.2. The effect of acute restraint stress during the light cycle on hippocampal glucocorticoid 
mineralocorticoid receptor mRNA expression ................................................................................... 113 
Figure 6.3. The effect of acute restraint stress on neural glutathione peroxidase 1 and 4 mRNA 
levels in the hippocampus and striatum ............................................................................................. 118 
Figure A1. The effect of acute restraint stress on neuronal nitric oxide synthase (Nos1) mRNA 
expression in the medial prefrontal cortex ......................................................................................... 154 
Figure A2. The effect of acute restraint stress on inducible nitric oxide synthase (Nos2) mRNA 
expression in the medial prefrontal cortex ......................................................................................... 155 
Figure A3. The effect of acute restraint stress on nuclear factor of kappa light polypeptide gene 







List of Tables 
Table 2.1. An overview of the treatment groups ................................................................................ 36 
Table 2.2. Applied Biosystems
TM by Life Technologies inventoried ‘assay-on-demandTM’ probes .... 44 
Table 6.1. The effects of blood sampling method on the baseline/pre-stress corticosterone 






























List of Abbreviations  




ACTH Adrenocorticotropic hormone 
AEA Anadamide 
AIBN Australian Institute of Bioengineering and Nanotechnology 
AM Adrenal medulla  
ANOVA Analysis of variance 
ANS Autonomic nervous system 
aPT Anterior pituitary 
ATP Adenosine-5’-triphosphate 





CB1R Cannabinoid receptor type 1 
CB2R Cannabinoid receptor type 2 
CBG Corticosteroid-binding globulin 
cGMP Cyclic guanosine monophosphate 




CREB cAMP response element-binding 




Cu, Zn-SOD Copper, zinc-superoxide dismutase 
DAF-FM DA 4-Amino-5-methylamino-2′, 7′-difluorofluorescein diacetate 
DAM-FM T Trizole form of 4-amino-5-methylamino-2′, 7′-difluorofluorescein 
DCF Dichlorofluorescein 
DCFH Dichlorofluorescin 
DCFH-DA 2’, 7’-Dichlorofluorescin diacetate 
DMSO Dimethyl sulfoxide 
EDTA Ethylenediaminetetraacetic acid 
EGTA Ethylene glycol tetraacetic acid 
eNOS Endothelial nitric oxide synthase 
ERK Extracellular signal-regulated kinase 





GABA Gamma-aminobutyric acid 
GAPDH Glyceraldehyde 3-phosphate dehydrogenase 
GPx Glutathione peroxidase 
xxii 
 
GRE Glucocorticoid response element 
GSH Reduced glutathione  
GSNO S-nitrosoglutathione 
GSNOR S-nitrosoglutathione reductase 
GSR Glutathione reductase 
GSSG Oxidised glutathione 
H2O2 Hydrogen peroxide  
HEPES 2-[4-(2-Hydroxyethyl)piperazin-1-yl]ethanesulfonic acid 
HPA Hypothalamic-pituitary-adrenocortical 
HSA Hypothalamic-spinal-adrenocortical 




IML Intermediolateral cell column 
iNOS Inducible nitric oxide synthase 
IκB-α Inhibitor of nuclear factor kappa B 
KPE Potassium buffer with ethylenediaminetetraacetic acid 
LC Locus coeruleus 
L-NAME Nω-nitro-L-arginine methyl ester hydrochloride 
LPO Lipid peroxidation 
LSD Least significant difference 
MDA Malondialdehyde 
Mhc2ta Major histocompatibility complex II transactivator 




Mn-SOD Manganese superoxide dismutase 
MR Mineralocorticoid receptor 
mtNOS Mitochondrial nitric oxide synthase 
NADPH Nicotinamide adenine dinucleotide phosphate 
NEM N-ethylmaleimide 
NF-κB Nuclear factor kappa-light-chain-enhancer of activated B cells 
NMDA N-methyl-D-aspartate 
nNOS Neuronal nitric oxide synthase 
NOS Nitric oxide synthase 
NOx Total nitrite and nitrate 
Nrf2 Nuclear factor-erythroid-2-related factor 2 
O2 ˉ Superoxide 




 Hydroxyl radical 
ONOO- Peroxynitrite  
OPA O-phthalaldehyde 
PBS Phosphate buffered saline 
PBS-G Phosphate buffered saline with porcine gelatin 
xxiii 
 
PEA N-pamitoyl ethanolamine 
PVC Polyvinyl chloride 
PVN Paraventricular nucleus 
RNS Reactive nitrogen species  
ROS Reactive oxygen species  
SAM Sympatho-adrenomedullary 
SEM Standard error of the mean  
sGC Soluble guanylyl cyclase 
SNP Sodium nitroprusside 
SOD Superoxide dismutase 
TACE TNF-α convertase 
TBARS Thiobarbituric acid reactive substances 
TNF-α Tumor necrosis factor-alpha 
TRIM 1-(-2-Trifluoromethylphenyl)-imidazole 
Tyr Tyrosine 
v/v Volume per volume 
VIC 2’-Chloro-7’-phenyl-1, 4-dichloro-6-carboxyfluorescein 
w/v Weight per volume 
  











































1.0 Thesis Overview 
Depression is characterised by persistent dejected mood, loss of interest and concentration, 
decreased liveliness and low self-confidence, disturbed sleep or appetite, helplessness, and suicidal 
ideation. It is a chronic disorder often accompanied by symptoms of anxiety, and is a significant 
contributor to the global burden of disease estimated to affect 350 million people with adverse 
societal costs. Due to the complexity and aetiological heterogeneity of depressive disorder, it has 
been difficult to fully elucidate its pathophysiology and identify proper diagnostic tools and 
efficacious treatment. Stress is one of the major risk factors in the aetiology of psychological 
illnesses and is often used as a model system in basic research and clinical studies to identify 
neurochemical and cellular alterations underlying depression and other stress-related disorders. 
Nitric oxide, a free radical with physiological, as well as pathological functions, has recently been 
shown to mediate stress-induced depressive-like behaviour in mice. Moreover, pharmacological 
inhibition of nitric oxide production results in anxiolytic- and antidepressant-like effects in animal 
models. Genetic polymorphisms in genes encoding nitric oxide synthesizing enzymes have been 
suggested to contribute to the risk of developing recurrent depressive disorder. Therefore, a 
dysfunction of the nitrergic system has been implicated in the neuropathogenesis of both anxiety 
and depression. However, the delineation between physiological function and pathological insult of 
nitrergic system activation remains unclear. Therefore, the principle aim of this thesis was to 

















1.1 Neuroendocrine Responses to Stress  
1.1.1 The stress systems 
Living organisms survive by maintaining a complex and dynamic homeostasis that is consistently 
challenged by intrinsic and extrinsic factors. When faced with excessive stress, whether physical or 
psychological, a subject’s adaptive responses react in a relatively stereotypic and non-specific 
nature, referred to by Hans Selye as the ‘general adaption syndrome’ (Selye, 1936, 1950). It 
consists of an initial alarm reaction, a second stage of resistance, and a final exhaustion stage with 
the second stage being favourable as it allows the body to compensate and restore homeostasis 
(Selye, 1936, 1976). Selye also proposed that not all states of stress or threatened homeostasis are 
deleterious, terming healthy stress ‘eustress’ and distress as ‘pathogenic’ stress. The more severe 
and uncontrollable situations of physical or psychological distress trigger disease and pathology as a 
consequence, while brief and controllable challenges may be perceived as pleasant or exciting and 
could act as positive stimuli for emotional and intellectual growth (Selye, 1976). This model was 
later revisited by McEwen (1998) with a focus on the long term effects of physiological response to 
stress and proposed the concept of adaptation to potentially stressful challenges involving the 
activation of neural, neuroendocrine, and neuroendocrine-immune mechanisms. For this reason, 
Sterling and Eyer (1988) introduced the term ‘allostasis’ or ‘stability through change’. McEwen 
further elaborate Selye’s eustress concept as an allostatic response whereas distress represented 
allostatic load or overload resulting from either too much stress or inefficient management of 
allostasis (McEwen, 1998). Two types of allostatic overload have been described, acute (type I) and 
chronic (type II) (McEwen and Wingfield, 2003). Type I overload is the stress response to different 
threats that increases the demand for energy whereas many chronic stress-related diseases such as 
hypertension, stroke, obesity, metabolic syndrome, memory impairment, and autoimmune diseases 
have been related to type II allostatic overload (McEwen and Wingfield, 2003; McEwen, 2005, 
2007).  
There are three discrete and dedicated systems required to maintain and reinstate homeostasis 
during a response to stress (Fig. 1.1). The autonomic nervous system quickly responds within 
seconds to stress exposure through the sympathetic and parasympathetic divisions, which provide 
rapid alterations in physiological states through neural innervation of end organs. Activation of the 
sympatho-adrenomedullary (SAM) system leads to release of catecholamines, adrenaline and 
noradrenaline, from the adrenal medulla into blood circulation generating a ‘fight-or-flight’ 
response (Jansen et al., 1995). This rapidly increases heart rate and blood pressure while enhancing 
arousal and vigilance. Within the same timeframe, an increased secretion of pituitary prolactin and 
growth hormone, and pancreatic glucagon is often observed following different types of stressors 
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(Lennartsson and Jonsdottir, 2011; Ranabir and Reetu, 2011; Jones et al., 2012). However, these 
secondary stress systems are activated as required to meet a stress-induced demand and those 
involving prolactin are still incompletely understood, with controversial roles in the dynamics of a 
response to stress. A less well characterised multisynaptic autonomic hypothalamic-spinal-
adrenocortical (HSA) axis is activated almost simultaneously to the SAM system. This axis sends 
projection from the hypothalamus, primarily the paraventricular nucleus, to the intermediolateral 
cell column of the spinal cord and via the splanchnic nerve to innervate the adrenal cortex (Lowry, 
2002). The HSA axis, through direct innervation of the glucocorticoid synthesizing adrenal cortex, 
has demonstrated important roles in modulation of ultradian and circadian rhythms and stress-
induced neuroendocrine function (Jasper and Engeland, 1994; Buijs et al., 1999). Ulrich-Lai and 
colleagues (2006) demonstrated that adrenal splanchnic innervation modulates the stress hormone, 
corticosterone (in rodents), by increasing adrenal sensitivity to adrenocorticotropic hormone 
(ACTH). Following activation of the SAM system and HSA axis, the stress system is primed and 
subsequent activation of the hypothalamic-pituitary-adrenocortical (HPA) axis results in amplified 
elevations in circulating corticosteroids with peak plasma levels occurring approximately ten to 
fifteen minutes after the initiation of stress (Chrousos and Gold, 1992; Droste et al., 2008). It should 
be noted that each of these systems have important roles in normal homeostatic physiology. For 
example, under basal unstressed conditions, the HPA axis exhibits a prominent daily circadian 
rhythm characterised by rapid ultradian oscillations with peak levels of corticosteroids occur during 
the active phase over a period of approximately 24 hours (Windle et al., 1998). The circadian 
rhythmicity is generated and synchronised by photic entrainment of the hypothalamic 
suprachiasmatic nuclei via the retino-hypothalamic tract (Moore and Lenn, 1972; Mohawk and 
Takahashi, 2011). This rhythmic activity of the suprachiasmatic nuclei gives rise to a 
transcriptional-translational autoregulatory network involving ‘clock genes’ generating oscillating 
biochemical signals which in turn regulate downstream behavioural and physiological processes 
(Stratmann and Schibler, 2006; Maywood et al., 2007). Numerous peripheral clocks have also been 
identified including studies suggesting that steroidogenesis can be regulated independently from the 
suprachiasmatic nuclei by a peripheral intra-adrenal circadian pacemaker (Oster et al., 2006; Son et 
al., 2008). Although the HPA axis has a well characterised circadian rhythm, during acute exposure 
to stress, this rhythm is superseded by the HPA axis to facilitate the secretion of glucocorticoids 
(Windle et al., 1998).  
The HPA axis involves the activation of parvocellular neuroendocrine cells within the 
paraventricular nucleus of the hypothalamus which secrete corticotropin-releasing hormone (CRH) 
and arginine vasopressin into the hypophyseal portal system (Tsigos and Chrousos, 1994). Arginine 
vasopressin is a potent synergistic factor acting concurrently with CRH on the anterior pituitary, 
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and via activating their respective transmembrane receptors, vasopressin V1b receptor and 
corticotropin-releasing hormone receptor 1, stimulates ACTH release to the systemic circulation 
(Smith and Vale, 2006). Circulating ACTH subsequently binds to the melanocortin type 2 receptor 
on the inner adrenal cortex (zona fasciculata) to initiate de novo synthesis through transcriptional 
activation of a number of steroidogenic genes to transport cholesterol across the mitochondrial 
membrane and ultimately increase the release of corticosteroids (Tsigos and Chrousos, 2002). The 
activity of parvocellular neuroendocrine cells is tightly regulated by the hippocampus via gamma-
aminobutyric acid (GABA)-ergic synaptic input from its interneuron populations that are in close 
proximity to the paraventricular nucleus including the bed nucleus of the stria terminalis or other 
hypothalamic nuclei within the dorsomedial hypothalamus and medial preoptic area (Roland and 
Sawchenko, 1993). This topographically organised output from the hippocampus involving 
subcortical GABAergic systems serves as a ‘gateway’ for inhibitory signals to affect the HPA and 
HSA pathways (Lowry, 2002). Injection of GABA-A antagonist into the paraventricular nucleus 
profoundly increases neural activity and circulating corticosterone levels indicating that GABA 
exerts an inhibitory effect which constrains parvocellular neuroendocrine cell activity under basal 
conditions (Borycz et al., 1992). It is believed that removal of this GABAergic inhibition is 
necessary for the initiation of the neuroendocrine response to stress (Borycz et al., 1992; Cole and 
Sawchenko, 2002). Hewitt and colleagues (2009) demonstrated that following acute restraint stress, 
the parvocellular neuroendocrine cells undergo a depolarizing shift in the reversal potential for 
chloride ions by activation of α1-adrenoceptors thereby inhibiting the activity of transmembrane 
potassium-chloride-cotransporter 2. This impaired chloride ion extrusion within the parvocellular 
neuroendocrine cells leads to impaired GABA-A receptor-mediated inhibitory control of the HPA 



























Figure 1.1. The three stress systems. 
Schematic representation of the three systems required to maintain and reinstate homeostasis during 
stress. Activation of the sympatho-adrenomedullary system (green) through the locus coeruleus 
(LC) within the brain stem leads to release of catecholamines, adrenaline and noradrenaline, from 
the adrenal medulla (AM) through the intermediolateral cell column (IML) of the spinal cord. The 
multisynaptic autonomic hypothalamic-spinal-adrenocortical axis (orange) is concurrently activated 
and sends projections from the paraventricular nucleus (PVN) of the hypothalamus to the IML and 
via the splanchnic nerve to innervate the adrenal cortex (AC). Activation of the hypothalamic-
pituitary-adrenal axis (red) stimulates release of corticotropin-releasing hormone (CRH) and 
arginine vasopressin (AVP) from the PVN into the pituitary portal circulation. These act 
concurrently on the anterior pituitary (aPT) causing release of adrenocorticotropic hormone 










- Sympatho-Adrenomedullary System 
- Hypothalamic-Spinal-Adrenocortical Axis 









1.1.2 Negative Feedback of the Hypothalamic-Pituitary-Adrenocortical Axis  
Under stressful conditions, the HPA axis is regulated by glucocorticoid-mediated negative feedback 
to extra-hypothalamic centres, hypothalamus, and anterior pituitary to terminate the stress response 
and restore homeostasis (Pardridge and Mietus, 1979; De Kloet et al., 1998). This feedback is 
mediated by biologically active glucocorticoids that are able to cross the blood brain barrier (Reul et 
al., 2000). In circulation, corticosterone can be found in free form, but approximately 95% of 
corticosterone is protein bound, mainly to the high-affinity corticosteroid-binding globulin (CBG; 
formally transcortin) and low-affinity albumin (Siiteri et al., 1982). Thus, plasma corticosterone can 
be partitioned into free corticosterone, CBG-bound and albumin-bound reservoirs. It has been 
shown that following acute stress, the rapid release of CBG from the liver restrains free 
corticosterone for approximately 20 minutes when compared with the total corticosterone response 
in the blood (Qian et al., 2011). Both the free and albumin-bound corticosterone pools (via 
dissociation) are capable of crossing the blood brain barrier and act as the final effectors of the HPA 
axis mediating negative feedback (Pardridge and Mietus, 1979). Slow transcription-dependent 
actions of biologically active glucocorticoids occur at each of the glucocorticoid feedback target 
sites and represent a longer form of negative feedback following stress exposure. Glucocorticoids 
regulate the transcription and translation of pro-opiomelanocorticotropic hormones thus lowering 
ACTH levels, as well as reducing CRH and arginine vasopressin expression within the pituitary and 
hypothalamus (Birnberg et al., 1983; Sawchenko, 1987; Makino et al., 1995; Aguilera and 
Rabadan-Diehl, 2000). The combined effects of decreased ACTH levels, CRH, and vasopressin 
expression contribute to a suppression of the HPA hormone response to stress.  
Two types of corticosteroid receptors have been identified in the rat brain; type I mineralocorticoid 
receptor (MR) with a higher binding affinity and type II glucocorticoid receptor (GR) with a ten-
fold lower binding affinity for endogenous corticosterone (Reul and de Kloet, 1985). Moreover, the 
distribution of these two receptors within the rodent brain differs with MR found predominantly in 
limbic areas, particularly the hippocampus, while GR are more widely distributed across all brain 
regions (Reul and de Kloet, 1985; Herman et al., 1989). Based on these differentiating properties, it 
is thought that corticosterone acts via MR to regulate circadian rhythmicity and maintain 
homeostasis, while GR become occupied concurrently with increasing plasma corticosterone 
following exposure to a stressor or circadian and ultradian peak and are therefore involved in 
regulation of negative feedback through repression of Crh and Avp gene expression (Reul et al., 
1987; Watts, 2005). This genomic effect of glucocorticoids is characterised by a lag-period ranging 
from at least 30 minutes to several hours or days from entry into the cell to the manifest action of its 
hormonal response.  
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Recently, corticosteroids have been shown to influence cognition, adaptive behaviour and 
neuroendocrine output within minutes, a time frame that is too rapid to be explained by genomic 
effects (Haller et al., 2008). These acute, non-genomic effects of glucocorticoids on the main 
feedback target sites tend predominantly toward the rapid suppression of HPA axis. For example, 
stress-induced corticosterone causes direct feedback on the hypothalamic PVN secretory neurons 
resulting in decreased excitability via reduced miniature excitatory postsynaptic currents in 
response to glutamate (Di et al., 2003). This effect was not able to be reversed with washout of 
corticosterone and was suggested to be mediated via a post-synaptic G-protein couple receptor 
mechanism triggering retrograde endocannabinoid signalling (discussed below). Conversely, the 
rapid effects of glucocorticoids in the hippocampus cause an increase in the probability of glutamate 
release onto CA1 pyramidal neurons resulting in an increase in the miniature excitatory 
postsynaptic currents mediated through transcription-independent actions at the MR (Karst et al., 
2005). Furthermore, this increased miniature excitatory postsynaptic current frequency in the 
hippocampus can be reversed following removal of available corticosterone. The increase in 
corticosterone-induced excitability in this region reflects the inhibitory nature of the hippocampus 
on activity of the HPA axis, an effect mediated via intermediary projections to GABAergic regions 
such as the bed nucleus of the stria terminalis 
As mentioned above, it has also being shown that corticosteroids rapidly reduce HPA axis activity 
in a non-genomic, membrane-associated manner via endocannabinoid signalling (Di et al., 2003; 
Evanson et al., 2010). The endocannabinoid system is a lipid signalling network throughout the 
brain and periphery composed of two G-protein coupled receptors. The cannabinoid receptor type 1 
(CB1R) is expressed ubiquitously throughout most regions of the brain with some expression in 
peripheral tissue whereas the cannabinoid receptor type 2 (CB2R) is expressed predominately in 
cells of the immune system such as microglia (Cabral and Griffin-Thomas, 2009). The two major 
endogenous ligands for both cannabinoid receptors, N-arachidonoylethanolamine (anadamide; 
AEA) and 2-arachidonoylglycerol (2-AG), are synthesised on demand in the postsynaptic 
membrane from phospholipid precursors. Furthermore, endocannabinoids are rapidly eliminated, 
with anandamide hydrolysis being catalysed by the enzyme fatty acid amide hydrolase (FAAH), 
while 2-AG is primarily catabolised by monoacylglycerol lipase. The endocannabinoids are 
released in a retrograde fashion to activate presynaptic cannabinoid receptors and act as inhibitory 
signalling messengers at glutamatergic and GABAergic synapses (Freund et al., 2003; Mackie, 
2008). They are capable of inhibiting voltage-gated calcium channels, and hence, neurotransmitter 
release including glutamate, GABA, acetylcholine, serotonin, and norepinephrine (Schlicker and 
Kathmann, 2001; Freund et al., 2003). Therefore, the aforementioned non-genomic feedback is 
achieved via rapid induction of glucocorticoid-induced endocannabinoid synthesis and release, 
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resulting in the suppression of excitatory glutamatergic neurotransmission to CRH neurosecretory 
cells thereby dampening the HPA response. To further clarify the profile of endocannabinoids 
following stress, an in vivo study demonstrated that 30 minutes of acute restraint stress in rats 
produced an elevation in 2-AG but not AEA content in the hypothalamus (Hill and McEwen, 2010). 
Interestingly, Hill and colleagues (2009) has also demonstrated a rapid loss of AEA levels in the 
basolateral amygdala may be involved in the natural activation of the HPA axis in response to 
stress. The mechanism behind this reduction is partly through a rapid 3-fold induction of FAAH 
activity. Nevertheless, the link between glucocorticoid and endocannabinoid signalling represents 
an important mechanism of rapid steroid hormone action in the brain and dysregulation of this 
system may be responsible for stress-related disorders (Hill et al., 2010; Hill and Tasker, 2012). 
Furthermore, due to the neuromodulating role, the endocannabinoid system could be involved in 
several other physiological functions such as memory processing, pain perception, and 
inflammation (Pacher et al., 2006). Recently, specific FAAH inhibitors have demonstrated 
anxiolytic, anti-depressant, and anti-inflammatory efficacies, implicating the endocannabinoid 
system as a potential therapeutic target (Ahn et al., 2009a).   
1.1.3 The physiological and pathophysiological effects of glucocorticoids 
Circulating corticosteroids regulate a board spectrum of physiological changes through at least 16 
different isoforms of ubiquitously distributed intracellular GR which belong to the nuclear receptor 
superfamily of transcription factors. During the inactive state, GR is part of a multiprotein complex 
that undergoes repeated cycles of dissociation and adenosine-5’-triphosphate (ATP)-dependent re-
association with regulatory proteins such as heat shock protein (HSP)-90 kDa, HSP-70, p59 
immunophilin, FK506-binding protein 4, and p23 phosphoprotein (Nicolaides et al., 2010). Upon 
ligand binding, GR dissociates from the complex and translocates into the nucleus and interacts 
with specific DNA motifs termed glucocorticoid response elements (GREs) in the promoter region 
of target genes as homo-or heterodimers, thus influencing the transcription rate in a positive or 
negative manner. However, GR has been shown to modulate gene expression independent of GRE-
binding through direct protein-protein interaction with other transcription factors including nuclear 
factor kappa-light-chain-enhancer of activated B cells (NF-κB) and activator protein 1 (Yang-Yen 
et al., 1990; Ray and Prefontaine, 1994). During times of stress, the biological effects of 
glucocorticoids are usually adaptive and include enhanced cognition, mobilisation of necessary 
energy substrates, immunosuppressive functions, and alteration of stress-related behaviours. These 
are beneficial as they permit the ‘fight-or-flight’ response and attempt to regain and maintain 
homeostasis.  
One of the foremost metabolic effects of glucocorticoids is their ability to increase circulating 
glucose through immediate stimulation of glycogenolysis, hepatic gluconeogenesis, and inhibition 
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of peripheral glucose transport and utilisation (Andrews and Walker, 1999; Marik and Raghavan, 
2004). Additionally, glucocorticoids decrease hepatic insulin sensitivity and enhance lipolysis in fat 
cells and proteolysis in various muscle types to mobilise lipids and amino acids to meet the 
increased energy demand following stress exposure (Simmons et al., 1984; Divertie et al., 1991; 
Ling et al., 1998). Glucocorticoids are also well known for their role in maintaining immune 
homeostasis following activation of the stress response. It is generally accepted that glucocorticoids 
are anti-inflammatory as they have been widely documented to (1) counteract the production of pro-
inflammatory cytokines; (2) stimulate the production of anti-inflammatory cytokines; and (3) 
directly suppress innate inflammatory mediators such as the pro-inflammatory transcription factor 
NF-κB via protein-protein interactions between activated GR and the p50/p65 subunits (De 
Bosscher et al., 2003; Silverman and Sternberg, 2012; Frank et al., 2013). Interestingly, suppression 
of pro-inflammatory cytokines by glucocorticoids exhibits a hierarchy of sensitivity with tumor 
necrosis factor-alpha (TNF-α) being the most sensitive, while IL-1 inhibition occurs only at 
supraphysiological levels, and IL-6 is relatively resistant when compared to other cytokines (DeRijk 
et al., 1997). However, it seems maladaptive to decrease central and peripheral immune activity 
during a ‘fight/flight’ emergency, as these are periods of increased risk for infection and injury, 
especially if one considers immunological challenge itself a stressor. To justify this paradox, several 
studies have demonstrated that there is a rapid immune activation prior to adrenocortical release of 
corticosteroids following exposure to endo- or exotoxins, infectious microorganisms or antigen, as 
well as non-infectious causes such as psychological stressors (Harbuz and Lightman, 1992; Stenzel-
Poore et al., 1993; Zhou et al., 1993). Therefore, Munck and colleagues (1984) proposed that the 
anti-inflammatory actions of glucocorticoids function to mediate recovery from this initial immune 
activation to prevent an organism suffering from hypersensitivity and autoimmunity. This is further 
supported by a study which demonstrates that following stressful events, there is enhanced free 
corticosterone due to a drop in CBG levels via an IL-6 dependent hepatic posttranscriptional 
blockade that suppresses further inflammatory responses (Pugeat et al., 1989). In terms of the initial 
increases in immune activity immediately following stress, it has being reported that it may be 
predominantly mediated by catecholamine release where α1- and β-adrenoceptor antagonists inhibit 
tail shock-induced increases in cytokine production in stress-related brain regions (Johnson et al., 
2005). However, it is important to note that basal corticosteroid levels are required for this immune 
activity as proper catecholamine signalling is modulated by glucocorticoids (Joels and de Kloet, 
1989). Interestingly, the rapid rise in prolactin has also being shown to mediate stress-induced 
immune deregulation and promote pro-inflammatory immune responses via NF-κB (Brand et al., 
2004a; Wu et al., 2014). Despite the aforementioned anti-inflammatory role of glucocorticoids, it is 
believed that it has the ability to enhance both the availability and activity of specific immune cells. 
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It has been shown that following a single episode of psychological stress, the resultant 
corticosterone decreases circulating leukocyte numbers and directs these cells to leave circulation 
and redistribute to other compartments of the body that might be in need (McEwen et al., 1997). It 
was proposed that this glucocorticoid-induced change in leukocytes is a passive process compared 
to the active recruitment of leukocytes by chemotactic factors following an active immune 
challenge. Based on this observation, McEwen and colleagues (1997) hypothesised that the stress-
induced relocation of immune cells by glucocorticoids may have significant contribution to the 
ability of the immune system to perform its surveillance function and ensure appropriate defence is 
present at the right place and the right time to potential or ongoing immune threats. In agreement 
with this view, there is increasing evidence that acute stress exposure promotes morphological 
transformation of microglia from a ramified-resting state to an ‘activated state’ (Walker et al., 
2013). Typically, ‘activated’ microglia retract and thicken the fine processes that extend from the 
soma and release a significant amount of pro-inflammatory molecules including TNF-α and, in 
some instances, become antigen presenting cells with many macrophage-like properties such as 
phagocytosis. Therefore, it has been proposed that during a ‘fight/flight’ emergency, in addition to 
the well-known anti-inflammatory actions, stress-induced corticosteroids function as a warning 
signal to the peripheral and central innate immune systems and perhaps primes the immune 
response for potential noxious insults (Sorrells et al., 2009; Frank et al., 2013). Following the 
emergency, levels of glucocorticoids dissipate, the peripheral and central (microglia) immune 
defences are now primed which enable a further potentiated inflammatory response to any 



























Figure 1.2. Priming of the neuroinflammatory response following peak glucocorticoid levels 
within the central nervous system.  
During the initial phase of a stress response, glucocorticoid levels rise and exert anti-inflammatory 
effects while simultaneously initiating a process which primes the pro-inflammatory response 
within the brain via microglial sensitization. Glucocorticoids return to baseline values following 
cessation of a stressor and the body enters a recuperative phase where a pro-inflammatory response 








While acute stress promotes adaptation and survival, prolonged impairments in HPA activity can 
have detrimental effects on metabolic, immune, and neural functions especially the limbic system. It 
is well known that the HPA axis plays an important role in the pathophysiology of stress-related 
psychiatric disorders such as anxiety and depressive disorders (de Kloet et al., 2005; McEwen, 
2008). Patients with psychiatric illnesses have being identified with symptoms such as (1) high 
concentrations of CRH in the central nervous system; (2) hyperactive CRH neurons; and (3) 
abnormal CRH receptor expression patterns (Kasckow et al., 2001; Claes, 2004). Moreover, 
positron emission tomography and functional magnetic resonance imaging studies in patients 
suffering from major recurrent depression demonstrated altered patterns and volume in stress-
related brain regions such as the hippocampus, amygdala and prefrontal cortex (Drevets et al., 1997; 
Sheline et al., 1999; Sheline et al., 2003). There is a plethora of animal models linking disturbed 
HPA response to depression. For example, Healy and colleagues (1999) reported that rodents 
administered with the corticosteroid synthesis inhibitor, metyrapone, exhibited anti-depressant-like 
behaviour. In an attempt to model human anxiety and depressive disorders in rodents, a wide range 
of behavioural testing has been developed. Elevated plus-maze is a well-established paradigm in 
assessing anxiety-like behaviours in laboratory animals. One of the earliest studies on depression in 
rodents began in 1967 with Overmier and Seligman’s work characterizing how prior exposure to an 
uncontrollable trauma termed ‘learned helplessness’ affects subsequent traumatic events (Overmier 
and Seligman, 1967). These initial observations were adapted by Porsolt (1977) utilising the same 
principles in rats using a forced swimming test until resigned despair was learned. Porsolt’s forced 
swimming model of behavioural despair was particularly powerful due to the sensitivity displayed 
by several antidepressant treatments (Porsolt et al., 1977; Porsolt et al., 1978). However this 
sensitivity was only displayed if animals were subjected to a pre-test (Borsini et al., 1989). 
Subsequently, a set of clearly defined active behaviours was characterised by Detke and colleagues 
(1995) which allowed discrimination between compounds specific or selective for particular 
neurotransmitters based on their distinct modulation of active behaviour patterns. Particularly, 
selective norepinephrine reuptake inhibitors specifically increased climbing behaviour, and 
selective serotonin uptake inhibitors specifically increased swimming behaviour while both 
decreased behavioural immobility (Detke et al., 1995; Detke and Lucki, 1996). The forced swim 
test was quickly adopted as a behavioural screen for predicting the efficacy of antidepressant 
compounds, and allowed investigation into the physiological and neurochemical changes associated 
with depression (Swiergiel et al., 2007; Dunn and Swiergiel, 2008). Recently, a series of molecules 
from the reduction/oxidation (redox) system have been implicated in various aspects of stress 




1.2 Oxidative and Antioxidative Systems 
1.2.1 Free radical production 
Normal cellular metabolism depends on oxygen to generate ATP, with a theoretical reduction of 
oxygen to water by the electron transport chain involving a coordinated four-electron transfer 
(Halliwell and Gutteridge, 1989). During this process, 1-3% of all electrons ‘leak’ from the electron 
transport chain to react with molecular oxygen, generating superoxide radicals instead of being 
reduced to water (Liu et al., 2002; Muller et al., 2004; Cash et al., 2007). Although this occurs at 
both complex I and complex III of the electron transfer chain, the majority occurs at complex I 
where it is facilitated by succinate (Liu et al., 2002). Most of the cellular superoxide is produced 
inside the inner mitochondrial membrane where the mitochondrial concentration of superoxide can 
be between 5-10 times that of the cytosol or nucleus (Cadenas and Davies, 2000). The remainder of 
mitochondrial superoxide is primarily formed by complex III on both sides of the mitochondrial 
membrane and by extra-mitochondrial flavoenzymes (Zimmerman and Granger, 1994; Cadenas and 
Sies, 1998; Brand et al., 2004b). Superoxide then undergoes spontaneous or enzymatic dismutation 
via superoxide dismutase (SOD) to generate hydrogen peroxide. Although hydrogen peroxide is 





 induce production of the highly toxic hydroxyl radical by Haber-Weiss and Fenton 
chemistry. This radical has been suggested to cause more damage to biological systems than any 
other reactive oxygen species (ROS) due to the extreme reactivity and very short in vivo half-life of 
≈9-10 milliseconds (Pastor et al., 2000).  
Outside the mitochondrion, there are three major processes responsible for the production of free 
radicals, principally in the form of reactive oxygen and nitrogen species. The first process involves 
the production of hydrogen peroxide as a by-product of fatty acid catabolism by peroxisomes 
(Ames et al., 1993; Wanders and Waterham, 2006). Although technically not a free radical, 
hydrogen peroxide is still classed as a ROS for its role in Fenton and Haber-Weiss chemistry 
(Cimen, 2008). Within the peroxisome, the majority of hydrogen peroxide is neutralised via 
canonical catalase activity or peroxidation to another catalase substrate (Wanders and Waterham, 
2006; Valko et al., 2007). However, under some conditions hydrogen peroxide can avoid 
degradation and escape the peroxisome, ultimately leading to cellular and nucleic acid damage 
(Kasai et al., 1989). The second process involves the reliance of the innate immune system on the 
ability of phagocytic cells such as neutrophils to engulf and digest foreign pathogens. Following the 
encapsulation of the foreign body into a phagosome, neutrophils increase their oxygen consumption 
specifically to supply the dormant nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase 
with molecular oxygen (Dahlgren and Karlsson, 1999). This enzyme catalyses the oxidation of 
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NADPH to form two superoxide radicals which, together with reactive metabolites of superoxide 
including hydrogen peroxide and hypochlorite, constitutes the respiratory burst responsible for 
killing the pathogen (Ames et al., 1993; Dahlgren and Karlsson, 1999; Stadtman et al., 2007; Valko 
et al., 2007). Hayashi and colleagues  (2008) have also demonstrated that NADPH-oxidase derived 
ROS can also be produced via a non-genomic mechanism following aldosterone administration in 









are essential for electron transfer in many enzymatic reactions, including the antioxidant enzymes of 
the oxidative cascade. However, these transitional metal ions can also undergo reactions resulting in 
the production of hydroxyl radicals (Rovira et al., 2007).  
Although there is a general negative connotation associated with ROS production, they have 
important cellular functions under normal physiological conditions. Even low levels of the 
extremely reactive hydroxyl radical have been shown to activate guanylate cyclase, stimulating the 
production of a cyclic guanosine monophosphate (cGMP) second messenger cascade (Mittal and 
Murad, 1977). In fact, the physiological roles of ROS vary significantly, ranging from specific 
oxidations of cysteine groups affecting enzyme activity and function, to cellular redox sensing in 
the determination of cell differentiation fate (Nicotera et al., 1985; Dalton et al., 1999; Wang et al., 
2011). Progression of the cell cycle itself has demonstrated dependence on radicals produced by 
NADPH-oxidase modulating mitogenic pathways (Burhans and Heintz, 2009). Several transcription 
factors are also regulated directly by ROS-induced modifications, thereby modulating the 
downstream expression of several gene families (Dalton et al., 1999). Notably, the dimerised 
protein products of immediate-early response genes FOS and JUN, AP-1, is activated by ROS 
through redox reactions and post-translational modification of the individual FOS and JUN proteins 
(Buscher et al., 1988; Abate et al., 1991; Devary et al., 1991). Under normal conditions, any 
excessive ROS not participating in these physiological functions are reduced by the antioxidant 
system. However, an imbalance between the production of ROS and the ability of the antioxidant 
defence system to readily detoxify the reactive intermediates, termed oxidative stress, leads to 
damage of biological macromolecules and dysregulation of normal metabolism (Sies, 1997; 
Nordberg and Arner, 2001).  
1.2.2 The endogenous antioxidant system  
In order to neutralise ROS, cells use a suite of enzymatic and non-enzymatic antioxidants, 
ultimately attempting to neutralise the radical by reduction to water. In the typical ROS reduction 
cascade, SOD is the top-tier antioxidant, catalyzing the dismutation of this radical to hydrogen 
peroxide. This is achieved through the transfer of electrons across the catalytic metal core of the 
enzymes to reduce the superoxide radicals. In mammals, the two major isoforms of SOD are the 
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copper, zinc-SOD which are found throughout most cell compartments, and the manganese-SOD 
that is specific for mitochondria. Catalase is centred around an iron-containing ferriheme group that 
acts as the transition metal during the reduction of hydrogen peroxide. Access to this active site is 
fairly specific as the channel opening is narrow and does not allow the passage of large molecules. 
High concentrations of superoxide anions are able to inactivate catalase by oxidizing the heme 
group in the active site. To prevent this, catalase binds NADPH to maintain this group in the 
reduced state (Nordberg and Arner, 2001; Fridovich et al., 2007). Hydrogen peroxide can also be 
reduced directly by both peroxiredoxins, which allow the oxidation of an active cysteine thiol group 
to degrade one molecule of hydrogen peroxide into two molecules of water, and the glutathione-
glutathione peroxidase system. Reduced glutathione (GSH) is the most abundant intracellular thiol-
based antioxidant which protects cells against oxidative stress by acting as a substrate for the 
selenium-containing glutathione peroxidase, subsequently forming oxidised glutathione disulphide 
(GSSG). In turn, GSSG is regenerated to GSH by glutathione reductase in a NADPH-dependent 
mechanism (Barycki et al., 2007). The cellular concentrations of this soluble tripeptide range from 1 
to 11 mM in the cytosol, 3 to 15 mM in the nucleus, and 5 to 11 mM in the mitochondria, although 
mitochondrial GSH requires membrane transport even against a concentration gradient (Shen et al., 
2005; Valko et al., 2007). Glutathione also acts as a substrate for the glutaredoxins, which reduce 
proteins that have been glutathionylated by reducing GSSG to a mixed disulphide protein and GSH. 
As the occurrence of mixed disulphides increases with increasing concentrations of GSSG, the ratio 
of the reduced to oxidised fractions (GSH/GSSG) of GSH within cells is often used as a reliable 
indicator of redox imbalance and has been shown to strongly influence cell cycle progression in 
proliferating cells (Menon et al., 2003; Öztürk and Gümüslü, 2004; Rose et al., 2012). The 
transcription factor nuclear factor-erythroid-2-related factor 2 (Nrf2) is essential for the coordinated 
induction of cytoprotective enzymes and related proteins in response to oxidative and electrophilic 
stresses (Itoh et al., 1999; Uruno and Motohashi, 2011). This transcription factor regulates a battery 
of redox genes such as the glutathione synthesis enzyme gamma-glutamylcysteine synthetase, 
glutathione peroxidase, glutathione disulphide reductase, glutathione S-transferase, thioredoxin-1, 
and heme oxygenase-1 through their antioxidant response element (Inamdar et al., 1996; Moinova 
and Mulcahy, 1999; Kim et al., 2003; Kwak et al., 2003; Gorrini et al., 2013). Under basal 
conditions, Nrf2 activity is sequestered in part by the actin-associated Keap1 protein within the 
cytoplasm. Activation of Nrf2 in response to oxidative and electrophilic agents is thought to be 
initiated by disruption of this Nrf2-Keap1 complex, releasing Nrf2, which translocates into the 




1.2.3 Adrenal glucocorticoids and oxidative stress 
One of the underlying initiators of oxidative stress is the increased rate of aerobic metabolism 
generated by exposure to physical and/or psychological stress. Mammalian erythrocytes are 
particularly susceptible to oxidative damage due to their high polyunsaturated fatty acid content 
within the membranes and high cellular concentrations of oxygen (Pandey and Rizvi, 2010). An 
accumulating number of rodent studies evidence the enhanced oxidative damage and altered 
antioxidant activity in erythrocytes following exposure to both acute and chronic stressors 
(Gumuslu et al., 2002; Öztürk and Gümüslü, 2004; Sahin et al., 2004). Given that erythrocytes are 
continuously exposed to ROS from extracellular sources, through anion channels and surrounding 
tissues, the accumulated oxidative damage within these cells can reflect the general oxidative status 
of many tissues and organs (Nwose et al., 2007). Although erythrocytes lack mitochondria, two 
mechanisms of intracellular ROS formation occur via haemoglobin auto-oxidation and plasma 
membrane deoxygenation (Kinoshita et al., 2007; Cimen, 2008). Additionally, erythrocytes exposed 
to an oxidative challenging environment initiate other ROS-generating mechanisms such as the 
Fenton reaction and peroxyl radical production that further exacerbate ROS formation (Minetti and 
Malorni, 2006). In our laboratory, we have examined the temporal relationship between stress and 
the onset of oxidative challenge (Spiers et al., 2013). Particularly, while known physiological stress 
markers like blood glucose and plasma corticosterone rapidly return to baseline values, changes in 
redox state suggest a slightly delayed onset after which persistent increases remain following the 
















































Figure 1.3. Temporal relationship between stress and the onset of oxidative challenge. 
Serial blood samples collected at 0 (baseline), 30, 60, 120, and 240 minutes from male Wistar rats 
with indwelling jugular catheters. Rats were randomly divided into Control (●) or 120 minute Stress 
(■) groups (n=6-9/group). Serial samples were used to determine (A) blood glucose levels; (B) 
plasma corticosterone concentrations; (C) general oxidative status measured by dichlorofluorescein 
(DCF) formation in erythrocytes; and (D) glutathione to glutathione disulfide ratio (GSH/GSSG) 
stress in erythrocytes of control or stressed rats. The black filled bar indicates time of exposure to 
acute restraint stress. Data are expressed as mean ± standard error of the mean (SEM) where 








Neuronal redox status has recently undergone intense scrutiny due to the association of oxidative 
stress with the pathology of neurodegenerative diseases (Bond and Greenfield, 2007; Cotella et al., 
2012). It has been shown that both chronic oxidative stress and glucocorticoid exposure promote 
gliogenesis over neurogenesis in hippocampal neural stem cell progenitors and may be the direct 
result of accumulated mitochondrial oxidative stress (Wang et al., 2011; Chetty et al., 2014). Glial 
cells play an important but poorly understood role in the modulation of neuronal redox state. It has 
recently been shown that astrocyte-derived L-lactate potentiates N-methyl-D-aspartate (NMDA) 
receptor activity by modulating neuronal redox status (Yang et al., 2014). This neuron-glia 
interaction can also increase noradrenaline release from the locus coeruleus and hypothalamic ATP 
production (Cortes-Campos et al., 2011; Tang et al., 2014). Furthermore, Reyes and colleagues 
(2012) have demonstrated that neuronal NADPH oxidase-derived superoxide can traverse the 
extracellular space to modulate the redox state in neighbouring neurons and astrocytes. However, in 
comparison to astrocytes, neurons are known to have relatively poor expression of endogenous 
antioxidants, making them highly susceptible to oxidative stress.  
Glucocorticoids induce neuronal oxidative stress directly through enhanced mitochondrial 
respiration and oxidative phosphorylation. This was demonstrated clearly in a study by Du and 
colleagues (2009), showing that acute incubation of cortical neurons with corticosterone increased 
mitochondrial oxidation, membrane potential, and calcium-holding capacity in a dose and time-
dependent manner. This was further clarified by You and colleagues (2009) using the oxidation 
product dichlorofluorescien as a ROS indicator in organotypic hippocampal slice cultures exposed 
to the synthetic glucocorticoid, dexamethasone, and the glucocorticoid receptor antagonist, RU486. 
The single and combination use of these compounds demonstrated that hippocampal neuronal 
death, marked by propidium iodide, was selectively induced by glucocorticoid exposure, while 
other steroid hormones had no effect. Acute incubation with dexamethasone increased the 
hippocampal oxidative status by approximately 200% in a dose dependent manner, an effect that 
was ameliorated with pre-treatment of RU486 or the ROS-scavenger, N-acetyl-L-cysteine. 
Furthermore, four hours of dexamethasone incubation, induced the highest increase in oxidative 
status, with concurrent gene expression up-regulation of the ROS-producing enzyme NADPH-
oxidase, while the antioxidant enzyme glutathione peroxidase was significantly down-regulated 
(You et al., 2009). This indicates that the increase in oxidative status is produced by a 
glucocorticoid-dependent and transcriptional increase in pro-oxidative drive, with concurrent 
inhibition of the antioxidant defence system, ultimately leading to increased neuronal cell death. 
Cortical and hippocampal neural cultures have also established that 24 hours of glucocorticoid 
exposure increases basal ROS production and exacerbates the concomitant ROS produced by 
adriamycin redox cycling, which negatively affects survival in hippocampal neurons (McIntosh and 
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Sapolsky, 1996). This is supported by in vivo evidence that administration of exogenous 
corticosterone over a 14 day period increases hippocampal oxidative indicators including lipid 
peroxidation and protein carbonyls, while the enzymatic antioxidants SOD, catalase, and 
glutathione peroxidase activities are all decreased (Sato et al., 2010). This study, performed by Sato 
and colleagues (2010), also demonstrated increased apoptosis and decreased glucocorticoid receptor 
expression, a hallmark of chronically high glucocorticoids, in the hippocampus. Furthermore, this 
study also utilised a serum measurement of iron-induced superoxide formation in blood serum, 
establishing that this peripheral marker increased with chronic corticosterone administration. 
Further in vivo studies have shown that both corticosterone administration and restraint stress for 21 
days induce an overall decrease in GSH in addition to SOD, catalase, glutathione transferase, and 
glutathione reductase activities in whole brain, liver, and heart tissues (Zafir and Banu, 2009). This 
study, by Zafir and Banu (2009), also demonstrated that these treatments increased lipid 
peroxidation and oxidised protein carbonyl groups in the same tissues. However, the overall 
increase in neural tissue is driven by specific increases in particular subregions that are susceptible 
to stress-induced oxidative stress. However, this overall increase in oxidative stress is not 
generalised in all areas of the brain but is likely due to increases in specific subregions. For 
example, Mendez-Cuesta and colleagues (2011) used an acute immobilisation stress to induce 
increased lipid peroxidation and decreased SOD activity in a highly oxidative-vulnerable region, the 
striatum. Interestingly, they found that the decrease in SOD activity was exclusively due to the 
mitochondrial isoform, manganese-SOD, while the copper, zinc-SOD showed little change. 
Furthermore, Lucca and colleagues (2009) used a chronic mild stress regime to show that SOD 
decreased and oxidised protein carbonyl groups increased in several cerebral regions including the 
striatum and hippocampus, while the cerebellum remained largely unaffected. We have also 
observed the induction of regional specific oxidative stress in the hippocampus but not the 
amygdala following an acute restraint stress, demonstrating that this process is not exclusive to 
chronic stress exposure (Spiers et al., 2013). Some of the aforementioned aspects of the redox 
system have been summarised in Figure 1.4.  
With the majority of studies focusing on the canonical stress-induced modulation of the redox 
system, several groups have also demonstrated regulatory role of ROS on the limbic stress axis. 
Asaba and colleagues (2004) demonstrated that ROS attenuate the glucocorticoid-induced down-
regulation of pro-opiomelanocortin in pituitary corticotrophs, thereby promoting an increase in 
HPA axis activity via dampened negative feedback. The expression and nuclear internalisation of 
GR have also demonstrated susceptibility to highly pro-oxidative environments (Zhou et al., 2011). 
Using a cultured fluorescently labelled chimeric GR, Okamoto and colleagues (1999) demonstrated 
that nuclear translocation of GR following acute dexamethasone treatment is impaired in the 
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presence of hydrogen peroxide. This effect was reduced in the presence of exogenous antioxidants 
or following substitution of serine for a redox-sensitive cysteine residue. The dissociation of heat 
shock proteins from the cytosolic GR was also impaired in a pro-oxidative environment, indicating 
that there may be multiple redox regulatory roles involved in the cellular response to 
glucocorticoids (Okamoto et al., 1999; Tanaka et al., 1999). These observations highlight that 

























Figure 1.4. The oxidation/reduction system. 
Stress causes an increase in corticosterone which activates cytosolic glucocorticoid receptors (GR). 
These translocate into the nucleus to modulate gene transcription through glucocorticoid responsive 
elements (GRE), or co-localise with the anti-apoptotic Bcl2 protein and translocate into the 
mitochondria. This increases mitochondrial membrane potential, calcium holding capacity, and 
mitochondrial oxidation. The increase in cellular metabolic rate promotes ATP synthesis in addition to 
spontaneous superoxide (O2
-) production via complex I and III of the electron transport chain. This is 
dismutated to hydrogen peroxide (H2O2) by manganese superoxide dismutase (Mn-SOD) and can be 
further converted to hydroxyl radical (OH-) or reduced to water by the mitochondrial antioxidant 
pathway. In the cytosol, a major source of superoxide production is via the oxidation of NADPH via 
NADPH oxidase. Cytosolic superoxide is dismutated to hydrogen peroxide by copper, zinc-superoxide 
dismutase (Cu, Zn-SOD). Hydrogen peroxide is neutralised by catalase (CAT) or glutathione peroxidase 
(GPx) which oxidises the reduced form of glutathione (GSH) to oxidised glutathione (GSSG). GSH is 
then regenerated from GSSG via the glutathione reductase (GSR) enzymatic system. Hydrogen peroxide 
can also interact with superoxide radicals and/or transition metals such as Fe2+ or Cu2+ to produce the 
highly toxic hydroxyl radical by Haber-Weiss and Fenton chemistry. An increase in the production of 
superoxide, hydrogen peroxide, and hydroxyl radicals leads to a state of cellular oxidative stress which 
causes oxidative damage to DNA, protein carbonyl formation, and membrane lipid peroxidation (LPO). 
Hydrogen peroxide is membrane permeable and moves freely from mitochondrial to cytosolic 
compartments, in addition to traversing the extracellular space to affect neighbouring neurons and glial 
cells. Superoxide radicals can also induce oxidative stress in neighbouring cells by diffusing through 
membrane-bound anion channels. The majority of neuronal and astrocytic reactive oxygen species are 
produced by mitochondrial oxidation, while other cell types such as microglia rely heavily on the 
cytosolic NADPH-oxidase system to produce a respiratory burst in response to invading pathogens. 
However, in comparison to glial cells, neurons display a relatively poor expression of endogenous 




1.3 The Nitrergic System  
1.3.1 Nitric oxide biosynthesis and functions  
Nitric oxide, a gaseous diatomic free radical belonging to the family of reactive nitrogen species 
(RNS), is synthesised through the conversion of amino acid ʟ-arginine to ʟ-citrulline by nitric oxide 
synthase (NOS) in the presence of oxygen, NADPH, and cofactors including flavin adenine 
dinucleotide, flavin mononucleotide, and (6R-)5, 6, 7, 8-tetrahydro-ʟ-biopterin (Andrew and Mayer, 
1999).  There are three main isoforms, each with a specific distribution profile; neuronal NOS 
(nNOS, type I), inducible NOS (iNOS, type II), and endothelial NOS (eNOS, type III) (Stuehr, 
1999). Though nNOS is predominantly active in the cytosol of central and peripheral neurons for 
signalling and regulation, it has also been found in the sarcolemma and cytoplasm of all muscle 
fibres (Frandsen et al., 1996). Interestingly, nNOS is present in the hippocampus, hypothalamus, 
pituitary, and adrenal gland, suggesting co-localisation with the HPA axis (Lai et al., 2005; Gadek-
Michalska et al., 2012). Furthermore, several studies have demonstrated transcriptional regulation 
of nNOS by glucocorticoids in the hippocampus, implicating its importance in the stress response, 
although the upstream promoter of NOS1 does not carry a glucocorticoid responsive element 
(López-Figueroa et al., 1998; Reagan et al., 1999; Zhou et al., 2011). There are four nNOS splice 
variants, α, β, γ, and µ, with nNOSα being the most dominant and therefore being physically and 
functionally coupled to the glutamate receptors of the NMDA subtype through their mutual 
postsynaptic density-95/discs-large/zona occludens-1 (PDZ) binding motif (Eliasson et al., 1997). 
Within the hippocampus, local calcium influx through NMDA receptors can trigger the production 
of NO, which subsequently activates its receptor, soluble guanylyl cyclase, leading to release of 
second messenger cGMP (Fig. 1.5). This NO-cGMP signalling has been implicated in the induction 
of hippocampal long-term potentiation which is known to be one of the principal mechanisms in 
learning and memory (Schuman and Madison, 1991; Arancio et al., 1996; Kelley et al., 2010). The 
nNOSµ mainly localises in the skeletal muscles interacting with the dystrophin-associated 
glycoprotein complex and muscles deficient in this isoform become myopathic (Percival et al., 
2008). The β-variant lacks the PDZ domain while nNOSγ has very little to no enzymatic activity 
(Eliasson et al., 1997). Endothelial NOS contains a putative shear stress responsive element in the 
promoter region of the NOS3 gene while the protein is membrane-bound to the golgi apparatus and 
caveolae, producing NO mainly in the endothelium of blood vessels responsible for vasodilation 
and smooth muscle relaxation (Smith et al., 2006). The inducible form of NOS was first identified 
in mouse macrophages, it is almost undetectable in resting cells but is induced at the transcriptional 
level by immunostimulatory cytokines, viral infection, or bacterial products such as 
lipopolysaccharides (Zamora et al., 2000; Aktan, 2004). Furthermore, lipopolysaccharides or 
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inflammatory cytokine-induced iNOS are thought to contribute to inflammation by increasing 
vascular permeability and leukocyte infiltration to inflamed tissues (Nagy et al., 2007). Within the 
central nervous system, iNOS expression is observed in astrocytes, microglia, endothelial cells, 
immature neurons, and invading macrophages where the iNOS-mediated release of NO by 
astrocytes and microglia has a major role in antimicrobial and tumoricidal activity (Heneka and 
Feinstein, 2001; Hua et al., 2002; Aktan, 2004; Brantley et al., 2010). Moreover, upon 
transcriptional activation, this soluble subtype can produce micromolar levels of NO and is known 
to be associated with diseases such as atherosclerosis, rheumatoid arthritis, diabetes, septic shock, 
and multiple sclerosis (Kuhlencordt et al., 2001; Hill et al., 2004; Maki-Petaja et al., 2008; 
Heemskerk et al., 2009; Soskic et al., 2011). Interestingly, despite most of its deleterious role, iNOS 
has recently being demonstrated to acts as an important signalling intermediate in plasma cell 
survival pathways (Saini et al., 2014). Both nNOS and eNOS are constitutively active isoforms 
producing low concentrations of NO (in the nanomolar range) over long periods and are activated 
by calcium ions though transient binding to the calcium-binding protein, calmodulin (Knott and 
Bossy-Wetzel, 2009). Comparatively, the inducible form of NOS can produce high concentrations 
of NO in relatively short periods and is calcium independent due to a high binding affinity to 
calmodulin (Aktan, 2004). A fourth NOS isoform, mitochondrial NOS (mtNOS) has been proposed, 
localising at the inner mitochondrial membrane controlling mitochondrial energetics (Ghafourifar et 
al., 2001; Ghafourifar and Cadenas, 2005). However, the existence of mtNOS as a unique enzyme is 
still a matter of debate (Tay et al., 2004; Venkatakrishnan et al., 2009).  
1.3.2 Nitric oxide metabolism and clearance 
In the vasculature, erythrocytes are the major scavenger of nitric oxide due to the high haemoglobin 
concentration and thus, nitric oxide is sequestered via the dioxygenation reaction in which nitric 
oxide reacts with oxygenated haemoglobin to form methaemoglobin and the more stable metabolite 
nitrite (Han et al., 2003). Excessive production of nitric oxide can also be counteracted by 
conjugation with reduced glutathione, forming the stable adduct S-nitrosoglutathione which can in 
turn be cleaved directly by mammalian thioredoxin (Nikitovic and Holmgren, 1996). The inorganic 
ions, nitrate and nitrite (NOx), were previously thought to be the end products of NO metabolism. 
However, recent studies have demonstrated a NOS-independent pathway in which NO can be 
produced by reducing NOx, a reaction catalysed by xanthine reductase under low oxygen tension 
and low pH environment. The NO produced by this nitrate-nitrite-NO pathway may have similar 
roles to NO generated from the ʟ-arginine-NOS pathway representing an important secondary pool 




1.3.3 Reactive nitrogen species and nitrosative stress 
High levels of NO and its derivatives are destructive to cellular components such as proteins, lipids 
and DNA. Nitric oxide can react directly with molecular oxygen to produce two relatively strong 
oxidants, nitrogen dioxide and dinitrogen trioxide. However, at physiological levels of NO these 
reactions are relatively slow. A primary reaction in the production of RNS is the combination of NO 
and superoxide anions to form the highly reactive metabolite, peroxynitrite, a potent neurotoxin 
(Lipton et al., 1993). It has been suggested that NO and peroxynitrite can disrupt ATP synthase and 
almost all components of the mitochondrial respiratory chain (Almeida and Bolanos, 2001; Sarti et 
al., 2012). These RNS reversibly or irreversibly inhibit mitochondrial oxygen consumption, 
particularly at complex IV (also known as cytochrome c oxidase), and may lead to cellular energy 
deficiency and ultimately cell death in pathological conditions (Sarti et al., 2012). Inhibition of 
cytochrome c oxidase by NO and peroxynitrite causes neuronal dysfunction and, in addition to high 
iNOS expression, has been observed in the cortex of Alzheimer’s patients (Mutisya et al., 1994; 
Haas et al., 2002).  
S-nitrosylation is the covalent attachment of NO to the thiol side chain of the amino acid cysteine, 
forming other NO derivatives termed S-nitroso-proteins. Under physiological conditions, it has been 
demonstrated that NO is converted to the nitrosonium ion which subsequently S-nitrosylates the 
NMDA receptor, thereby preventing glutamate excitotoxicity by blocking calcium influx, 
promoting cell survival (Lipton and Stamler, 1994). Excessive production of NO can be 
counteracted by conjugation with reduced glutathione, forming the stable adduct S-
nitrosoglutathione which has important role in signal transduction and regulation of a variety of 
protein functions (Klatt and Lamas, 2000; Anand and Stamler, 2012). Abnormal S-nitrosylation to 
proteins such as apolipoprotein E, cyclin-dependent kinase 5, dynamin-related protein 1, parkin, 
peroxiredoxin 2, protein disulfide isomerase, heat-shock protein 90, and X-linked inhibitor of 
apoptosis have all being linked to neurodegenerative conditions such as Alzheimer’s and 
Parkinson’s diseases (Anand and Stamler, 2012). Lastly, peroxynitrite provokes protein 
nitrotyrosination, an irreversible chemical addition of a nitro group to the tyrosine residue in target 
proteins generating 3-nitrotyrosine. This posttranslational modification usually impairs the normal 
physiological function of the proteins and therefore nitrotyrosination has been used as a marker in 
several neurodegenerative conditions such as amyotrophic lateral sclerosis (Peluffo et al., 2004). 




Figure 1.5. A schematic representation of the nitrergic system and its downstream effects in 
hippocampal neurons following stress exposure.  
In hippocampal neurons, the majority of nitric oxide (NO) production occurs via the conversion of 
ʟ-arginine to ʟ-citrulline by the neuronal isoform of nitric oxide synthase (nNOS) ①. High 
concentrations of NO can then covalently bond with protein thiol groups (protein-SH) to form S-
nitroso-proteins (protein-SNO) ②
 
or interact with the reduced form of glutathione (GSH) forming 
S-nitrosoglutathione (GSNO) ③. This can be regenerated back to GSH via an initial conversion to 
oxidised glutathione (GSSG) by S-nitrosoglutathione reductase (GSNOR), and subsequent 
reduction of GSSG by glutathione reductase (GSR) ④. Interaction of NO with the superoxide 
radical (O2
-
) results in the formation of the neurotoxic radical, peroxynitrite (ONOO
-
) which 
irreversibly reacts with protein tyrosine (Tyr) residues to form 3-nitrotyrosine (3-NT) ⑤. Increased 
NO and ONOO
-
 are capable of causing cellular energy deficiency by inhibition of all components 
of the electron transport chain (Complex I - IV), including ATP synthase, resulting in decreased 
ATP production ⑥. Both post-synaptically produced NO, and NO produced by the inducible 
isoform of nitric oxide synthase (iNOS), can act as a neurotransmitter on pre-synaptic neurons ⑦. 
This pre-synaptic NO causes glutamate release, which activates post-synaptic NMDA receptors 
(NMDAR) to increase calcium (Ca
2+
) concentration and, in the presence of calmodulin, further 
potentiate nNOS-derived NO ⑧. Stress exposure increases NO by activating inflammatory 
cytokines to potentiate glial/astrocyte iNOS activity ⑨, and by increasing circulating corticosterone 
(CORT) which induces nNOS activity via a mineralocorticoid receptor (MR)-mediated pathway ⑩. 
This increase in NO results in downregulation of hippocampal glucocorticoid receptor (GR) thereby 






1.3.4 Stress-evoked modulation of the nitrergic system 
It has been generally accepted that psychophysiological stress is associated with upregulation of 
NOS mRNA expression and enzymatic activity. For example, a single six hour acute 
immobilisation stress induces upregulation of iNOS expression and activity in the cerebral cortex 
which is mediated by the NMDA receptor and subsequent activation of the transcriptional factor, 
nuclear factor kappa-light-chain-enhancer of activated B cells (NF-кB)  (Madrigal et al., 2001). The 
acute stress-induced activation of the NMDA receptor also increases TNF-α via upregulation of 
TNFα-convertase. Antagonism of TNFα-convertase prevents the stress-induced translocation of 
NF-кB and subsequent iNOS expression, thus confirming the involvement of TNF-α (Madrigal et 
al., 2002). This is also supported by Shirakawa and colleagues (2004) who demonstrated 
glutamatergic activation and not catecholaminergic drive of the hypothalamic paraventricular 
nucleus to be responsible for the acute stress-induced increase in NO metabolites. Interestingly, 
biting activity is capable of suppressing the stress-induced increase in hypothalamic nNOS mRNA 
expression in rats (Hori et al., 2005). A single two hour acute restraint stress significantly increases 
the density of neurons expressing nNOS visualised by nicotinamide adenine dinucleotide 
phosphate-diaphorase histochemistry in the amygdaloid nucleus, an effect delayed by 5 days in the 
hippocampus and entorhinal cortex (Echeverry et al., 2004). Predator-induced posttraumatic stress 
significantly increases nNOS positive neurons and total NOx in the medial prefrontal cortex seven 
days after the 10 minute predator stress treatment (Campos et al., 2013). Conversely, Chakaborti 
and colleagues (2014) demonstrated that acute restraint stress causes a reduction in total NOx and 
an increase in the major endogenous NOS inhibitor, asymmetric dimethylarginine, in whole brain 
homogenates. This suggests that the stress-induced NOx increases in regions such as the 
hippocampus and hypothalamus may hold a high degree of functional significance. These 
biochemical changes in NOx and asymmetric dimethylarginine were observed alongside anxiety-
like behaviour and were more pronounced in male compared to female rats. The pharmacological 
blockade of oestrogen biosynthesis exacerbated these biochemical and behavioural changes in 
females, suggesting that the observed sex differences are due to a protective role of oestrogen. 
Interestingly, bilateral injection of an NMDA receptor antagonist, NOS inhibitor, or NO scavenger 
into the dorsal hippocampus attenuated autonomic responses such as hypertension and tachycardia 
following a 60 minute acute restraint stress, suggesting that NMDA/NOS activation within the 
hippocampus plays a role in autonomic modulation during stress (Moraes-Neto et al., 2014). 
Another study from the same group proposed a glutamatergic NMDA receptor-NO-cGMP 
signalling pathway in modulating contextual fear conditioning within the dorsal hippocampus, 
where intra-hippocampal injection of NMDA receptor antagonist DL-AP7, NO scavenger 2-(4-
carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (CPTIO), and cGMP inhibitor 1H-
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[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one, attenuated the fear-conditioned response (Fabri et al., 
2014). 
Chronic immobilisation stress has been shown to increase NOx, iNOS activity, and peroxynitrite-
induced 3-nitrotyrosine accumulation in cortical neurons (Olivenza et al., 2000). Notably, de Pablos 
and colleagues (2014) recently found a degree of regional specificity associated with this chronic 
stress-induced iNOS expression, with little to no constitutive expression in the substantia nigra 
following 9 days of unpredictable stress exposure. However, this same unpredictable stress model 
potentiates iNOS expression following exposure to exogenous immunostimulatory stressors such as 
lipopolysaccharides. Recent studies in several animal paradigms have demonstrated that inhibitors 
of NOS significantly modulate stress-related behaviours. In support of these findings, the 
commercially available antidepressant paroxetine, a selective serotonin reuptake inhibitor, also 
possesses NOS inhibition capability (Finkel et al., 1996). Wegener and Volke (2010) have reviewed 
and summarised these studies including data on each of the NOS inhibitor’s specificity and potency, 
and their anxiolytic- and antidepressant-like properties. Chronic unpredictable mild stress increases 
plasma nitrite levels and iNOS mRNA expression in the cortex, in addition to damaging cortical 
neurons and inducing depressive-like behaviour (Wang et al., 2008; Peng et al., 2012). These 
effects can be attenuated or prevented using NOS inhibitors, which was demonstrated by intra-
hippocampal injection of the selective iNOS inhibitor, aminoguanidine, resulting in suppression of 
the chronic unpredictable mild stress-induced depressive-like behaviour in rats (Wang et al., 2008). 
Regional infusion of a selective nNOS inhibitor 7-nitroindazole (7-NI) into the hippocampus 
showed antidepressant-like effects similar to those with the iNOS inhibitor, aminoguanidine (Joca 
and Guimaraes, 2006). Likewise, the anxiogenic-like behaviours observed in rats during ethanol 
withdrawal is inhibited by administration of the selective iNOS inhibitor, 1400W, into the 
dorsolateral periaqueductal gray (Bonassoli et al., 2013). The data with intra-cerebral NOS 
inhibition is further supported by studies using systemic treatment. Intraperitoneal injection of 
1400W increases survival of cortical neurons and decreases the depressive-like behaviour in mice 
(Peng et al., 2012). The nNOS inhibitor 1-(-2-trifluoromethylphenyl)-imidazole (TRIM) given 
systemically 30 minutes prior to testing induces anxiolytic-like behaviours shown by increased time 
spent in the light compartment of a light-dark compartment test (Volke et al., 2003). Furthermore, 
TRIM administration decreased the immobility time in the forced swimming test, demonstrating an 
antidepressant-like effect comparable to the tricyclic antidepressant imipramine. In agreement with 
these observations, Ulak and colleagues (2008) injected TRIM intraperitoneally 50 minutes before a 
forced swim test and showed the involvement of the serotonergic system in the antidepressant-like 
actions of TRIM. This was further clarified in a later study in which the serotonin type II receptors 
were found to be responsible for this effect (Ulak et al., 2010). Furthermore, Joung and colleagues 
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(2012) demonstrated that following a two hour immobilisation stress, the selective inhibitor 7-NI 
produced its anxiolytic-like effects shown by an increase in the time spent on the open arms of the 
elevated plus-maze through the direct reduction of NO metabolites in the PVN and locus coeruleus. 
A less specific NOS inhibitor, ʟ-NG-Nitroarginine methyl ester (ʟ-NAME), injected systemically 30 
minutes prior to testing shows protective effects against chronic swim stress-induced impairment of 
passive avoidance learning and hyperalgesia in rats (Nazeri et al., 2014). In a similar vein, Ferreira 
and colleagues (2012) performed behavioural, genomic, and proteomic analyses in rats and 
suggested that the antidepressant-like effects of NOS inhibition may involve the expression of 
additional factors including members of the glutathione redox system. 
Genetic animal models have also contributed to the current understanding of nitrergic changes in 
stress. Thus, inhibition of NO production by nNOS gene deletion in mice suppressed hippocampal 
neurogenesis and exhibited antidepressant-like properties while nNOS over-expression in the 
hippocampus was essential for chronic stress-induced depression (Zhou et al., 2007). Recently, a 
number of studies have proposed a regulatory role of NO on the limbic HPA stress axis. Zhang and 
colleagues (2010) used mice lacking the nNOS gene to demonstrate an anxiolytic-like phenotype 
when tested using an elevated plus-maze, similar to normal mice treated with intra-hippocampal 
microinjection of the selective nNOS inhibitor 7-NI. The authors proposed a signalling pathway 
involving the activation of serotonin type IA receptors which mediate, via an unknown mechanism, 
the downregulation of hippocampal nNOS, leading to a decrease in NO and subsequent inhibition 
of cAMP response element-binding (CREB) protein phosphorylation. A follow up study elucidated 
further the link between NO and the HPA axis by showing that chronic mild stress and 
glucocorticoid exposure lead to hippocampal nNOS overexpression via activating hippocampal 
mineralocorticoid receptor (MR) (Zhou et al., 2011). The excessive nNOS-derived NO significantly 
downregulated local glucocorticoid receptor (GR) expression through either the soluble guanylyl 
cyclase/cGMP or peroxynitrite/extracellular signal-regulated kinase (ERK) signalling pathways. 
The significant downregulation of GR in the hippocampus leads to an elevation in hypothalamic 
corticotropin-releasing hormone and the depressive-like behaviours in mice as illustrated in Figure 
1.5. It is important to note that nNOS deletion, infusion of intrahippocampal nNOS inhibitor, and 
NO-cGMP signalling blockade prevented the chronic mild stress-evoked behavioural modification. 
Conversely, Gao and colleagues (2014) have demonstrated a significant decrease in constitutive 
NOS activity and neuronal NOS immunoreactivity in the hypothalamic paraventricular nucleus of 
rats exposed to chronic unpredictable stress. However, the chronic glucocorticoid-induced MR-
nNOS-NO pathway may not be present in the hypothalamus and is exclusive to the MR-rich 




The considerable body of evidence from animal models is progressively expanding and supported 
by modest but significant clinical studies. Several reports have shown that increased levels of NO 
metabolites are present in depressed and autistic patients (Suzuki et al., 2001; Sogut et al., 2003; 
Lee et al., 2006). Patients with recurrent depressive behaviour displayed higher plasma NOx 
concentrations which were associated with cognitive impairment (Talarowska et al., 2012). Galecki 
and colleagues (2010, 2011) discovered single nucleotide polymorphisms in exon 22 of the NOS2A 
gene (iNOS) and exon 29 of the NOSI gene (nNOS) in depressed Caucasian individuals. 
Furthermore, three single nucleotide polymorphisms located at the regulatory region of NOSI gene 
are responsible for the susceptibility of an individual to depressive disorders (Sarginson et al., 
2014). The intrinsic cross talk between neuroendocrine stress and the nitrergic system activation is 
now an important physiological consideration. Further understanding the role of this system is 


























1.4 Thesis Rationale  
A growing body of evidence suggests that the aetiology of anxiety and depressive-related 
conditions can be derived from the sensitization of particular stress circuits that are ‘primed’ 
following exposure to a short-term stressor. The duration for stress-related circuitry priming far 
exceeds responses to adrenergic and glucocorticoid-mediated signalling. Understanding the 
mechanisms underlying the induction of this long latency will provide a significant link between 
stress and the pathogenesis of anxiety and depressive disorders. The nitrergic system has been 
implicated in the regulation of the neuroendocrine stress response with chronic mild stress 
increasing hippocampal nNOS expression via a MR-dependent mechanism causing chronic 
production of NO, ultimately leading to down-regulation of GR. This augmentation in hippocampal 
GR is associated with abnormal negative feedback of glucocorticoids upon the HPA axis and has 
been linked to the pathogenesis of depression. However, this represents changes occurring in 
chronic stress conditions, while the acute physiology of altered nitrergic status in both peripheral 
and central tissues is poorly understood. Therefore, the present thesis used an acute stress model to 
establish the time course and extent of nitrosative changes in peripheral blood and stress-related 
neural regions such as the hippocampus. Another signalling pathway with an important role in 
mediating the stress response is the endogenous cannabinoid (endocannabinoid) system. 
Interestingly, it has been suggested that inhibition of endocannabinoid degradation with an enzyme 
inhibitor suppresses the inflammatory-related nitrergic activation following traumatic brain injury in 
mice. However, little is known on the effects of endocannabinoid degradation on the nitrergic 
system following short term stress. Therefore, the involvement of endocannabinoid-mediated 














1.5 Overall Aim  
This thesis aims to establish the temporal profile and functional output of nitrergic indicators 
responsive to an acute psychological stress in peripheral and central tissues. In addition, this thesis 
examined the relationship between endocannabinoid signalling and the nitrergic-related 
inflammatory response in the hippocampus following short term stress.  
 
To achieve these overall aims, three separate but closely related studies were undertaken:  
1. To establish the temporal profile of nitrosative changes in peripheral plasma and 
erythrocytes following short term stress. (Chapter III) 
 
2. To establish the physiological and functional output of nitrergic indicators in brain regions 
displaying differential stress sensitivity following short term stress. (Chapter IV) 
 
3. To determine if an increase in endocannabinoid signalling will prevent the acute stress-




























































2.0 General Methods 
The following describes in length the general methods used in the generation of the present thesis as 
this is often truncated in manuscript preparation. 
2.1 Ethics Clearance  
Experiments carried out in Chapter III received ethical clearance from The University of 
Queensland Animal Ethics Committee under approval number SBS/363/11/URG. Experiments 
carried out in Chapter IV and V were performed under approval number SBMS/018/11/URG and 
SBS/456/14/URG respectively. All experiments strictly adhered to the Animal Care and Protection 
Act Qld (2002), Australian Code of Practice for the Care and Use of Animals for Scientific 
Purposes (7th edition 2004), and the University Animal Ethics Committee policies and standard 
operating procedures. 
2.2 Animal Housing  
Outbred male Wistar rats (Rattus norvegicus) aged 5-7 weeks postnatal were sourced from The 
University of Queensland Biological Resources breeding colony. Rats were housed in standard 
animal cages within a colony room with temperature controlled between 21-23
o
C and humidity kept 
between 50-60% in the Australian Institute of Bioengineering and Nanotechnology (AIBN) animal 
house (The University of Queensland, St Lucia, Queensland, Australia). The colony room was fitted 
with an automatic timer maintaining a 12:12h light-dark cycle with lights off at 12:30 h. Rats were 
given ad libitum access to standard rat chow and water at all times outside of experimental 
procedures. 
2.3 Habituation and Transportation 
Upon arrival to the AIBN animal facility, rats were given a period of habituation (7 days) to this 
new environment prior to any experimental habituation. Rats were then habituated to human 
handling for 10 minutes per day over 6 days. During this habituation period, only the two 
experimenters were in contact with the animals. On each experimental day, rats were transported in 
their home cages immediately prior to the changeover from light to dark cycle to an experimental 
room that was under low light and noise within the same animal facility and given one hour 
acclimatization to this new environment. Upon arrival to the experimental room, rat cages were 
housed within a larger containment chamber (68 cm (L) x 45 cm (W) x 38.5 cm (H)) to minimise 
sound, light and noise. Over the duration of the treatment, only the two experimenters entered this 
room to minimise any additional stress.  
2.4 Acute Stress 
In Chapter III, rats were immobilised according to a well-established protocol by Hori and 





board (18×25 cm) in the supine position using a polyester strapping with their legs fixed at an angle 
of 45 degrees to the midline with adhesive tape. Acute immobilisation stress was applied within the 
individual home cages enclosed with the larger containment chamber. In Chapter IV and V, acute 
restraint stress was applied using adjustable wire mesh restrainers in order to minimise overheating 
and avoid unnecessary body compression (Dayas et al., 1999). The restrainers were constructed 
from a polyvinyl chloride (PVC) pipe skeleton (20 cm (L) x 7.5 cm (D)) externally coated with 
welded wire mesh (6 mm x 6 mm grid), an adjustable internal nasal insert allowing ventilation, and 
a rear tail aperture. In order to isolate the effects of acute stress for both models, control animals 
were deprived of food and water for an equal time during experiments using these two stressors.  
2.5 PF-3845 Administration 
In Chapter V, the fatty acid amide hydrolase (FAAH) inhibitor, PF-3845 (5 mg/kg), was dissolved 
in 2% dimethyl sulfoxide (DMSO) in normal saline (0.9% sodium chloride) and injected 
intraperitoneally (i.p.) 60 minutes before stress treatment with an injection volume of 10 mL/kg. 
The PF-3845 hydrate was purchased from Sigma under catalogue number PZ0158 (St. Louis, MO). 
The dose and injection route was adapted according to studies by Ahn and colleagues (2009b) and 
Tchantochou and colleagues (2014). Figure 2.1 demonstrates injection of PF-3845 significantly 
elevated AEA levels by 10-fold in mouse brain as well as other N-acylethanolamines including N-
pamitoyl ethanolamine and N-oleoylethanolamine which peaked at 3 hours post injection and 





Figure 2.1. Levels of (A) endocannabinoid N-arachidonoyl ethanolamine (anandamide; AEA), and 
two other N-acylethanolamines with affinity to cannabinoid-like G-coupled receptors (B) N-
pamitoyl ethanolamine (PEA) and (C) N-oleoylethanolamine (OEA) in brain tissue following 
intraperitoneal injection of two different fatty acid amide hydrolase inhibitors, PF-3845 and 





2.6 Experimental Groups  
Table 2.1. An overview of the treatment groups used in three experimental chapters of this thesis.  
 Treatment Groups 
Experiment 1 
(Chapter III)  




Control 60 min restraint stress 
120 min restraint stress 




Control with Vehicle injection Control with PF-3845 injection 
60 min restraint stress  
with Vehicle injection 
60 min restraint stress  
with PF-3845 injection 
240 min restraint stress  
with Vehicle injection 
240 min restraint stress  
with PF-3845 injection 
360 min restraint stress  
with Vehicle injection 
360 min restraint stress  
with PF-3845 injection 
 
2.7 Sample Collection 
In Chapter III, baseline blood samples were collected via tail-tip sampling into both heparinised (20 
IU/mL blood) and ethylenediaminetetraacetic acid (EDTA)-coated (1.5 mg/mL blood) Eppendorf 
tubes prior to treatment. Subsequent sampling at 60, 90, and 120 minutes during stress was 
achieved by gently removing clotted blood. Blood samples were each around 150 µL to guarantee 
that the total amount of blood collected remains under 10% of the calculated blood volume. The 
EDTA-treated samples were used for total nitrite and nitrate determination, as heparin in plasma 
may produce precipitation upon addition of the Griess reagent. Heparinised whole blood (2.5 µL 
aliquot) was used for the determination of glucose using a standard glucometer (Accu-Chek® 
Performa®, Roche Diagnostics Aust. Pty. Ltd., Castle Hill NSW 2154, Australia). The remaining 
blood samples were immediately centrifuged at 200 x g for 5 minutes to avoid degradation. 
Phosphate buffered saline (PBS; 50 mM, pH=7.4)-washed erythrocytes were immediately used to 
determine the general oxidative status, while aliquots of erythrocytes and supernatant plasma were 
stored at -80
 o
C for later analysis of nitric oxide production, plasma oxidative status, reduced and 
oxidised glutathione, lipid peroxidation, haemoglobin, and plasma hormones. At the end of the 
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treatment, rats were weighed and sacrificed with sodium pentobarbital (100 mg/kg i.p. injection, 
Lethabarb, Virbac). 
In Chapter IV, following each allocated treatment, terminal blood samples were collected following 
sodium pentobarbital injection via cardiac puncture into ice-chilled heparinised tubes (20 IU/mL 
blood). Whole blood was centrifuged at 200 × g for 5 minutes and supernatant plasma was collected 
and stored at -80°C for later determination of corticosterone. Brains were rapidly removed 
following cervical dislocation and frozen immediately on a sheet of aluminium foil embedded in 
powdered dry ice. The brain regions of interest were then cryo-dissected prior to analysis. This was 
achieved by mounting the cerebellar face of the brain with Optimum Cutting Temperature (OCT) 
compound and sectioning in a cryostat. The striatum (Bregma 2.52 to 0.36 mm) and hippocampus 
(Bregma -2.64 to -4.44 mm) were identified using a rat brain atlas (Paxinos and Watson, 2007) and 
then removed from individual serial sections on a metallic dry ice-embedded platform using a 
scalpel and dissection microscope. Regionalised tissue was stored in Eppendorf tubes at -80
o
C until 
later determination of nitric oxide production and metabolism, enzymatic activity of nitric oxide 
synthases, and relative gene expression.  
In Chapter V, post-treatment samples were collected via tail-tip sampling into ice-chilled 
heparinised tubes (20 IU/mL blood). Blood samples were each around 150 µL to guarantee that the 
total amount of blood collected remains under 10% of the calculated blood volume. Whole blood 
was centrifuged at 200 × g for 5 minutes and supernatant plasma was collected and stored at -80°C 
for later determination of corticosterone. Following each allocated treatment, rats were sacrificed 
with sodium pentobarbital. Brains were rapidly removed following cervical dislocation and frozen 
immediately. The brain regions of interest were then cryo-dissected as described previously and 
regionalised hippocampus was stored in Eppendorf tubes at -80
o
C until later determination of 
relative gene expression. 
2.8 Plasma Prolactin 
A commercially available ELISA (Demeditec Diagnostics, GmbH, Kiel, Germany) was used to 
determine prolactin concentrations in Chapter III with a lower detection limit of 0.6 ng/mL. A 10 
µL plasma aliquot was diluted with 15 µL of rat prolactin calibrator/sample diluent, standards were 
serial diluted to range of 2.5-80 ng/mL, both diluted samples and standards were loaded into a 
monoclonal anti-rat prolactin antibody-coated microplate. To these 25 µL aliquots, 50 µL of sample 
buffer was added and shaken for 2 hours at room temperature. The contents of the microplate were 
discarded and the wells washed 4 times with 300 µL washing buffer prior to the addition of 200 µL 
of enzyme-labelled rat prolactin antibody conjugated to horseradish peroxidase and shaken again 
for 1 hour. The plate was washed 4 times with wash buffer followed by the addition of 200 µL of 3, 
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3', 5, 5'-tetra-methyl-benzidine in buffered peroxide solution and incubated for 30 minutes in the 
dark. A 50 µL aliquot of 2 M hydrochloric acid stop solution was subsequently loaded to each well 
and the absorbance was measured at 450 nm using a Sunrise
TM
 microplate absorbance reader 
(TECAN, Groedig, Austria). Prolactin concentrations were determined using the log-linear standard 
curve and corrected for dilution. 
2.9 Plasma Corticosterone 
Plasma corticosterone concentrations were determined in duplicate using an in-house 
radioimmunoassay with a minimum detection of 10 pg/mL. Unlabelled steroids were reconstituted 
in phosphate buffered saline (0.1 M, pH=7.0) containing 0.1% (w/v) porcine gelatin (PBS-G) to 
generate a standard curve with a range of 0-10,000 pg/mL. Anti-rat corticosterone polyclonal 
antibody raised in sheep using corticosterone-3-monoxime coupled to keyhole limpet hemocyanin 
was purchased from Sapphire Bioscience Pty. Ltd., Waterloo, Australia. The antibody was diluted 
with PBS-G to yield an optimum working titer that binds 50% of the tritium radiolabelled 
corticosterone tracer in the absence of competing unlabelled steroid. A 5 µl aliquot of vortex 
homogenised plasma was extracted by adding 2 mL of glass-distilled dichloromethane followed by 
a 5 minute vortex allowing the separation of aqueous phase and steroid-containing organic phase. 
The aqueous phase was frozen along the wall of a large test tube (16 × 100 mm) using liquid 
nitrogen while the organic phase will be decanted to a smaller glass tube (12 × 75 mm) for 
radioimmunoassay. Extracts was dried at 55
o
C under a stream of nitrogen gas and reconstituted in 2 
mL of PBS-G. A 100 µL aliquot of unlabelled corticosterone standard or reconstituted sample was 
incubated with 100 µL of the highly specific anti-rat corticosterone polyclonal antibody and 100 µL 
of [1, 2, 6, 7-
3
H]-corticosterone tracer (100 Ci.mmol
-1
, Perkin Elmer) overnight at 4°C after a gentle 
vortex and centrifuge at 1000 x g for 1 minute. The following day, samples were loaded with 500 
µL of dextran-coated charcoal (50 mM, pH=7.4) to strip any unbound steroids and centrifuged at 
1000 x g for 10 minutes at 4 °C. Radioactivity was counted in a 100 µL aliquot of the resulting 
supernatant with 2 mL of liquid scintillation cocktail (Ultima Gold
TM
, Perkin Elmer) using a Liquid 
Scintillation Spectrometer (Tri-Carb 3100 TR, Perkin Elmer). The counts per minute were then 
converted to equivalent corticosterone concentrations from the standard curve and corrected for 
dilution and dichloromethane extraction recovery.  
2.10 Plasma Insulin  
Plasma insulin concentrations were measured in Chapter IV using a commercial radioimmunoassay 
kit (Coat-a-Count ® Insulin, Siemens Healthcare, Frimley, UK) and the assay sensitivity was 0.25 
mIU/L. A 40 µL plasma aliquot was diluted to 200 µL of assay buffer and standards were serial 
diluted to a range of 2.5-80 mIU/L. Diluted samples and standards were pipetted directly to the 
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bottom of the insulin antibody-coated polypropylene tubes followed by a 1 mL addition of [
125
I]-
insulin tracer. Samples were incubated at room temperature overnight after which the contents 
within each tube were decanted thoroughly. Radioactivity was then counted using a 2470 Automatic 
Gamma Counter (WALLAC Wizard
2
, Perkin Elmer). The counts per minute were corrected for 
non-specific binding and then converted to equivalent insulin concentrations from a standard curve 
and corrected for dilution. 
2.11 DAF-FM DA Assay 
2.11.1 Plasma assay 
Intracellular nitric oxide were assayed with 4-amino-5-methylamino-2′, 7′-difluorofluorescein 
diacetate (DAF-FM DA) developed by Kojima and colleagues (1998) to measure low 
concentrations of nitric oxide. This pH-insensitive fluorescent compound is cell-permeable and 
passively diffuses across cell membrane. It is essentially non-fluorescent, however, once inside the 
cell, it is de-acetylated by intracellular esterases to become a weakly fluorescent DAF-FM. After 
reacting with nitric oxide specifically, the produced trizole form (DAF-FM T) shows stable and 
intense fluorescence which can be detected with excitation/emission maxima of 495/515 nm. Itoh 
and colleagues (2000) have demonstrated that DAF-FM does not interact with nitrite, nitrate, or 
other ROS including peroxynitrite, superoxide, and hydrogen peroxide. Briefly, a 4 µM DAF-FM 
DA working solution was prepared fresh in PBS (50 mM, pH=7.4). Frozen plasma was rapidly 
defrosted and a 1% (v/v) plasma suspension was prepared in PBS. Four replicates were plated on a 
96-well plate containing final concentrations of 0.5% (v/v) plasma suspension and 2 µM of DAF-
FM DA under low light conditions. Plates were incubated for 60 minutes at room temperature and 
sample fluorescence was measured by a POLARstar OPTIMA microplate reader (BMG 
Labtechnologies). Data were corrected with corresponding protein concentrations and expressed as 
the percentage change in arbitrary fluorescence units relative to baseline/control values. 
2.11.2 Tissue assay  
A 4 µM DAF-FM DA working solution was prepared fresh in PBS (50 mM, pH=7.4). Four 
replicates of PBS-diluted tissue supernatant (0.1% w/v) were plated on a 96-well plate containing a 
final concentration of 2 µM of DAF-FM DA. Plates were incubated for 60 minutes and sample 
fluorescence was measured by a POLARstar OPTIMA microplate reader (BMG Labtechnologies). 
Data were corrected with corresponding protein concentrations and expressed as the percentage 





2.12 Total Nitrite and Nitrate Levels  
2.12.1 Plasma assay 
The total nitric oxide metabolites, NOx, were measured with the Griess reaction using a commercial 
nitrate/nitrite colorimetric assay kit (Cayman Chemical Company, Ann Arbor, MI, U.S.A) with a 
minimum sensitivity of 2.5 µM/L. Plasma samples using EDTA as an anticoagulant were ultra-
filtered through a 10-kDa molecular weight cut-off centrifugal device with omega membrane (Pall 
Nanosep
®
) to reduce background absorbance due to the presence of haemoglobin. These filters were 
pre-rinsed twice with 500 µL of MiliQ water (centrifuged at 10, 000 x g for 5 minutes each). For 
assaying NOx, 20 µL of ultra-filtered plasma was diluted with 60 µL of assay buffer followed by a 
10 µL addition of enzyme cofactor mixture. The plate was incubated at room temperature for 3 
hours on an orbital shaker after the addition of nitrate reductase (10 µL). Following incubation, 50 
µL of Griess reagent R1 was added to each wells and immediately followed by 50 µL of Griess 
reagent R2. Colour was developed for 10 minutes at room temperature and read at 540 nm using a 
Sunrise
TM
 microplate absorbance reader. Within the assay, nitrate standards were serial diluted to a 
range of 5-40 µM. Samples were corrected with corresponding protein concentrations and 
expressed as a percentage change relative to baseline values.  
2.12.2 Tissue assay 
The commercial nitrate/nitrite colorimetric assay kit (Cayman Chemical Company, Ann Arbor, MI, 
USA) was used to measure NOx in the hippocampus and striatum. Tissue homogenate (20X in 
PBS) was ultra-filtered through the centrifugal device (Pall Nanosep
®
) at 10, 000 x g for 20 minutes 
as this will improve colour development with the Griess reagent. Assay protocol is as described 
above in the plasma assay. Samples were corrected with corresponding protein concentrations and 
expressed as µM per mg of protein. 
2.13 Plasma Oxidative Status 
A fluorometric assay modified from the erythrocyte assay in Spiers and colleagues (2013) involving 
the direct oxidation of dichlorofluorescin (DCFH) by non-specific ROS to a highly fluorescent 
product, dichlorofluorescein (DCF) was used to determine the overall cellular oxidative status in 
plasma. This fluorometric assay relies on the nonionic and nonpolar 2’, 7’-dichlorofluorescin 
diacetate (DCFH-DA) crossing the cell membrane when applied to intact cells. It is then hydrolysed 
by non-specific intracellular esterases to non-fluorescent DCFH. In the presence of ROS, non-
fluorescent DCFH is rapidly oxidised to a highly fluorescent DCF. A 1 mM DCFH-DA stock 
solution was prepared in dimethyl sulfoxide and ethanol in a ratio of 1:4 to a final volume of 1 mL. 
The stock solution was wrapped in aluminium foil to prevent photo-oxidation and stored at -20°C. 
The DCFH-DA working solution was prepared fresh each day by diluting 100 µL of the stock 
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solution with 4.9 mL of PBS to achieve a final concentration of 200 µM. A 1% plasma suspension 
(v/v) was prepared in PBS. Eight replicates each containing 50 µL of 1% plasma suspension and 50 
µL of 200 µM DCFH-DA were plated on a 96-well plate. To ensure sample reliability and 
reproducibility, the loaded plate was manually shaken prior to double-orbital shaking in a 
POLARstar OPTIMA multidetection microplate reader for 30 seconds. Sample fluorescence was 
analysed with absorbance and emission filters set at 485 nm and 520 nm respectively. After the 
initial reading, the microplate was wrapped with aluminium foil and kept in the dark at room 
temperature for 10 minutes until the final reading. Samples fluorescence was corrected with 
corresponding protein concentrations and data expressed as a percentage change relative to baseline 
values.  
2.14 Reduced and Oxidised Glutathione Assay in Erythrocytes  
A fluorometric assay modified from Senft and colleagues (2000) for the measurement of both 
reduced glutathione (GSH) and glutathione disulphide (GSSG) was used employing the fluorophore 
O-phthalaldehyde (OPA). Briefly, 50 µL of erythrocytes were suspended with 450 µL of 5% 
metaphosphoric acid and vortexed thoroughly to deproteinate the sample. The acidic suspension 
was left on ice for 10 minutes and centrifuged at 2300 x g for 5 minutes. Since OPA reacts with 
GSH only (not GSSG), 150 µL of deproteinated sample was redox quenched with 250 µL of 
potassium phosphate buffer (1 M; pH=7.0) and incubated with 20 µL of OPA (4 mg/mL of 
methanol) at room temperature for 30 minutes to specifically quantify GSH. The concentration of 
GSH was corrected with the non-glutathione dependent fluorescence by a corresponding volume 
matched 7.5 mM N-ethylmaleimide-reacted sample. The protocol for quantifying GSSG 
specifically requires a GSH quencher to remove all GSH thus preventing the reaction with OPA 
while GSSG is unaffected. A reducing agent was then added to remove any excess GSH quencher 
and to convert GSSG to GSH. This converted GSH was then measured fluorometrically using OPA. 
Duplicates of the deproteinated supernatant (150 µL) were incubated with 20 µL of 7.5 mM N-
ethylmaleimide for 5 minutes at room temperature to quench GSH and this was subsequently redox 
quenched in 1 M potassium phosphate buffer. A 30 µL aliquot of the reducing agent sodium 
dithionite was then added to one duplicate to remove any excess N-ethylmaleimide and convert 
GSSG to GSH. This converted GSH was measured fluorometrically following a 30 minute 
incubation with 20 µL of OPA. The concentration of GSSG was calculated by the difference 
between sodium dithionite-reacted sample and its corresponding blank using 0.1 M potassium 
buffer with EDTA (pH=7.5). The OPA-derived fluorescence was measured at 365 nm (excitation) 
and 430 nm (emission) with a POLARstar OPTIMA multidetection microplate reader. Sample 
values were determined directly from linear GSH and GSSG standard curves ranging between 
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5.085-81.353 µM. Data was corrected with corresponding hemoglobin concentrations and 
expressed as a percentage of total glutathione equivalents [GSH+2GSSG] and GSH/GSSG ratio 
relative to baseline values.  
2.15 Plasma Lipid Peroxidation Assay  
The peroxidation of lipids was assessed using the thiobarbituric acid reactive substances (TBARS) 
assay through quantification of malondialdehyde (MDA) production using a modified protocol from 
Zavodnik and colleagues (2002). To prevent further sample peroxidation occurring during the assay 
process, 10 µL of butylated hydroxytoluene in methanol was added to 50 µL of diluted samples or 
1, 1, 3, 3-tetraethoxypropane standards ranging from 3.125 to 100 nmol/mL. A 125 µL aliquot of 
1% (w/v) thiobarbituric acid in 0.1 M sodium hydroxide pH adjusted with concentrated 
hydrochloric acid to pH=3.5 was loaded and vortexed vigorously. Samples were then acidified with 
315 µL of a 20% (w/v) trichloroacetic acid solution and incubated in an 85
o
C water bath for 30 
minutes using glass marbles as condensers. Glass test tubes were subsequently cooled for 10 
minutes on ice and loaded with 500 µL of n-butanol and centrifuged at 1000 x g for 5 minutes at 
4
o
C. The extracted pink adduct in the supernatant was loaded to a 96-well plate and measured 
fluorometrically at 544 nm excitation and 590 nm emission with a POLARstar OPTIMA microplate 
reader (BMG Labtechnologies). Sample values were quantified directly from the linear standard 
curve, adjusted for protein content, and data were expressed as a percentage change relative to 
baseline values.  
2.16 Nitric Oxide Synthase Activity in Tissue 
The activity of nitric oxide synthase in brain regions of interest were determined by a standard 
citrulline formation assay as previously described (Weissman and Gross, 2001). The assay is based 
on the biochemical conversion of ʟ-arginine to nitric oxide along with the stoichiometric production 
of L-citrulline by nitric oxide synthase. This assay includes the use of radioactive substrates, ʟ-
[
14
C(U)]-arginine (274 mCi/mmol, Perkin Elmer) enabling sensitivity at the picomole level. Briefly, 
tissue was homogenised in 15X (w/v) of PBS (50 mM, pH=7.4) using a homogeniser (Ultra 
Turrax
®
 T10) for 15 seconds. The homogenate was centrifuged at 10,000 x g for 10 minute at 4
o
C. 
Tissue supernatant  (10 µL) was then added with 12.5 µL of assay buffer (50 mM Tris-HCl; pH=7.4 
with 1.25 mM CaCl2, 1 mM of MgCl2, 0.6 mM of L-valine, and 1 mM of dithiothreitol). A 12.5 µL 
aliquot of a mixture of cofactors containing 50 mM Tris-HCl with 100 nM calmodulin, 40 µM of 
(6R)-5, 6, 7, 8-tetrahydrobiopterin dihydrochloride, 8 µM of flavin adenine dinucleotide, and 8 µM 
of riboflavin 5′-monophosphate was then added. A 2.5 µL aliquot of either MiliQ or 20 mM 
ethylene glycol tetraacetic acid (EGTA) was added to determine total or calcium-independent iNOS 
activity respectively. An enzyme blank was included for every sample which requires a 12.5 µL of 
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8 mM Nω-nitro- ʟ-arginine methyl ester hydrochloride (ʟ-NAME) instead of the cofactors followed 
by the addition of a 2.5 µL EGTA (20 mM). Reaction was initiated by the addition of radiotracer 
mix (12.5 µL) containing 50 mM of Tris-HCl, 2 µCi/mL of L-[
14
C(U)]-citrulline, and 4 mM of 
NADPH at 25°C and this was incubated for 30 minutes. The reaction was stopped by 700 µL of 1 
part Dowex AG 50W-X8 (100-200 mesh, Na
+
 form) to 2 parts EDTA-HEPES buffer (pH=5.5; v/v) 
with 80 µM of N
G
-nitro-L-arginine methyl ester (L-NAME) followed by 2 mL of MiliQ. L-
[
14
C(U)]-citrulline was specifically eluted by centrifugation at 1000 x g for 5 minutes and the 
radioactivity was quantified with a Liquid Scintillation Spectrometer (Tri-Carb 3100 TR, Perkin 
Elmer). Enzyme activities were calculated as pmol/min/mg protein accounting for individual 
enzyme blanks and the presence or absence of EGTA and data were expressed relative to control 
values.  
2.17 Ribonucleic Acid Extraction and Preparation of cDNA 
Total RNA was extracted from each brain region of interest using lysis buffer RLT with β-
mercaptoethanol (10 µL/mL) provided in a RNeasy mini kit (QIAGEN, Doncaster, Australia). 
Tissues were homogenised with an Ultra-Turrax
®
 T8 homogeniser (IKA
®
, Labtek, Brendale, 
Australia) and cellular debris was pelleted by centrifugation for 3 minutes at top speed. The 
resulting supernatant was mixed with an equal volume of 70% ethanol in RNAase-free water and 
transferred to the provided spin columns which binds nucleic acid and allows the eluent to pass 
through and discard. The RNA isolation was completed with the presence of deoxyribonuclease I 
(approximately 30 Kunitz units; QIAGEN, Doncaster, Australia) for 15 minutes to digest any 
genomic DNA contaminating the RNA preparation. The total RNA was eluted in 30 µL of 
RNase/DNase-free water prior to determining sample concentration and quality by the A260 reading 
with a Nanodrop 1000 spectrophotometer (Thermo Fisher Scientific, Scoresby Vic, Australia). The 
quantity of RNA was determined using the Beer-Lambert law and the optical density at 260 nm, 
while the quality of the RNA yield was taken as the A260/A280 ratio (acceptable 260/280 ratio 
≥1.80). The RNA preparations were stored frozen at -80°C until use.  
The synthesis of cDNA was performed using 1 μg of total RNA from each sample and reverse 
transcribed with the iScript™ Reverse Transcription Supermix for RT-qPCR (Bio-Rad) using an 
optimised blend of oligo(dT) and random primers according to the manufacturer's instructions. 
Negative samples were generated using extracted RNA under the same conditions with the 






2.18 mRNA Expression 
Taqman gene expression ‘assay-on-demandTM’ kits (Life Technologies, Mulgrave, Australia) with 
optimised primers and reporter dye labelled-probes (FAM; 6-carboxyfluorescein) were used to 
detect gene expression for the following targets in Table 2.2.    
 
Table 2.2. Applied Biosystems
TM by Life Technologies inventoried ‘assay-on-demandTM’ probes 
used in this thesis.  
Gene 
Symbol 
Gene Name Gene Aliases Assay ID 
Adam17 ADAM metallopeptidase 
domain 17 








complex II transactivator 
(Mhc2ta) 
Rn01424725_m1 
Il1b Interleukin 1 beta IL-1β Rn00580432_m1 
Il6 Interleukin 6 IL-6 Rn01410330_m1 
Mif Macrophage migration 
inhibitory factor  
MIF or glycosylation-
inhibiting factor (GIF) 
Rn00821234_g1 
Nfkbia Nuclear factor of kappa light 
polypeptide gene enhancer in 
B-cells inhibitor, alpha 
Inhibitor of nuclear factor 
kappa B (NF-κB) alpha 
(IκB-α) 
Rn01473657_g1 
Nos1 Nitric oxide synthase 1, 
neuronal 
Neuronal nitric oxide 
synthase (nNOS) 
Rn00583793_m1 
Nos2 Nitric oxide synthase 2, 
inducible 
Inducible nitric oxide 
synthase (iNOS) 
Rn00561646_m1 
Nr3c1 Nuclear receptor subfamily 3, 




Nr3c2 Nuclear receptor subfamily 3, 









Tnf Tumor necrosis factor TNF Rn01525859_g1 
 
All expression assays were multiplexed with 2’-chloro-7’-phenyl-1, 4-dichloro-6-
carboxyfluorescein (VIC)-labelled glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as 
endogenous control on the QuantStudio
TM
 6 Flex Real-Time PCR System (Applied Biosystems, 
Foster City, CA). The fold change in expression of each target gene was calculated using the ∆∆CT 





2.19 Haemoglobin Determination  
Haemoglobin concentrations were used to standardise reduced and oxidised glutathione assay in 
erythrocytes. This was determined using a modification to the cyanmethemoglobin method of 
Fairbanks and Klee (1999). Drabkin’s solution was prepared by dissolving 0.2 g potassium 
ferricyanide (K3Fe[CN]6), 0.05 g potassium cyanide (KCN), and 1.0 g sodium bicarbonate 
(NaHCO3) successively in 1000 mL of MiliQ water. To this solution, 0.5 mL of 30% Brij 35 (w/v) 
was added as a surfactant to minimise the turbidity created by erythrocytes. This assay was adapted 
for microplates allowing the measurement of 10 µL of diluted samples in 125 µL of Drabkin’s 
solution read at 540 nm on a spectrophotometer with a 700 nm reference wavelength. Sample 
values were determined directly from a linear standard curve constructed from bovine haemoglobin 
ranging 0.07-9 mg/mL. 
2.20 Protein Estimation 
Protein was routinely measured to standardise assays performed with plasma and tissue samples 
utilising the RED 660
TM
 Protein Assay (G-235 Biosciences, St Louis, MO, USA) using bovine 
serum albumin as a standard ranging between 37.5-2000 µg/mL. This kit was scaled for microplates 
allowing the determination of protein content in 6 µL diluted samples directly incubated in 120 µL 
of assay reagent. This was developed at room temperature for 15 minutes and the absorbance read 
at 660 nm with a 700 nm reference on a Sunrise
TM
 microplate absorbance reader.  
2.21 Statistical Analysis  
Data were analysed using GraphPad Prism (Versions 5.0.3 and 6.0, GraphPad Software Inc., San 
Diego, CA, USA). Two-way repeated measure ANOVAs with Bonferroni post-test were used to 
compare control and stress data for the intra-individual time course analysis in Chapter III. One-
way ANOVAs followed by Dunnet’s multiple comparisons test were used to compare control and 
stress groups sacrificed at different time intervals in Chapter IV. Where data were not normally 
distributed, appropriate non-parametric Kruskal-Wallis ANOVA with Dunn’s multiple comparisons 
test was utilised. Lastly, two-way repeated measure ANOVAs with Fisher’s Least Significant 
Difference (LSD) test were used to compare between vehicle and PF-3845-injected groups in 
Chapter V. Results were expressed as mean ± standard error of the mean (± SEM) and p-values less 





















Reactive nitrogen species contribute to the 
rapid onset of redox changes induced by 
























3.1 Abstract  
Acute stress leads to the rapid secretion of glucocorticoids, which accelerates cellular metabolism, 
resulting in increased reactive oxygen and nitrogen species generation. Although the nitrergic 
system has been implicated in numerous stress-related diseases, the time course and extent of 
nitrosative changes during acute stress have not been characterised. Outbred male Wistar rats were 
randomly allocated into control (n=9) or 120 minute acute immobilisation stress (n=9) groups. 
Serial blood samples were collected at 0 (baseline), 60, 90, and 120 minutes. Plasma corticosterone 
concentrations increased by approximately 350% at 60, 90, and 120 (p<0.001) minutes of stress. 
The production of nitric oxide, measured as the benzotriazole form of 4-amino-5-methylamino-
2’,7’-difluorofluorescein, increased during stress exposure by approximately 5%, 10%, and 15% at 
60 (p<0.05), 90 (p<0.01) and 120 (p<0.001) minutes respectively compared to controls. Nitric oxide 
metabolism, measured as the stable metabolites nitrite and nitrate, showed a 40% to 60% increase at 
60, 90, and 120 (p<0.001) minutes of stress. The oxidative status of 2’, 7’-dichlorofluorescein in 
plasma was significantly elevated at 60 (p<0.01), 90, and 120 (p<0.001) minutes. A delayed 
decrease of approximately 25% in the glutathione redox ratio at 120 minutes (p<0.001) also 
indicates stress-induced cellular oxidative stress. The peroxidation of plasma lipids increased by 
approximately 10% at 90 (p<0.05) and 15% at 120 (p<0.001) minutes, indicative of oxidative 
damage. It was concluded that a single episode of stress causes early and marked changes of both 


















Living organisms maintain a complex and dynamic homeostasis that is continually challenged by 
intrinsic and extrinsic stressors. Three discrete and dedicated systems maintain and reinstate 
homeostasis during stress. The autonomic nervous system (ANS) quickly responds to stress 
exposure through the sympathetic and parasympathetic divisions. The rapidly activated sympathetic 
catecholamines are responsible for generation of the ‘fight or flight’ response in addition to 
potentiating the pituitary gland to subsequent hypothalamic activation (Wamsteeker and Bains, 
2010). The hypothalamic-spinal-adrenocortical (HSA) axis modulates adrenal sensitivity to 
adrenocorticotropic hormone (ACTH) through a nitric oxide-mediated pathway (Jansen et al., 1995; 
Mohn et al., 2005; Ulrich-Lai et al., 2006). In addition, prolactin facilitates adrenal sensitivity to 
ACTH by a neural pathway that is independent of glucocorticoid-mediated negative feedback 
(Jaroenporn et al., 2009). Together, stress-induced activation of both the ANS and HSA axis prime 
the stress system, and subsequent activation of the hypothalamic-pituitary-adrenocortical (HPA) 
axis produces maximal ACTH-induced release of adrenal glucocorticoids. This results in an 
increase in gluconeogenesis and cellular metabolism leading to a spontaneous increase in different 
forms of free radicals including both reactive oxygen species (ROS) and nitrogen species (RNS) 
which ultimately lead to both oxidative and nitrosative stress (Zhou et al., 2011; Liu and Zhou, 
2012).  
The gaseous RNS, nitric oxide, is endogenously synthesised through conversion of L-arginine to L-
citrulline by nitric oxide synthases or the nitrate-nitrite-nitric oxide pathway (Lundberg et al., 2008). 
Nitric oxide is involved in the regulation of many physiological processes, such as vascular tone, 
neurotransmission, and the immune system (Ignarro et al., 1987; Hibbs et al., 1988; Knowles et al., 
1989). However, the pro-oxidant actions of nitric oxide cause nitrosative stress, which is defined as 
an increase in RNS occuring in response to the by-products formed from an oxidative challenge 
(Ghafourifar et al., 2001). A primary reaction in the production of RNS is the combination of nitric 
oxide and superoxide anions to form the highly reactive metabolite, peroxynitrite, a potent 
neurotoxin. It is now considered that nitric oxide and peroxynitrite can inhibit components of the 
mitochondrial respiratory chain such as cytochrome c oxidase, thereby decreasing the affinity to 
oxygen, potentially leading to cellular energy deficiency and ultimately cell death (Bolanos et al., 
1994; Guidarelli et al., 2000). In the circulation, erythrocytes are the major scavenger of nitric oxide 
in which the reaction of nitric oxide with oxyhemoglobin produces the more stable metabolite 
nitrate and non-oxygen binding methemoglobin (Lundberg et al., 2008).  
Assessment of total nitrite and nitrate (NOx) content in biological fluids is routinely used as an 
indirect estimate of nitric oxide production and metabolism in vivo. There is considerable evidence 
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for a link between altered NOx content and neurodegenerative conditions including Alzheimer’s, 
Huntington’s, and Parkinson’s diseases (Boje, 2004). Clinical studies have also demonstrated an 
increase in total nitrate and nitrite levels in major depression and autistic patients using peripheral 
measures (Suzuki et al., 2001; Sogut et al., 2003). However, these represent changes occurring in 
chronic conditions, while the acute physiology of altered nitrosative status is poorly understood. We 
hypothesised that the production of reactive nitrogen species contribute to the acute increase in 
oxidative status observed following stress exposure. Therefore, in the present study, an acute 
immobilisation stress model was used to establish the temporal profile of nitrosative changes and its 
involvement in the rapid onset of redox imbalance. 
3.3 Materials and Methods  
3.3.1 Experimental animals 
Outbred male Wistar rats (Rattus norvegicus) aged 6-7 weeks postnatal, weighing 255.6 ± 2.82 g, 
were sourced from the University of Queensland Biological Resources breeding colony. Animals 
were housed individually under standard laboratory conditions (22 ± 2°C; 55 ± 5% humidity) with a 
12 hour light-dark cycle (lights off at 12.30). Standard rat chow and water were available ad 
libitum. All experimental procedures were in accordance with regulations and policies outlined by 
The University of Queensland Animal Ethics Committee with AEC approval number 
SBS/363/11/URG.  
3.3.2 Acute immobilisation stress  
Acute immobilisation stress was applied according to a well-established protocol by Hori and 
colleagues (2004). Rats were immobilised on a Perspex
®
 board (18×25 cm) in the supine position 
using a polyester strapping and adhesive tape with their legs set at 45 degrees to the midline. Acute 
immobilisation stress was applied for 2 hours (stress treatment starts at 13:30) within individual 
home cages enclosed with a larger containment chamber (68 cm (L) × 45 cm (W) × 38.5 cm (H)) to 
reduce external disturbances. To isolate the effects of immobilisation stress, control animals were 
deprived of food and water during the treatment period. 
3.3.3 Experimental protocol  
Animals were habituated to human handling for 10 minutes per day one week prior to 
experimentation. On each experimental day, animals were transported in their home cages from the 
colony room to an experimental room that was under low light and noise within the same animal 
facility. They were acclimatised to the novel experimental room for one hour and then randomly 
allocated to either control (n=9) or 2 hour immobilisation stress (n=9) treatment groups. The distal 1 
to 2 mm of the tail was clipped once only and a baseline (0 minute) blood sample was collected into 
both ethylenediaminetetraacetic acid (EDTA)-coated Eppendorf tubes (1.5 mg mL
-1
 blood) and ice-
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chilled heparinised tubes (20 IU mL
-1
 blood). Subsequent collection at 60, 90, and 120 minutes was 
achieved by gentle removal of clotted blood. Blood samples were around 150 µL to guarantee that 
the total amount of blood collected remains under 10% of the calculated blood volume. A 2.5 µL 
aliquot of heparinised whole blood was used for the determination of glucose using a standard 
glucometer and test strips (Accu-Chek® Performa ®, Roche Diagnostics Aust. Pty. Ltd., Castle 
Hill, Australia) and the remaining sample was centrifuged at 200 × g for 5 minutes. Supernatant 
plasma was collected and stored at -80°C for later determination of nitric oxide production, general 
oxidative status, lipid peroxidation, prolactin, and corticosterone concentrations. Supernatant 
plasma with EDTA as anticoagulant was stored at -80°C for measuring nitric oxide metabolism, 
NOx. Aliquots of heparinised erythrocytes were stored at -80°C for later analysis of reduced and 
oxidised glutathione and hemoglobin. Following the final sample, animals were weighed and 
overdosed with the anesthetic sodium pentobarbital (100 mg kg
-1 
i.p. injection, Lethabarb, Virbac, 
Peakhurst, Australia).  
3.3.4 Hormone assays 
Plasma prolactin concentrations were assayed using commercially available ELISA kits (Demeditec 
Diagnostics, GmbH; Germany) with a lower detection limit of 0.6 ng mL
-1
 according to the 
manufacturer’s protocols. The intra- and inter-assay coefficients of variation were 4.2% and 4.0% 
respectively. Plasma corticosterone concentrations were determined in duplicate using 
radioimmunoassay with a minimum sensitivity of 10 pg mL
-1
 as described in Spiers and colleagues 
(2013). A 5 µL plasma aliquot was extracted in 2 mL of glass-distilled dichloromethane. Extracts 
were dried under a stream of nitrogen gas and reconstituted in phosphate buffered saline (PBS; 100 
mmol L
-1
, pH=7.0) containing 0.1% (w/v) porcine gelatin. A 100 µL aliquot of unlabeled 
corticosterone standard or reconstituted sample was incubated with 100 µL of anti-rat 
corticosterone polyclonal antibody (Sapphire Bioscience Pty. Ltd., Waterloo, Australia) and 100 µL 
of [1, 2, 6, 7-
3
H]-corticosterone tracer and incubated overnight at 4°C. The following day, samples 
were loaded with 500 µL of dextran-coated charcoal (50 mmol L
-1
, pH=7.4) and centrifuged at 1000 
× g for 10 minutes at 4 °C. Radioactivity was counted in a 100 µL aliquot of the resulting 
supernatant using a Liquid Scintillation Spectrometer (Tri-Carb 3100 TR, Perkin Elmer, Waltham, 
MA). Unknown sample concentrations were determined from a standard curve and corrected for 
dilution and extraction efficiency. Dichloromethane extraction efficiency was 89.6% and intra- and 
inter-assay coefficients of variation were 4.5% and 3.1% respectively. Plasma insulin 
concentrations were measured using a commercial radioimmunoassay kit (Coat-a-Count
®
 Insulin, 
Siemens Healthcare, Frimley, UK) according to manufacturer's protocol. Assay sensitivity was 0.25 
mIU L
-1
 with intra- and inter-assay coefficients of variation of 3.1 % and 5.0% respectively. 
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3.3.5 Nitrosative status  
The production of nitric oxide was assayed in plasma with 4-amino-5-methylamino-2′, 7′-
difluorofluorescein diacetate (DAF-FM DA) synthesised by Kojima and colleagues (1999). This 
pH-independent fluorescent dye undergoes de-acetylation by esterases to become a weakly 
fluorescent DAF-FM with a fluorescence quantum yield of around 0.005 (Kojima et al., 1999). 
After reacting directly with nitric oxide in the presence of molecular oxygen, the resultant 
benzotriazole form (DAF-FM T) shows stable and an approximately 160-fold increase in 
fluorescence intensity which can be detected with excitation and emission maxima of 485 nm and 
520 nm respectively (Kojima et al., 1999). Briefly, a 4 µmol L
-1
 DAF-FM DA working solution was 
prepared fresh in PBS (50 mmol L
-1
, pH=7.4). Frozen plasma was defrosted and a 1% (v/v) plasma 
suspension was prepared in PBS. Four replicates were plated on a 96-well plate containing final 
concentrations of 0.5% (v/v) plasma suspension and 2 µmol L
-1
 of DAF-FM DA under low light 
conditions. Plates were incubated for 60 minutes and sample fluorescence was measured by a 
POLARstar OPTIMA microplate reader (BMG Labtechnologies). Data were corrected with 
corresponding protein concentrations and expressed as the percentage change in arbitrary 
fluorescence units relative to baseline values. The intra-assay coefficient of variation was 2.4%.  
The total nitric oxide metabolites, NOx, were measured with the Griess reaction using a 
commercially available colorimetric assay kit (Cayman Chemical Company, Ann Arbor, MI) with a 
minimum sensitivity of 2.5 µmol L
-1
 according to the manufacturer’s instructions. Plasma samples 
using EDTA as an anticoagulant were ultra-filtered through a 10-kDa molecular weight cut-off 
filter using commercially available centrifugal devices (Pall Nanosep
®
, Cheltenham, Australia). 
Samples were corrected with corresponding protein concentrations and expressed as a percentage 
change from baseline values. All samples were run on the same day with an intra-assay coefficient 
of variation of 3.3%. 
3.3.6 General oxidative status assay 
General oxidative status in plasma was measured fluorometrically using methods modified from 
Spiers and colleagues (2013). Frozen plasma was vortex-defrosted and a 1% (v/v) plasma 
suspension was prepared in PBS. Four replicates were plated on a 96-well plate containing final 
concentrations of 0.5% (v/v) plasma suspension and 100 µmol L
-1
 of 2’, 7’-dichlorofluorescin 
diacetate (DCFH-DA). Sample fluorescence was measured by a POLARstar OPTIMA microplate 
reader (BMG Labtechnologies) with excitation and emission filters set at 485 nm and 520 nm 
respectively. Data were corrected with corresponding protein concentrations in plasma and 
expressed as the percentage change in arbitrary fluorescence units relative to baseline values. The 
intra-assay coefficient of variation was 2.5%.  
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3.3.7 Reduced and oxidised glutathione assay  
Reduced (GSH) and oxidised (GSSG) glutathione disulfide were measured with the fluorophore O-
phthalaldehyde (OPA) using a procedure modified from Senft and colleagues (2000). Briefly, a 50 
µL aliquot of erythrocytes was suspended in 450 µL of 5% (w/v) metaphosphoric acid. The 
denatured protein precipitate was removed by centrifugation (2300 × g for 5 minutes). Aliquots of 
the supernatant were redox quenched with potassium phosphate buffer (1.0 M, pH=7.0) and 
incubated with 20 µL of OPA (4 mg mL
-1
 in methanol) to specifically quantify GSH. The 
concentration of GSH was corrected with the non-glutathione dependent fluorescence by a 
corresponding volume matched 7.5 mmol L
-1
 N-ethylmaleimide (NEM)-reacted sample. For the 
determination of GSSG, deproteinated supernatant was incubated with 20 µL of 7.5 mmol L
-1
 NEM 
for 5 minutes to remove GSH and redox quenched in potassium phosphate buffer. A 30 µL aliquot 
of 100 mmol L
-1
 sodium dithionite was added to one duplicate to convert GSSG to GSH. This 
converted GSH was measured fluorometrically following incubation with OPA. The concentration 
of GSSG was calculated by the difference between sodium dithionite-reacted sample and its 
corresponding blank using 0.1 mol L
-1
 potassium buffer with EDTA (KPE buffer; pH=7.5). The 
OPA-derived fluorescence was measured using a POLARstar OPTIMA microplate reader (BMG 
Labtechnologies) with excitation and emission filters set at 365 nm and 430 nm respectively and 
sample values were determined directly from linear GSH and GSSG standard curves with a 
minimum sensitivity of 2.5 µmol L
-1
. The intra- and inter-assay coefficients of variation were 1.5% 
and 8.1% respectively for the GSH assays and 4.0% and 8.3% respectively for GSSG assays. Data 
were corrected with corresponding hemoglobin concentrations and expressed as the GSH/GSSG 
ratio relative to baseline values.  
3.3.8 Lipid peroxidation in plasma  
The peroxidation of lipid in plasma was determined according to method previously described by 
Zavodnik and colleagues (2002) by quantifying the production of malondialdehyde using a 
thiobarbituric acid reactive substances (TBARS) assay. 1, 1, 3, 3-tetraethoxypropane was used as an 
external standard for malondialdehyde (MDA) with a minimum detection sensitivity of 3.1 nmol L
-
1
. To prevent further peroxidation during the assay, 10 µl of butylated hydroxytoluene in methanol 
was added into 50 µl of standards or diluted plasma. A 125 µl aliquot of 1% (w/v) thiobarbituric 
acid (TBA) in 0.05 mol mol L
-1
 sodium hydroxide solution (pH=3.5) was added and vortexed 
vigorously. Following the addition of 315 µl of 20% trichloroacetic acid (w/v), the mixture was 
incubated in an 85
 o
C water bath for 30 minutes using glass marbles as condensers. After cooling on 
ice for 10 minutes, the coloured product was extracted with n-butanol (500 µl) and the mixture was 
centrifuged at 1000 x g for 5 minutes. The extracted adduct was plated on a 96-well plate and 
measured fluorometrically at 544 nm (excitation) and 590 nm (emission) using a POLARstar 
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OPTIMA microplate reader (BMG Labtechnologies). Samples were corrected for corresponding 
protein concentrations and expressed as the percentage change in MDA-TBA adduct formation 
relative to baseline values. The intra- and inter-assay coefficients of variation were 4.3% and 7.5% 
respectively 
3.3.9 Haemoglobin and protein determination  
Haemoglobin was determined by a modification of the cyanmethemoglobin method of Fairbanks 
and Klee (1999) using bovine haemoglobin as a standard. Protein content was determined with a 
commercially available RED 660
TM
 Protein Assay (G-Biosciences, St Louis, MO, USA) using 
bovine serum albumin as a standard.  
3.3.10 Statistics 
Data were analysed using statistical software GraphPad Prism (Version 5.0.3, GraphPad Software 
Inc., San Diego, CA, U.S.A). Two-way repeated measure ANOVAs with Bonferroni post-test were 
used to compare control and stress data for all time course analyses. Results were expressed as 
mean ± standard error of the mean (± SEM) and p-values less than 0.05 were considered 





















3.4.1 Endocrine and metabolic 
This study associated specific indicators of nitrosative activation with profiles of known endocrine 
and oxidative parameters following an acute immobilisation stress. Plasma prolactin significantly 
increased during immobilisation stress [F(1,16)=36.60, p<0.0001] in a time-dependent manner 
[F(3,48)=14.59, p<0.0001]. A comparison of group means showed highly significant increases in 
prolactin at 60, 90, and 120 minutes of immobilisation when compared with control concentrations 
(Fig. 3.1A). The changes in plasma corticosterone following immobilisation stress are shown in Fig. 
3.1B. Baseline concentrations of corticosterone prior to immobilisation were not statistically 
different between control and stress groups. Immobilisation significantly increased corticosterone 
concentration above controls [F(1,16)=70.11, p<0.0001] over the time-course of the experiment 
[F(3,48)=16.35, p<0.0001]. The effect of treatment over time was also significant [F(3,48)=11.26, 
p<0.0001]. Corticosterone concentrations increased approximately 150-300% above controls at 60, 
90, and 120 minutes of immobilisation while no significant differences were observed in controls. 
The accompanying changes in blood glucose following the onset of immobilisation are illustrated in 
Fig. 3.1C. A Two-way repeated measures ANOVA demonstrated a time-dependent effect 
[F(3,48)=4.77, p=0.005], and a significant interaction between time and stress treatment [F(3,48)=6.74, 
p=0.0007], while the main effect of stress was not significant [F(1,16)=3.12, p=0.097]. Post-test 
analysis revealed a significant increase in blood glucose after 60 minutes following the onset of 
stress. Plasma insulin decreased in a stress [F(1,14)=7.36, p=0.017] and time [F(3,42)=2.89, p=0.047] 
dependent manner with no significant interaction between stress and time [F(3,42)=1.18, p=0.33]. 
Post-test analysis showed a significant decrease in plasma insulin following 90 minutes of 
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Figure 3.1. The effect of acute immobilisation stress on (A) plasma prolactin, (B) plasma 
corticosterone, (C) blood glucose, and (D) plasma insulin concentrations from control (○) and 
stressed (■) rats (n=9 per group for plasma prolactin, corticosterone, and blood glucose; n=8 per 
group for plasma insulin). All measures were determined from serial blood samples collected at 0 
(baseline), 60, 90, and 120 minutes. Data are expressed as mean ± SEM (Two-way ANOVA with 












3.4.2 Nitrosative status 
The nitrergic system forms a subgroup of reactive species, including nitric oxide, responsible for 
numerous important physiological functions. Following the onset of immobilisation stress, there 
was a linear increase in nitric oxide production with a correlation coefficient of r
2
=0.99 [p<0.001] 
while there was no significant change in controls (Fig. 3.2). A Two-way repeated measures 
ANOVA demonstrated stress treatment significantly increased nitric oxide production 
[F(1,16)=15.57, p=0.0012] over the duration of the experiment [F(3,48)=3.32, p=0.0274], and the 
interaction between stress treatment and time was also significant [F(3,48)=8.77, p<0.0001]. Post-test 




Figure 3.2. The effect of acute immobilisation stress on nitric oxide production measured by the 
benzotriazole derivative of 4-amino-5-methylamino-2’, 7’-difluorofluorescein (DAF-FM T) 
formation in plasma from control (○) and stressed (■) rats (n=9 per group). Relative DAF-FM T 
formation was determined from serial blood samples collected at 0 (baseline), 60, 90, and 120 
minutes. Data are expressed as mean ± SEM (Two-way ANOVA with Bonferroni post-test, 











Nitric oxide metabolism, measured as the stable metabolites NOx, also demonstrated linear 
increases [r
2
=0.94, p<0.05] following application of immobilisation stress. NOx production 
increased [F(1,16)=41.68, p<0.0001] in a time dependent manner [F(3,48)=5.47, p=0.0026] and  the 
interaction of stress treatment and time was also highly significant [F(3,48)=10.25, p<0.0001]. NOx 




Figure 3.3. The effect of acute immobilisation stress on total nitrite and nitrate (NOx) levels from 
control (○) and stressed (■) rats (n=9 per group). Relative total NOx was determined from serial 
blood samples collected at 0 (baseline), 60, 90, and 120 minutes. Data are expressed as mean ± 
















3.4.3 Redox status  
Figure 3.4 shows the changes in plasma general oxidative status following immobilisation stress. 
Plasma oxidative status demonstrated highly significant linear increases [r
2
=0.98, p<0.05] following 
exposure to immobilisation [F(1,16)=30.57, p<0.0001] in a time-dependent manner [F(3,48)=15.64, 
p<0.0001]. The interaction between treatment and time also demonstrated high significance 
[F(3,48)=17.36, p<0.0001]. Post-test analysis showed immobilisation stress increased plasma 




Figure 3.4. The effect of acute immobilisation stress on the general oxidative status measured by 
dichlorofluorescein (DCF) formation in plasma from control (○) and stressed (■) rats (n=9 per 
group). Relative DCF formation was determined from serial blood samples collected at 0 (baseline), 
60, 90, and 120 minutes. Data are expressed as mean ± SEM (Two-way ANOVA with Bonferroni 













Over the duration of the experiment, concentrations of total erythrocytic GSH did not change 
significantly. However, application of immobilisation stress increased the oxidised fraction while 
decreasing the reduced fraction of glutathione equivalents relative to baseline values. This resulted 
in delayed decreases in the ratio of GSH/GSSG from baseline, indicative of oxidative stress onset 
following immobilisation stress [F(1,16)=15.78, p=0.011]. The interaction of stress with time was 
also significant overall [F(3,48)=5.38, p=0.0028]. Bonferroni post-test analysis demonstrated that this 




Figure 3.5. The effect of acute immobilisation stress on the erythrocytic glutathione to glutathione 
disulfide (GSH/GSSG) ratio indicative of oxidative stress from control (○) and stressed (■) rats 
(n=9 per group). The relative ratio was determined from serial blood samples collected at 0 
(baseline), 60, 90, and 120 minutes. Data are expressed as mean ± SEM (Two-way ANOVA with 













3.4.4 Lipid peroxidation  
Immobilisation stress effectively elevated MDA production [F(1,16)=7.52, p=0.0145]. The interaction 
of stress with time was also statistically significant [F(3,48)=5.49, p=0.0025]. Post-test analysis 
showed that this increase became significant at 90, and 120 minutes of stress exposure (Fig. 3.6). 
 
 
Figure 3.6. The effect of acute immobilisation stress on plasma lipid peroxidation measured by 
malondialdehyde-thiobarbituric acid (MDA-TBA) adduct formation from control (○) and stressed 
(■) rats (n=9 per group). Relative plasma MDA-TBA was determined from serial blood samples 
collected at 0 (baseline), 60, 90, and 120 minutes. Data are expressed as mean ± SEM (Two-way 
















3.5 Discussion  
This study has demonstrated that alongside known hormonal parameters, acute psychological stress 
increases the production and metabolism of nitric oxide, likely contributing to the observed increase 
in the general oxidative status assay. The marked 250% increase in plasma prolactin from baseline 
observed at 60 minutes of immobilisation stress is in agreement with Ren and colleagues (2010). 
Moreover, the 350% increase in plasma corticosterone at 60 minutes is comparable with previous 
findings by Lee and colleagues (2008) using the same stressor. Acute immobilisation stress 
increased circulating blood glucose by approximately 25% at 60 minutes, which then progressively 
declined towards baseline. These results are supported by the findings of Sanchez and colleagues 
(2002) who reported a similar initial increase in plasma glucose of tape-immobilised mice at 20 
minutes, which significantly declined between 20- and 180-minutes. The decline in circulating 
glucose during stress noted in the present study does not seem to be insulin-dependent, as we found 
that stress decreased insulin concentrations. Such a reduction in plasma insulin is suggested to be 
adrenergic-mediated and has been demonstrated in previous reports accompanied by a rise in the 
hyperglycemic hormone glucagon (Mioduszewski and Critchlow, 1982; Perez-Llamas et al., 1992; 
Yamada et al., 1993; Amrani et al., 1994; Machado et al., 1995). The fall in blood glucose in rats 
exposed to immobilisation stress is likely a result of increased glucose utilisation due to enhanced 
skeletal muscle activity that has been observed in this particular stress model (Sanchez et al., 2002).  
The present study demonstrated a 7% increase in nitric oxide measured by DAF-FM T formation at 
60 minutes in response to immobilisation stress, with a further linear increase to 15% at 120 
minutes. Several experiments have utilised DAF-FM DA to assess nitric oxide dynamics, such as 
bioimaging intracellular nitric oxide in smooth muscle cells pretreated with various cytokines 
showing a fluorescence increase following DAF-FM DA loading (Itoh et al., 2000). The increased 
fluorescence was reversed using a nitric oxide synthase inhibitor, N
G
-nitro-L-arginine methyl ester 
(L-NAME). Sicard and colleagues (2008) measured nitric oxide with DAF-FM DA using flow 
cytometry as an oxidative/nitrosative stress index in blood monocytes of normal and hypertensive 
rats. Under these conditions, DAF-FM T fluorescence increased significantly by approximately 
25% in genetically hypertensive rats compare to the normotensive strain. It has been reported that 
these diaminofluorescein probes react specifically with nitric oxide without interacting with the 
metabolites, nitrite and nitrate, or other ROS and RNS including superoxide, hydrogen peroxide, 
and peroxynitrite (Kojima et al., 1998). It was later confirmed that both DAF-FM and the diacetate 
form is pH-insensitive above pH 5.5 and more photostable and sensitive for nitric oxide than DAF-
2 and DAF-2 DA (Kojima et al., 1999; Itoh et al., 2000; Freitas et al., 2009). Balcerczyk and 
colleagues (2005) reported an induction of DAF-FM fluorescence using various peroxynitrite 
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concentrations. However, this was limited to less than one fluorescent unit in the diacetate form 
even in the presence of supra-physiological concentrations of peroxynitrite. Moreover, DAF-FM 
DA fluorescence induced by peroxynitrite is 300 times less than DAF-FM at similar peroxynitrite 
concentrations. In a recent study, the sensitivity of DAF-FM DA was examined by incubating plant 
tissue with the nitric oxide donor or scavenger, sodium nitroprusside (SNP) and 2-(4-
Carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (cPTIO) respectively (Kolbert et 
al., 2012). Incubation with SNP significantly increased fluorescence intensity of DAF-FM T over 
all concentrations tested. However, this SNP-induced increase was abolished with co-incubation of 
cPTIO. No change was observed in DAF-FM T fluorescence when tissues were incubated with 
increasing concentrations of hydrogen peroxide. Based on these studies, it can be concluded that 
DAF-FM DA is specific for nitric oxide as long as precaution is taken to limit photobleaching. The 
present study and previous reported observations demonstrate that DAF-FM DA is a reliable 
indicator of nitric oxide in biological samples. However, to validate this stress-induced increase in 
nitric oxide, this study utilised the conventional method of assessing the stable metabolites, NOx.  
Immobilisation stress induced an increase in nitric oxide metabolites by approximately 40-60% 
from baseline over the duration of stress exposure. The magnitude of changes in NOx is in the range 
reported in blood from patients suffering major depression, suicidal ideation, and autism. (Suzuki et 
al., 2001; Sogut et al., 2003; Lee et al., 2006). The significance of this comparison lies in the link 
between increased nitric oxide and release of the excitatory amino acid glutamate in the central 
nervous system (Segieth et al., 1995). It is a common observation in stress models that glutamate 
release is enhanced while glial-mediated glutamate cycling is reduced, leading to altered synaptic 
transmission in limbic and cortical areas (Yuen et al., 2009). Although the underlying mechanisms 
between stress and the nitrergic system remain unclear, a number of studies have demonstrated that 
various inhibitors of nitric oxide synthase possess anxiolytic- and antidepressant-like properties 
(Volke et al., 2003; Joca and Guimaraes, 2006; Zhang et al., 2010). Interestingly, Zhang and 
colleagues (2010) demonstrated that selective serotonin type 1A receptor agonist 8-hydroxy-2-(di-
n-propylamino)tetralin (8-OH-DPAT) and selective serotonin reuptake inhibitor fluoxetine reduce 
neuronal nitric oxide synthase protein expression in the hippocampus and display a reduction in 
anxiety-like behaviours. Furthermore, knock out mice lacking neuronal nitric oxide synthase also 
demonstrated a reduction in anxiety-like behaviour and were no longer sensitive to serotonin 
agonists or uptake inhibitors. A follow up study revealed that chronic mild stress and glucocorticoid 
exposure lead to hippocampal neuronal nitric oxide synthase overexpression (Zhou et al., 2011). 
This increase in neuronal nitric oxide synthase-derived nitric oxide caused the downregulation of 




In addition to changes in central nervous system activity, persistent increases in nitric oxide lead to 
cellular damage directly, or by interaction with superoxide, leading to the formation of peroxynitrite 
radicals. Damage via protein carbonyl formation and lipid peroxidation has been shown in 
erythrocytes and neural tissues following exposure to different stressors (Sahin et al., 2004; Sahin 
and Gumuslu, 2007). In the present study, oxidative status increased by approximately 30% at 120 
minutes of immobilisation stress. Increases in GSH oxidation to GSSG should follow increases in 
cellular oxidative status, as is evident in our data after 120 minutes of stress exposure. This 
coincided with increased plasma malondialdehyde production, a widely accepted general indicator 
of oxidative damage. Liu and colleagues (1994) demonstrated a significant increase in plasma lipid 
peroxidation using similar methods following 6 hours of immobilisation stress which could be 
reversed by reduced glutathione treatment, implicating directly the causative role of oxidative 
damage.  
By showing changes in the oxidative and nitrosative systems, and linking these to indices of cellular 
oxidative damage, the present study has confirmed the involvement of RNS in the rapid redox 
response to stress. Together with ROS, these likely contribute to the depletion of the cellular 
glutathione ratio and increase in markers of lipid peroxidation. Interestingly, it has been suggested 
that NOx, particularly nitrite, act as a nitric oxide reservoir. The rapid oxidation of nitric oxide to 
nitrite allows this stable metabolite to increase bioavailability by requiring only a single electron for 
regeneration to nitric oxide, a step catalysed enzymatically by xanthine oxidoreductase and non-
enzymatically by deoxygenated haem proteins under low oxygen tension. This regeneration of nitric 
oxide can partially offset local hypoxic conditions where production by the nitric oxide synthase 
system would not be possible. Under stress, particularly in tissues with increased cellular 
metabolism, localised hypoxia caused by increased oxygen consumption may be offset by nitric 
oxide production in this manner. Moreover, preferential metabolism of nitric oxide to nitrite and 
nitrate would limit the production of other reactive metabolites such as peroxynitrite, thereby 
playing a potential protective role in the acute response to psychological stress. The time domain 
and recovery of these physiological changes following stress exposure in the current study is an 
important consideration for future studies utilising oxidative measures in peripheral blood. 
Furthermore, the mechanistic link between stress exposure, glucocorticoids, and increased nitric 







We would like to thank Ms. Kerri Tyrrell for her technical assistance and the animal technicians 
from the University of Queensland Biological Resources animal house.  
3.7 Conflict of Interest 
The authors declare no competing financial interests. 
3.8 Role of Funding Source 











































Acute restraint stress induces specific changes in 
nitric oxide production and inflammatory markers 








This chapter has been published in: Free Radical Biology and 















4.1 Abstract  
Chronic mild stress has been shown to cause hippocampal neuronal nitric oxide synthase (NOS) 
overexpression and the resultant nitric oxide (NO) production has been implicated in the aetiology 
of depression. However, the extent of nitrosative changes including NOS enzymatic activity and the 
overall output of NO production in regions of the brain like the hippocampus and striatum 
following acute stress has not been characterised. In this study, outbred male Wistar rats aged 6-7 
weeks were randomly allocated into 0 (control), 60, 120, or 240 minute stress groups and neural 
regions were cryodissected for measurement of constitutive and inducible NOS enzymatic activity, 
nitrosative status, and relative gene expression of neuronal and inducible NOS. Hippocampal 
constitutive NOS activity increased initially but was superseded by the inducible isoform as stress 
duration was prolonged. Interestingly, hippocampal neuronal NOS and interleukin 1β mRNA 
expression was downregulated, while the inducible NOS isoform was upregulated in conjunction 
with other inflammatory markers. This pro-inflammatory phenotype within the hippocampus was 
further confirmed with an increase in the glucocorticoid-antagonizing macrophage migration 
inhibitory factor, Mif, and the glial surveillance marker, Ciita. This indicates that despite high levels 
of glucocorticoids, acute stress sensitises a neuroinflammatory response within the hippocampus 
involving both pro-inflammatory cytokines and inducible NOS while concurrently modulating the 
immunophenotype of glia. Furthermore, there was a delayed increase in striatal inducible NOS 
expression while no change was found in other pro-inflammatory mediators. This suggests that 
short term stress induces a generalised increase in inducible NOS signalling that coincides with 















4.2 Introduction  
In response to a stressor, sympathetic activation results in the release of epinephrine and 
norepinephrine from the adrenal medulla, causing a catecholamine surge in the blood circulation, 
generating a ‘fight-or-flight’ response (Jansen et al., 1995). Subsequent activation of the 
hypothalamic-pituitary-adrenal (HPA) axis leads to an increase in the amplitude and 
synchronization of corticotropin-releasing hormone (CRH) and arginine vasopressin (AVP) 
secretions from the parvocellular neuroendocrine cells (Tsigos and Chrousos, 2002). 
Synergistically, AVP acts with CRH on the anterior pituitary corticotrophs, potentiating the release 
of adrenocorticotropic hormone (ACTH), which in turn stimulates adrenal glucocorticoid 
production. The stress-induced hyperactivity also activates the renin-angiotensin-aldosterone 
system which, via the action of angiotensin II on the paraventricular nucleus of the hypothalamus, 
facilitates stimulation of CRH, ACTH, and adrenal glucocorticoids (Ganong and Murakami, 1987; 
Veltmar et al., 1992; Saavedra and Benicky, 2007; Bali and Jaggi, 2013). The biologically available 
fractions of corticosterone not bound to high affinity carrier proteins are capable of crossing the 
blood-brain barrier and are responsible for mediating negative feedback (Pardridge and Mietus, 
1979). This feedback mechanism depends on the binding of corticosteroids to cytosolic 
glucocorticoid receptors (GR) which translocate into the nucleus and interact as homodimers with 
specific glucocorticoid responsive elements, thus repressing Crh and Avp gene expression to 
terminate the stress response and restore homeostasis (Watts, 2005).  
Following the release of the stress hormone corticosterone, blood glucose concentrations rapidly 
elevate through processes of hepatic gluconeogenesis and insulin resistance necessary for the 
adaptive responses to stress, including increased mitochondrial ATP production via oxidative 
phosphorylation (Teague et al., 2007; Du et al., 2009; Li et al., 2013). This glucocorticoid-driven 
increase in cellular metabolism is subject to a small percentage of electron ‘leakage’ from the 
electron transport chain, ultimately generating free radicals such as superoxide in place of water 
molecules, in addition to other members of the reduction/oxidation (redox) system such as nitric 
oxide (NO) (Spiers et al., 2014a). We have previously demonstrated that peripheral measures of 
oxidative and nitrosative status are affected significantly by an acute psychological stress and can 
persist beyond the cessation of the stressor (Spiers et al., 2013; Chen et al., 2014). Recently, there 
has been considerable interest in elucidating the role of the redox system in the downstream cellular 
events initiated by stress exposure. Zhou and colleagues (2007) found that the expression and 
activity of the constitutive enzyme, neuronal nitric oxide synthase (nNOS), which produces NO in 
central and peripheral neurons, increased following chronic mild stress in the hippocampus of adult 
mice. No change was observed in the constitutive endothelial isoform (endothelial nitric oxide 
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synthase; eNOS) and the transcription-dependent inducible nitric oxide synthase (iNOS). However, 
Olivenza and colleagues (2000), using a chronic immobilisation paradigm, and Peng and colleagues 
(2012), using unpredictable chronic mild stress, demonstrated that iNOS expression was increased 
in the cerebral cortex. The latter group suggested that this iNOS-derived NO following chronic 
stress may contribute to depressive-like behaviours in mice. A single episode of 6 hours acute 
restraint stress in rats also significantly increased iNOS activity in the cerebral cortex, an effect 
mediated by nuclear factor Kappa-light-chain-enhancer of activated B cells (NF-κB) signalling 
(Madrigal et al., 2001; Madrigal et al., 2002).  
A number of studies have now implicated NO at both the modulatory and mechanistic levels of the 
stress system. Mohn and colleagues (2005) discovered that corticosterone is released via a NO and 
prostaglandin-dependent pathway stimulated by either ACTH or the NO donor, sodium 
nitroprusside, highlighting the importance of redox molecules in the neuroendocrine stress system 
under physiological conditions. Using a chronic mild stress paradigm, Zhou and colleagues (2011) 
showed that stress increases hippocampal nNOS expression via a MR-dependent mechanism 
causing chronic production of NO, ultimately leading to down-regulation of GR, a factor linked to 
the development of depression. Together, these studies demonstrate that the neuronal isoform of 
NOS in limbic regions is predominately associated with chronic stress exposure, while iNOS in 
cortical regions is responsive to both acute and chronic stress. However, the cellular, physiological, 
and functional effects of the nitrergic system following short term stress are poorly understood. In 
this study, we used the hippocampus and striatum, regions that display differential stress sensitivity 
and redox responses, to characterise the temporal changes in the neuronal and inducible NOS 
isoforms and pro-inflammatory markers following acute psychological stress. 
4.3 Materials and Methods  
4.3.1 Experimental animals  
Outbred male Wistar rats (Rattus norvegicus) aged 6-7 weeks postnatal, weighing 297.9 ± 3.8 g 
were sourced from The University of Queensland Biological Resources breeding colony. Rats were 
housed individually under standard laboratory conditions (22 ± 2°C; 55 ± 5% humidity) with a 
12:12h light-dark cycle (lights off at 12.30h). Standard rat chow and water were available ad 
libitum. All experimental procedures were in accordance with regulations and policies outlined by 
The University of Queensland Animal Ethics Committee with AEC approval numbers 018/11.  
4.3.2 Habituation and transportation  
Rats were habituated to human handling for 10 minutes per day one week prior to experimentation. 
On each experimental day, rats were transported in individual home cages from the colony room to 
an experimental room within the same animal facility. Rats were acclimatised to the novel 
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experimental room under low light and noise for one hour prior to treatment. To isolate the effects 
of restraint stress, all rats were deprived of food and water during the one hour habituation and 
treatment period. 
4.3.3 Acute restraint stress  
Rats were subjected to acute restraint stress using adjustable wire mesh restrainers to avoid 
overheating and body compression. The wire mesh restrainer was made of a PVC skeleton coated 
externally with welded wire mesh (6 mm × 6 mm grid). Acute restraint stress was applied for 60, 
120, and 240 minutes (stress treatment starting at 13:30h) within individual home cages enclosed 
with a larger ventilated containment chamber (68 cm (L) × 45 cm (W) × 38.5 cm (H)) to reduce any 
external disturbances.  
4.3.4 Treatment protocol and tissue collection  
Animals were randomly allocated to 0 (control), 60, 120, or 240 minutes stress treatment groups 
(n=5-8 per group). At the end of each treatment period, rats were weighed and sacrificed with 
sodium pentobarbital (100 mg/kg i.p. injection, Lethabarb, Virbac) and a single blood sample was 
collected via cardiac puncture into ice-chilled heparinised tubes (20 IU/mL blood). The brain was 
rapidly removed and frozen on powdered dry ice for storage at -80°C. Whole blood was centrifuged 
at 200 × g for 5 minutes and supernatant plasma was collected and stored at -80°C for later 
determination of corticosterone. Frozen brains were sectioned on a cryostat and the hippocampus 
and striatum were dissected out on a powdered dry ice-embedded metal platform according to the 
rat brain atlas (Paxinos and Watson, 2007). Regionalised neural tissues were stored at -80°C for 
later determination of the enzymatic activity of NOS, NO metabolism, 4-amino-5-methylamino-2’, 
7’-difluorofluorescein (DAF-FM) activation, and relative gene expression.  
4.3.5 Plasma corticosterone assay 
Corticosterone concentrations were determined using an in-house radioimmunoassay employing a 
highly specific ovine anti-rat corticosterone polyclonal antibody (Sapphire Bioscience Pty. Ltd.) 
and tritiated [1, 2, 6, 7 - 
3
H]-corticosterone tracer as previously described in Spiers and colleagues 
(2013). Radioactivity was counted in liquid scintillation cocktail (Ultima Gold
TM
, Perkin Elmer) 
using a Liquid Scintillation Spectrometer (Tri-Carb 3100 TR, Perkin Elmer). Concentrations of 
unknown sample were determined from a standard curve and corrected for dilution and extraction 
efficiency. Dichloromethane extraction recovery was 89.65% and intra- and inter-assay coefficients 
of variation were 4.70% and 4.59% respectively.  
4.3.6 Neural tissue preparation  
The hippocampus and striatum were homogenised (IKA® Ultra-Turrax® T10) in 20 volumes (w/v) 
of phosphate buffered saline (PBS; 50 mM, pH=7.4) and the crude homogenates were centrifuged 
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at 10,000 x g for 10 minutes at 4°C. The resulting supernatant was used for the determination of 
NOS enzymatic activity, DAF-FM activation, and protein concentrations. For the quantification of 
total nitrite and nitrate (NOx), 60 µL of the 20 volume supernatant was ultra-filtered through a 10-
kDa molecular weight cut-off filter using commercially available centrifugal devices (Pall 
Nanosep
®
, Cheltenham, Australia).  
4.3.7 Assay of calcium-independent and dependent nitric oxide synthase activity 
The enzymatic activity of calcium-independent and dependent NOS isoform was determined by 




C(U)]-citrulline as described by 
Weissman and Gross (2001) with modifications. In brief, 10 µL of tissue supernatant was added 
with 12.5 µL of assay buffer (50 mM Tris-HCl; pH=7.4 with 1.25 mM CaCl2, 1 mM of MgCl2, 0.6 
mM of L-valine, and 1 mM of dithiothreitol). A 12.5 µL aliquot of a mixture of cofactors 
containing 50 mM Tris-HCl with 100 nM calmodulin, 40 µM of (6R)-5, 6, 7, 8-tetrahydrobiopterin 
dihydrochloride, 8 µM of flavin adenine dinucleotide, and 8 µM of riboflavin 5′-monophosphate 
was then added. A 2.5 µL aliquot of either MiliQ or 20 mM EGTA was added to determine total or 
calcium-independent iNOS activity respectively. An enzyme blank control was included for every 
sample using a non-specific NOS inhibitor which required 12.5 µL of 8 mM Nω-nitro-L-arginine 
methyl ester hydrochloride (L-NAME) instead of the cofactors followed by the addition of 2.5 µL 
EGTA (20 mM). Reactions were initiated by the addition of radiotracer mix (12.5 µL) containing 
50 mM of Tris-HCl, 2 µCi/mL of L-[
14
C(U)]-citrulline, and 4 mM of NADPH at 25°C and 
incubated for 30 minutes. The reaction was stopped by addition of 700 µL of 1 part Dowex AG 
50W-X8 (100-200 mesh, Na
+
 form) to 2 parts EDTA-HEPES buffer (pH=5.5; v/v) with 80 µM of 
L-NAME followed by 2 mL of MiliQ. L-[
14
C(U)]-citrulline was specifically eluted by 
centrifugation at 1000 x g for 5 minutes and the radioactivity was quantified with a Liquid 
Scintillation Spectrometer (Tri-Carb 3100 TR, Perkin Elmer). Enzyme activities were calculated as 
pmol/min/mg protein after accounting for individual enzyme blank controls and the presence or 
absence of EGTA and data were expressed relative to control values.  
4.3.8 Nitric oxide metabolism in neural tissue  
The total NO metabolites, NOx, were measured in ultra-filtered supernatant using a commercially 
available colorimetric assay kit according to the manufacturer’s instructions (Cayman Chemical 
Company, Ann Arbor, MI, USA). Samples were corrected with corresponding protein 
concentrations and expressed as µM per mg of protein.  
4.3.9 Nitric oxide production in neural tissue 
Production of NO was assayed with 4-amino-5-methylamino-2′, 7′-difluorofluorescein diacetate 
(DAF-FM DA) according to method previously described in Chen and colleagues (2014). Briefly, a 
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4 µM DAF-FM DA working solution was prepared fresh in PBS (50 mM, pH=7.4). Four replicates 
of diluted tissue supernatant were plated on a 96-well plate containing a final concentration of 2 µM 
of DAF-FM DA under low light conditions. Plates were incubated for 60 minutes at room 
temperature and sample fluorescence was measured by a POLARstar OPTIMA microplate reader 
(BMG Labtechnologies). Data were corrected with corresponding protein concentrations and 
expressed as the percentage change in arbitrary fluorescence units relative to control values.  
4.3.10 Real-time PCR 
Total RNA from each representative region was extracted using the RNeasy mini kit (Qiagen, 
Doncaster, Australia) treated with deoxyribonuclease I and reversed transcribed into cDNA using 
iScript™ Reverse Transcription Supermix (Bio-Rad Laboratories, Gladesville, Australia) according 
to the manufacturer’s instructions. Taqman gene expression ‘assay-on-demandTM’ kits (Life 
Technologies, Mulgrave, Australia) with optimised primers and reporter dye labelled-probes (FAM; 
6-carboxyfluorescein) were used to detect gene expression of Nr3c1 (glucocorticoid receptor; 
Rn00561369_m1), Nr3c2 (mineralocorticoid receptor; Rn00565562_m1), Nos1 (neuronal nitric 
oxide synthase; Rn00583793_m1), Nos2 (inducible nitric oxide synthase; Rn00561646_m1), Il1b 
(interleukin 1 beta; Rn00580432_m1), Il6 (interleukin 6; Rn01410330_m1), Nfkbia (nuclear factor 
of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; Rn01473657_g1), Ciita (class 
II, major histocompatibility complex, transactivator; Rn01424725_m1), and Mif (macrophage 
migration inhibitory factor; Rn00821234_g1). All expression assays were multiplexed with 2’-
chloro-7’-phenyl-1, 4-dichloro-6-carboxyfluorescein (VIC)-labelled glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) as endogenous control on the QuantStudio
TM
 6 Flex Real-Time PCR 
System (Applied Biosystems, Foster City, CA). The fold change in expression of each target gene 
was calculated using the ∆∆CT method relative to the control group.  
4.3.11 Protein estimation 
Protein content was determined with a commercially available RED 660
TM
 Protein Assay (G-
Biosciences, St Louis, USA) using bovine serum albumin as a standard.  
4.3.12 Statistical analysis 
Data were analysed using statistical software GraphPad Prism (Version 6.0, GraphPad Software 
Inc., San Diego, CA, USA). Initially, data were tested for equal group variance and normality using 
Brown-Forsythe and Bartlett’s tests. Any data with significant group variability were compared 
using a non-parametric Kruskal-Wallis ANOVA with Dunn’s multiple comparisons post-test. All 
other normally distributed data were compared using one-way ANOVA with Dunnet’s multiple 
comparisons post-test to compare control and stress data. Results were expressed as mean ± 





4.4.1 Indicators of HPA activity 
To indicate that restraint in the dark-cycle is a highly effective stressor, we determined 
concentrations of the plasma stress hormone, corticosterone, which demonstrated significant 
increases above values of unrestrained controls (288.6 ± 21.01 ng/mL) when compared using a non-
parametric Kruskal-Wallis test (p≤0.001). Dunn’s post-test analysis demonstrated a greater than 2-
fold increase above controls at 60 [711.0 ± 95.54 ng/mL; p<0.01], 120 [609.7 ± 72.82 ng/mL; 
p<0.01], and 240 [591.6 ± 39.08 ng/mL; p<0.01] minutes (Fig. 4.1A). High levels of circulating 
corticosterone are known to cause down-regulation of GR mRNA in HPA-regulatory regions such 
as the hippocampus. One-way ANOVA of hippocampal GR mRNA [F(3,20)=4.023, p=0.0216] 
revealed significant decreases relative to controls at 60 [0.88 ± 0.03; p<0.05], 120 [0.85 ± 0.03; 
p<0.05], and 240 [0.87 ± 0.04; p<0.05] minutes of stress exposure (Fig. 4.1B). No significant 
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Figure 4.1. The effect of acute restraint stress on (A) plasma corticosterone, (B) hippocampal 
glucocorticoid receptor (Nr3c1), and (C) hippocampal mineralocorticoid receptor (Nr3c2) mRNA 
expression in control and stressed rats (n=6-8 per group). Plasma corticosterone concentration was 
determined in blood samples collected via cardiac puncture and the relative mRNA expression was 
determined in isolated hippocampal tissue from rats exposed to 0 (control), 60, 120, and 240 












4.4.2 Hippocampal nitrergic activity 
The synthesis of NO was determined using an established radiometric assay of citrulline formation 
by the NOS enzyme. This assay measures the total, calcium-dependent activity of both neuronal and 
endothelial isoforms, and the calcium-independent activity of the inducible isoform. One-way 
ANOVA [F(3,16)=6.375, p=0.0048] demonstrated stress was effective at increasing total NOS 
activity. A Dunnet’s post-test analysis revealed significant increases at 60 [140.7 ± 5.83%; p<0.01], 
120 [126.7 ± 5.02%; p<0.05], and 240 [131.8 ± 10.29%; p<0.05] minutes (Fig. 4.2A). This increase 
was due in part to calcium-dependent NOS activity which was shown to increase after stress 
[F(3,16)=5.595, p=0.0081]. This increase was only significantly elevated above unstressed controls at 
60 minutes [142.6 ± 5.32%; p<0.01] of stress exposure (Fig. 4.2B). A one-way ANOVA also 
demonstrated a significant effect of stress on calcium-independent NOS activity [F(3,16)=3.73, 
p=0.0331]. However, in contrast to the calcium-dependent isoforms, post-test analysis demonstrated 
that the activity of the iNOS isoform was only significantly elevated following 240 [219.2 ± 
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Figure 4.2. The effect of acute restraint stress on (A) total nitric oxide synthase (NOS), (B) 
constitutive NOS, and (C) inducible NOS enzymatic activity in the hippocampus of control and 
stressed rats (n=5 per group). Enzymatic activities were determined in isolated hippocampal tissue 
collected from rats exposed to 0 (control), 60, 120, and 240 minutes of restraint stress. Data are 














Figure 4.3A shows the effects of stress on the stable metabolites of NO, NOx. A one-way ANOVA 
[F(3,28)=4.952, p<0.007] showed that the concentration of NOx increased significantly relative to 
controls (5.27 ± 0.37 µM/mg protein). Dunnet’s post-test analysis demonstrated increases at 60 
[8.67 ± 1.03 µM/mg protein; p<0.01] and 120 [7.98 ± 0.60 µM/mg protein; p<0.05] minutes of 
stress. Figure 4.3B shows the overall hippocampal DAF-FM activation assessed using a novel semi-
quantitative assay monitoring the formation of the highly fluorescent benzotriazole derivative of 
DAF-FM. One-way ANOVA of DAF-FM T formation [F(3,28)=4.105, p=0.0156] demonstrated 
increases relative to unstressed controls (26.3 ± 0.92 AU/mg protein). Post-test analysis revealed 
significantly increased DAF FM T at 60 [32.76 ± 1.96 AU/mg protein; p<0.05], 120 [33.56 ± 1.78 
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Figure 4.3. The effect of acute restraint stress on hippocampal (A) total nitrite and nitrate (NOx) 
and (B) nitrosative status measured by the benzotriazole derivative of 4-amino-5-methylamino-2’, 
7’-difluorofluorescein (DAF-FM T) formation in control and stressed rats (n=8 per group). The 
metabolism and general production of nitric oxide were determined in isolated hippocampal tissue 
collected from rats exposed to 0 (control), 60, 120, and 240 minutes of restraint stress. Data are 









4.4.3 Hippocampal mRNA expression of NOS and inflammatory markers 
To further evaluate the changes observed in the hippocampal nitrergic system, mRNA levels for the 
neuronal and inducible NOS isoforms were measured by quantitative real-time PCR. One-Way 
ANOVA [F(3,20)=3.141, p=0.0481] of hippocampal nNOS showed that stress decreased the mRNA 
expression (Fig. 4.4A). Post-test analysis showed that this was significantly lower relative to 
unstressed controls at 60 [0.82 ± 0.03; p<0.05] and 120 [0.83 ± 0.05; p<0.05] minutes. Figure 4.4B 
shows the effects of stress on iNOS expression. A non-parametric Kruskal-Wallis test (p≤0.01) with 
Dunn’s post-test analysis revealed a substantial increase in iNOS mRNA expression of 
approximately 10.5-fold at 240 [13.84 ± 5.76; p<0.01] minutes. Expression of the inhibitory 
subunit, Nfkbia (or IκB-α), were also monitored following stress exposure (Fig. 4.4C). A one-way 
ANOVA [F(3,20)=29.71,p<0.0001] of IκB-α mRNA demonstrated stress was highly effective at 
increasing the expression of this subunit. Post-test analysis revealed significant increases at 60 [1.83 
± 0.12; p<0.001], 120 [2.13 ± 0.04; p<0.001], and 240 [1.81 ± 0.09; p<0.001] minutes. 
To determine if the changes in iNOS expression were accompanied by other inflammatory 
indicators, mRNA levels of the pro-inflammatory cytokines interleukin-1β (IL-1β) and interleukin-6 
(IL-6) were determined. One-way ANOVA [F(3,18)=3.836, p=0.0276] of IL-1β showed stress 
significantly decreased expression of this cytokine in the hippocampus. Post-test analysis indicated 
that 60 [0.63 ± 0.05; p<0.05] minutes of stress exposure significantly decreased IL-1β expression, 
with subsequent stress durations returning towards control values (Fig. 4.4D). Figure 4.4E shows 
hippocampal IL-6 expression following stress exposure. A one-way ANOVA [F(3,18)=3.896, 
p=0.0262] of this data showed a significant increase in expression of this cytokine following stress 
exposure. Dunnett’s post-test analysis revealed this increase was significant at 60 [1.71 ± 0.21; 
p<0.05], 120 [1.66 ± 0.09; p<0.05], and 240 [1.70 ± 0.18; p<0.05] minutes of stress exposure 
relative to controls. Expression of the novel pro-inflammatory cytokine, Mif, was also shown to 
increase in a one-way ANOVA [F(3,18)=3.461, p=0.0382], becoming significantly upregulated at 240 
[1.24 ± 0.04; p<0.05] minutes of stress exposure (Fig. 4.4F). Figure 4.4G demonstrates the effects 
of stress exposure on the glial-specific transcriptional coactivator of class II major 
histocompatibility complex, Ciita, in the hippocampus. A non-parametric Kruskal-Wallis test 
(p<0.001) with Dunn’s post-test analysis revealed a significant increase in Ciita expression 
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Figure 4.4. The effect of acute restraint stress on hippocampal (A) neuronal nitric oxide synthase 
(Nos1), (B) inducible nitric oxide synthase (Nos2), (C) nuclear factor of kappa light polypeptide 
gene enhancer in B-cells inhibitor, alpha (Nfkbia), (D) interleukin-1β (Il1b), (E) interleukin-6 (Il6), 
(F) macrophage migration inhibitory factor (Mif), and (G) class II, major histocompatibility 
complex, transactivator (Ciita) mRNA expression in control and stressed rats (n=6 per group). The 
relative expression was determined in isolated hippocampal tissue collected from rats exposed to 0 





















4.4.4 Striatal NO production, metabolism, and synthesis 
Figure 4.5A shows the changes observed in total NOS activity in the striatum. A one-way ANOVA 
[F(3,16)=3.53, p=0.039] demonstrated significant increases in total activity at 120 [131.2 ± 9.25%; 
p<0.05], and 240 [129.6 ± 6.93%; p<0.05] minutes. Although no changes were observed in 
constitutive NOS activity (Fig. 4.5B), calcium-independent activity was significantly increased 
following stress exposure (Fig. 4.5C). Post-test analysis of these results indicated that this inducible 
activity was increased above non-stressed controls at 120 [212.5 ± 23.97%; p<0.05] and 240 [233.9 
± 22.44%; p<0.01] minutes. 
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Figure 4.5. The effect of acute restraint stress on (A) total nitric oxide synthase (NOS), (B) 
constitutive NOS, and (C) inducible NOS enzymatic activity in the striatum of control and stressed 
rats (n=5 per group). The enzymatic activities were determined in isolated striatal tissue collected 
from rats exposed to 0 (control), 60, 120, and 240 minutes of restraint stress. Data are expressed as 





There were no significant changes observed in striatal NOx concentrations (Fig. 4.6A). However, 
Figure 4.6B highlights the changes in striatal DAF-FM T formation following stress exposure. A 
one-way ANOVA [p=0.08] and post-test of these results suggested that there may be a non-
significant trend towards an increase at 240 [p<0.05] minutes of stress exposure. 
 




Figure 4.6. The effect of acute restraint stress on striatal (A) total nitrite and nitrate (NOx) and (B) 
nitrosative status measured by the benzotriazole derivative of 4-amino-5-methylamino-2’, 7’-
difluorofluorescein (DAF-FM T) formation in control and stressed rats (n=8 per group). The 
metabolism and general production of nitric oxide were determined in isolated striatal tissue 
collected from rats exposed to 0 (control), 60, 120, and 240 minutes of restraint stress. Data are 
















4.4.5 Striatal mRNA expression of NOS and inflammatory markers 
Similar to the observations in NO synthesis, no changes were observed in nNOS mRNA expression 
in the striatum (Fig. 4.7A). Furthermore, iNOS mRNA demonstrated significant increases relative 
to controls in a non-parametric Kruskal-Wallis test (p≤0.021) at 120 [5.06 ± 1.10; p<0.05] and 240 
[7.70 ± 2.77; p<0.05] minutes (Fig. 4.7B). These results were also observed alongside increases in 
IκB-α mRNA [F(3,20)=25.91, p<0.0001] which demonstrated a similar expression profile to the 
hippocampus, with significant increases at 60 [1.92 ± 0.04; p<0.001], 120 [2.09 ± 0.10; p<0.001], 
and 240 [1.66 ± 0.14; p<0.001] minutes of stress exposure (Fig. 4.7C). Figure 4.7D shows the 
changes in striatal IL-1β following stress exposure. A one-Way ANOVA [F(3,20)=3.48, p=0.0351] 
indicated stress significantly decreased expression of IL-1β relative to controls. A Dunnett’s post-
test analysis showed, similar to the hippocampus, this decrease occurred at 60 [0.53 ± 0.09; p<0.05] 
minutes of stress exposure, with a recovery at subsequent time points. No differences were observed 
in striatal expression of IL-6 (Fig. 4.7E) or Mif (Fig. 4.7F), while Ciita (data not shown) was not 
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Figure 4.7. The effect of acute restraint stress on striatal (A) neuronal nitric oxide synthase (Nos1), 
(B) inducible nitric oxide synthase (Nos2), (C) nuclear factor of kappa light polypeptide gene 
enhancer in B-cells inhibitor, alpha (Nfkbia), (D) interleukin-1β (Il1b), (E) interleukin-6 (Il6), and 
(F) macrophage migration inhibitory factor (Mif) mRNA expression in control and stressed rats 
(n=6 per group). The relative expression was determined in isolated striatal tissue collected from 
rats exposed to 0 (control), 60, 120, and 240 minutes of restraint stress. Data are expressed as mean 




This study examined the physiological changes occurring in the nitrergic system following 60, 120, 
and 240 minutes of restraint stress in the hippocampus and striatum, regions known to display 
differential redox responses following stress (Liu et al., 1996). There was a rapid increase in 
hippocampal nitrosative status due to an initial increase in the activity of calcium-dependent 
constitutive NOS at 60 minutes of restraint stress. Interestingly, nNOS mRNA levels decreased 
following 60 and 120 minutes of stress exposure. Transcriptional activation of iNOS at 240 minutes 
of stress was observed with increased iNOS activity which sustains the elevation in overall 
hippocampal DAF-FM activation. Specific changes in inflammatory markers were also observed 
alongside an increase in Ciita, a transactivation marker of antigen presenting cells predominately 
expressed in glia. In comparison, there was a delayed stress-induced increase in striatal nitrosative 
status at 240 minutes of stress which was driven by the inducible isoform, while changes in 
inflammatory markers remained consistent with the anti-inflammatory properties of increased 
glucocorticoid concentrations. Furthermore, increases in mRNA expression of the inhibitory 
subunit, IκB-α, indicate activation of NF-κB in both the hippocampus and striatum.  
It is well known that corticosterone mediates adaptation to stress through intrinsic negative 
feedback mechanisms. In the present study, acute restraint stress elicited increases in plasma 
corticosterone secretion of approximately 150% at 60 minutes, and 100% at both 120 and 240 
minutes following stress induction. Within the hippocampus, ligand-activated cytosolic GR 
translocate into the nucleus to regulate target gene expression, including down-regulation of GR 
itself. As a positive control for neural gene expression, we assessed hippocampal GR mRNA levels 
which demonstrate an approximately 15% reduction at all stress periods relative to controls. This is 
comparable to similar time-course experiments suggesting intact negative feedback mechanisms 
(Noguchi et al., 2010). No change was observed in hippocampal MR mRNA level, a result similar 
to the study by Paskitti and colleagues (2000) who demonstrated unchanged full-length MR mRNA. 
However, they also demonstrated a 50% reduction in MR heterogeneous nuclear RNA in rat 
hippocampus 60-120 minutes following a 30 minute restraint stress, suggesting an increase in the 
stability of full-length MR mRNA following acute stress.  
Under basal conditions, NO serves many important functions in the central nervous system 
including synaptic plasticity, neurotransmitter release, immune-like activity, and hormonal secretion 
via activating soluble guanylyl cyclase (sGC), leading to the release of second messenger cyclic 
guanosine monophosphate (cGMP) (Cao et al., 1996; Bogdan, 2001; Calka, 2006; Garthwaite, 
2008). The present study demonstrated a 25-30% stress-induced increase in hippocampal DAM-FM 





2 which reacts with DAF-FM to form a non-fluorescent intermediate before a second reaction 
with NO forms the highly fluorescent DAF-FM triazole product (Namin et al., 2013). Alternatively, 
NO production can be estimated by determining the concentrations of total NO metabolites, NOx. 
Restraint stress significantly induced an increase in hippocampal NOx by approximately 65% at 60 
minutes and 50% at 120 minutes of stress exposure, with a non-significant 20% increase at 240 
minutes. In comparison, Moraes-Neto and colleagues (2014) observed an increase in rat dorsal 
hippocampal NOx following 10 and 30 minutes of acute restraint stress, while no significant 
changes were detected following 60 minutes of stress applied in the early light phase of the 
circadian cycle. Basal NOS activity within the rat brain, including the hippocampus, displays 
prominent circadian oscillations, with the highest NOS activity found toward the end of the 
behaviourally active dark phase (Ayers et al., 1996). This flux in NOS activity may account for the 
differential results observed in these two studies and highlights an important experimental 
consideration. 
To determine which class of NOS isoforms produced the overall increase in the functional output of 
NO within the hippocampus, the enzymatic activity of constitutive NOS and iNOS were measured 




C(U)]-citrulline. Total NOS activity 
was elevated by approximately 30-40% at all stress periods when compared to unstressed controls. 
Furthermore, there was an initial 40% increase in constitutive NOS activity at 60 minutes of stress, 
with a non-significant 25% and 20% increase at 120 and 240 minutes respectively. In the brain, 
nNOS is tethered to the glutamatergic NMDA receptor, with calcium influx through this receptor 
triggering NO production. Using one hour restraint stress in rats, Lowy and colleagues (1993) 
reported an initial increase in glutamate release in the hippocampus at 10 minutes of stress which 
peaked at 20 minutes, and returned to baseline values by 40 minutes. Furthermore, nNOS-derived 
NO produced through the NMDA-mediated Ca
2+
 influx acts as a retrograde transmitter on 
presynaptic neurons to enhance neurotransmitter release and long term potentiation in the 
hippocampus, with the majority of these effects being mediated via NO-stimulated sGC binding and 
cGMP synthesis (Prast and Philippu, 2001; Chen et al., 2015). Additionally, Kotsonis and 
colleagues (1999) demonstrated that under defined conditions, the enzyme-derived reactive nitrogen 
species such as NO, and oxygen species such as hydrogen peroxide, have the potential to 
autoinhibit nNOS enzyme activity. Together, phasic activation of the glutamatergic NMDA 
receptor and NO/oxygen species-induced autoinhibition may begin to explain the observed decrease 
in nNOS activity following 60 minutes of stress. Conversely, iNOS activity in the hippocampus 
increased non-significantly by 15% and 35% at 60 and 120 minutes of stress, followed by a 
substantial and significant increase of approximately 120% at 240 minutes compared to controls. 
This production of NO can be sustained over a period of days as iNOS remains very stable at both 
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the mRNA and protein level (Vodovotz et al., 1993). In comparison, Gadek-Michalska and 
colleagues (2012) demonstrated that 10 minutes of restraint stress increased hippocampal nNOS 
protein content two hours post-stress, while no increase in iNOS was observed. Although this is 
likely due to the shorter duration of stress exposure employed, the measurement of protein content 
during the early light cycle where NOS protein expression is lowest may also be a contributing 
factor. Mechanistically, the observed increase in iNOS activity may be the result of glutamate 
receptor activation following stress, which induces up-regulation of TNF-α convertase, hence TNF-
α, and the subsequent activation of NF-κB (Madrigal et al., 2002). 
Interestingly, there was a 20% reduction in hippocampal nNOS mRNA levels at 60 and 120 minutes 
of restraint stress. Schwarz and colleagues (1998) have demonstrated down-regulation of nNOS 
expression by glucocorticoids in a concentration-dependent manner without changing the activity of 
the enzyme in a murine neuroblastoma cell line. Notably, NO and IL-1β have been reported to exert 
tonic inhibitory action on the sympathetic nervous system. However, within the brain, increased 
angiotensin II can inhibit mRNA expression of both nNOS and IL-1β to induce greater sympathetic 
nervous activity (Campese et al., 2002). In the present study, the observed down-regulation of both 
nNOS and IL-1β mRNA following stress likely results from the combination of increased 
corticosterone and angiotensin II release. Typically, iNOS is not expressed in resting cells, and yet 
there is a significant 10.5-fold increase in hippocampal iNOS mRNA levels following a 240 minute 
restraint stress which corresponds to the increased iNOS activity. Madrigal and colleagues (2002) 
demonstrated that the induction of iNOS protein expression and subsequent activity is dependent on 
NF-κB signalling. Under basal conditions, NF-κB is sequestered in the cytoplasm complexed to its 
inhibitor, IκB-α. In response to extracellular signalling, mainly by inflammatory cytokines, IκB 
kinases are rapidly activated and phosphorylate two critical serines in the N-terminal regulatory 
domain of the IκB molecule (Hayden and Ghosh, 2012). Phosphorylated IκB molecules undergo 
polyubiquitination and subsequent degradation, leading to NF-κB translocation to the nucleus and 
activation of target gene expression such as iNOS. Newly synthesised IκB-α can enter the nucleus 
to terminate NF-κB-dependent signals by removing the DNA binding and exporting the complex 
back to the cytoplasm to restore the original latent state. However, Madrigal and colleagues (2002) 
also demonstrated that the increase in TNF-α convertase activity, and subsequent TNF-α 
production, required for NF-κB activation are completely dependent on NMDA receptor signalling 
during stress exposure. The time domain of each of these events likely favour NF-κB activation as 
increased NMDA receptor signalling occurs rapidly in comparison to the inhibitory protein-protein 
interactions and increased IκB-α which require sufficient GR activation and protein synthesis 
respectively. Bottero and colleagues (2003) have proposed a different method for monitoring NF-
κB transactivation potential by quantifying IκB-α mRNA levels using real-time PCR. In the present 
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study, stress-induced increases in IκB-α mRNA levels, indicative of NF-κB activation, supports the 
extensive expression of iNOS. Furthermore, the observation of increased Ciita expression in the 
hippocampus indicates that glial cells likely play a role in these stress-induced mechanisms. 
Expression of Ciita is most prominent in glia and functions as a critical coactivator required for 
transcription of the antigen-presenting major histocompatibility complex II (Otten et al., 1998). It 
has also been suggested that iNOS expression in the CNS is primarily localised to astrocytes and 
microglia, becoming induced under pro-inflammatory conditions (Calabrese et al., 2007). 
Interestingly, while the inflammatory profile of IL-1β expression is consistent with the anti-
inflammatory effects of increased corticosterone, IL-6 expression is capable of overcoming this to 
be significantly elevated in hippocampal tissue. However, IL-6 is known to be resistant to 
glucocorticoid-mediated repression and acts as a potentiator of HPA activity (DeRijk et al., 1997; 
Lenczowski et al., 1999). Furthermore, the increase in Mif expression may begin to explain the 
rapid recovery of IL-1β expression in the presence of increased glucocorticoids. In the brain, this 
pro-inflammatory cytokine is released during stress and functions as a counter-regulator of 
glucocorticoid anti-inflammatory activity, allowing the expression of other pro-inflammatory 
cytokines such as IL-1β (Bucala, 1996). It has also been suggested that Mif can induce iNOS 
expression, though this may be an indirect effect via antagonism of glucocorticoid-induced NF-κB 
inhibition (Daun and Cannon, 2000; Bogdan, 2001). 
It is known that NO is one of the key regulators of neuronal activity in the striatum where 
production by nNOS interneurons is stimulated following concurrent activation of the glutamatergic 
corticostriatal and dopaminergic nigrostriatal pathways (West and Grace, 2000; Fino et al., 2009). 
Many studies have focused on the augmented striatal NO-sGC-cGMP signalling following 
dopamine depletion, the hallmark feature in the pathogenesis of Parkinson’s disease (West and 
Tseng, 2011; Friend et al., 2013; Schwenkgrub et al., 2013). However, the effect of stress on striatal 
nitrergic activity is not yet well characterised. Total NOS activity in the striatum was elevated at 
both 120 and 240 minutes of stress by approximately 40% when compared to unstressed controls. 
No change in activity was detected in the constitutive forms and nNOS mRNA levels across all 
stress periods examined, despite nNOS being relatively abundant in the dorsal striatum and nucleus 
accumbens (Bredt et al., 1990; Vincent, 1994). Acute restraint stress caused a delayed increase in 
the formation of DAF-FM T of approximately 25% compared to controls at 240 minutes in the 
striatum, while no change was observed in striatal total NOx. The output of NO in the striatum was 
entirely driven by iNOS activity, with an apparent 110-130% increase at 120 and 240 minutes of 
restraint stress exposure alongside a 4 to 6-fold elevation in iNOS mRNA levels at 120 and 240 
minutes of stress respectively. Expression of iNOS was also observed alongside increased IκB-α 
mRNA, though striatal IL-1β expression showed significant stress-induced repression, and both IL-
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6 and Mif expression were not significantly elevated due to stress exposure. This increase in NF-κB 
signalling could be the result of other rapidly accumulating inflammatory cytokines and 
oxidative/nitrosative stress caused by increased peroxynitrite and hydrogen peroxide production and 
subsequent glutathione depletion (Christman et al., 2000; Oliveira-Marques et al., 2009). Moreover, 
expression of iNOS and IκB-α mRNA is also observed in the medial prefrontal cortex, indicating 
that this may be a generalised response to stress exposure (Appendix Fig. A2 and A3).  
In summary, this study has demonstrated that short term restraint stress rapidly increases 
hippocampal nitrergic activity through a switch from constitutive to inducible NOS signaling 
accompanied by increased expression of inflammatory cytokines. This was consistent with a primed 
pro-inflammatory phenotype and shift towards adaptive immunity involving major 
histocompatibility complex-expressing glial elements. Conversely, striatal nitrosative status 
following stress is predominately mediated by iNOS with no change in other pro-inflammatory 
markers. Therefore, it is thought that despite the anti-inflammatory action of glucocorticoids, they 
may function as a warning signal to the central immune system and sensitise an array of specific 
immune adaptations including iNOS activation following acute stress. It is interesting to note that 
this increased iNOS activity appears to be a generalised response, while nNOS expression 
specifically decreased in the hippocampus, remained neutral in the striatum, and increased 
significantly within the medial prefrontal cortex by four hours of restraint (Appendix Fig. A1). This 
regional specificity in the expression pattern of nNOS may be due to the crucial role played by the 
limbic system in HPA axis activation. Taken together, the response to acute psychological stress 
involves regional and isoform specific changes in the nitrergic system observed concurrent ly 
alongside priming of central adaptive immunity. The link between nitrergic activity and 
inflammatory processes should be further explored to determine the contribution of immunologic 
priming to the pathogenesis of stress-related disorders such as depression. 
4.6 Acknowledgements 
We would like to thank Dr. James Cuffe for his advice in the real-time PCR analysis, Associate 
Professor Karen Moritz for her continuous support, Ms Mary White for her assistance with general 
laboratory maintenance, and the animal technicians from the University of Queensland Biological 
Resources animal house.  
4.7 Conflict of Interest 
The authors declare no competing financial interests. 
4.8 Role of Funding Source 
















Inhibition of fatty acid amide hydrolase by 
PF-3845 alleviates nitrergic-related 





































Contributor Statement of contribution 
Hsiao-Jou Cortina Chen  
 
Study design (50%)  
Animal treatment (50%)  
Hormone assay (60%)  
Real-time PCR (100%) 
Interpretation of results (60%)  
Manuscript preparation (80%)  
Reviewing and editing manuscript (50%)  
Jereme G. Spiers  
 
Study design (30%)  
Animal treatment (50%)  
Hormone assay (40%)  
Interpretation of results (30%)  
Manuscript preparation (20%)  
Reviewing and editing manuscript (20%) 
Conrad Sernia  
 
Study design (10%)  
Interpretation of results (5%)  
Reviewing and editing manuscript (15%) 
Nickolas A. Lavidis  
 
Study design (10%)  
Interpretation of results (5%)  




Psychological stressors are undoubtedly amongst the most examined risk factors in studying 
depressive disorders. An increasing body of evidence suggests that immune dyshomeostasis 
following stress plays a major role in the pathophysiology of stress-related illnesses. Long term 
exposure to stress has been demonstrated to cause neuroinflammation through a sustained 
overproduction of free radicals, including nitric oxide, via an increased inducible nitric oxide 
synthase (iNOS) activity. This enzyme is regulated by cytokines and inflammatory complexes 
following noxious stimuli and consequently mediates cytotoxicity through oxidative/nitrosative 
stress under chronic stress conditions. We have previously demonstrated that iNOS activity and 
mRNA expression are upregulated in the hippocampus following just 4 hours of acute restraint 
stress. Interestingly, the nitrergic system has recently demonstrated interactions with the 
endocannabinoid system following stressful or aversive situations. Similar to nitric oxide, the 
endogenous cannabinoids are synthesised on demand and have been classified as atypical 
neurotransmitters, with preclinical findings suggesting that cannabinoid receptor agonists and 
endocannabinoid enhancers inhibit nitrergic activity and display antidepressant-like properties. 
Specifically, pharmacological enhancement of endocannabinoid content by fatty acid amide 
hydrolase inhibitor (FAAH), PF-3845, has been demonstrated to alleviate neuroinflammation by 
decreasing the number of iNOS-expressing microglia following traumatic brain injury. However, 
this describes cannabinoid modulation during pathological conditions and therefore the present 
study aim to examine the effects of systemically injected PF-3845 in the modulation of nitrergic and 
inflammatory-related genes within the hippocampus after acute stress exposure. Following vehicle 
or PF-3845 injections (5 mg/kg in normal saline; i.p.), outbred male Wistar rats aged 5-6 weeks 
postnatal were exposed to a single episode of 0 (control), 60, 240, or 360 minute of restraint stress 
(n=5-6 per group). The hippocampus was cryodissected and assayed for relative expression of 
nitrergic and inflammatory-related genes. The results demonstrate that pretreatment with the FAAH 
inhibitor rapidly reduces restraint stress-induced plasma corticosterone release. This was 
accompanied by a reduction in the stress-induced pro-inflammatory response including iNOS, 
interleukin-1β, interleukin-6, and cyclooxygenase-2 mRNA in the hippocampus. Furthermore, 
transcriptional potential of NF-κB was inhibited by PF-3845 suggesting that enhanced 
endocannabinoid levels in the hippocampus have an overall anti-inflammatory effect following 







During stress exposure the hypothalamic-pituitary-adrenal (HPA) axis functions synergistically 
with the autonomic nervous system to orchestrate appropriate adaptive responses in central and 
peripheral tissues. Glucocorticoids are the final hormonal effector of an activated HPA-axis which 
exerts a plethora of physiological functions through the ubiquitously expressed glucocorticoid 
receptors. One of the essential roles of glucocorticoids along with protecting the host from noxious 
insults is the regulation of immune homeostasis (Chrousos and Gold, 1992; Cancedda et al., 2002). 
Stress and glucocorticoids are generally regarded to be anti-inflammatory as numerous studies have 
demonstrated their ability to suppress gene transcription of several pro-inflammatory cytokines 
(Barnes, 1998; Coutinho and Chapman, 2011). However, this anti-inflammatory action exhibits a 
hierarchy, with tumour necrosis factor (TNF) having the greatest sensitivity to glucocorticoid 
suppression at physiological levels, while interleukin-1β (IL-1β) displays intermediate sensitivity 
and interleukin-6 (IL-6) is comparatively resistant (DeRijk et al., 1997). Nevertheless, in addition to 
the anti-inflammatory actions, it has become increasingly apparent that the initial rise in 
glucocorticoids following stress exposure primes the immune effector cells through innate immune 
signalling pathways such as toll-like receptor upregulation (de Pablos et al., 2006; Frank et al., 
2007; Wohleb et al., 2011; Frank et al., 2012). This is considered to be an important adaptive action 
by glucocorticoids, with dissipation of the ‘fight/flight’ response heightening immune defences and 
vigilance beyond basal levels and promoting more vigorous reactions to persisting or impending 
threats (Sapolsky et al., 2000; Johnson et al., 2002; Sorrells et al., 2009). Specifically within the 
central nervous system (CNS), it has been demonstrated that short term stress can modulate 
microglial immunophenotype to sensitise a neuroinflammatory response which may be exaggerated 
in subsequent inflammatory challenges (Blandino et al., 2006; Frank et al., 2007; Sugama et al., 
2007; Blandino et al., 2009; Sugama et al., 2009; Sugama et al., 2011). Activated microglia 
upregulate antigen presentation molecules such as major histocompatibility complex, increase 
phagocytic activity, generate pro-inflammatory cytokines and reactive oxygen/nitrogen species, 
overall inducing a neuroinflammatory response (de Pablos et al., 2006; Frank et al., 2007; Colton, 
2009).  
Pro-inflammatory cytokines including TNF and IL-1β are among the principle messengers 
responsible for initiating and coordinating the acute phase inflammatory response, with IL-1β acting 
through autocrine/paracrine signalling to further potentiate IL-6 production (Dinarello, 1998). It has 
been reported that following acute immobilisation stress, there was an increase in soluble TNF 
which was released by membrane-anchored zinc metalloproteinase, commonly known as TNF-α 
convertase (TACE), in the rat brain cortex (Madrigal et al., 2002). This cytokine has been 
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implicated in the pathogenesis of various neurodegenerative conditions including Alzheimer’s and 
Parkinson’s disease (Fischer and Maier, 2015). Central administration of the archetypal pro-
inflammatory cytokine, IL-1, has been shown to produce endocrine, neurochemical, and 
behavioural modifications similar to those elicited by psychological stressors (Song et al., 2006). 
Several studies have demonstrated that IL-1 activates nuclear factor kappa-light-chain-enhancer of 
activated B cells (NF-κB) pathways which subsequently initiate downstream inflammatory, 
oxidative, and nitrosative signalling (Mercurio and Manning, 1999; Albrecht et al., 2007; Solt et al., 
2007). Specifically, cytokine-induced NF-κB transactivation is capable of increasing the activity of 
inducible nitric oxide synthase (iNOS), a widely accepted pro-inflammatory mediator which may 
contribute to cellular toxicity by extensive and prolonged production of nitric oxide (NO) and the 
downstream oxidant, peroxynitrite (Chen et al., 2015). Madrigal and colleagues (2001) have 
demonstrated that inhibition of NF-κB translocation in the rat brain cortex decreased iNOS activity 
and expression following acute stress. Natural compounds such as curcumin, α-tocopherol, and 
resveratrol have also been shown to inhibit NF-κB activation and the associated neuroinflammatory 
response including both cytokines and iNOS induction (Suzuki and Packer, 1993; Lu et al., 2010; 
Olivera et al., 2012). Another important inflammatory signalling cascade involves cyclooxygenase-
2 (COX-2), a constitutively expressed enzyme in the brain that converts arachidonic acid into 
prostaglandin. Upon stimulation, it can be rapidly upregulated in cells that are involved in 
inflammation, thereby mediating fever and sensitivity to pain (Dubois et al., 1998). A number of 
recent studies have demonstrated its involvement in HPA axis activation, with inhibition of COX-2 
demonstrating anti-depressant like properties following lipopolysaccharide-injection without 
affecting major cytokine responses (de Paiva et al., 2010; Teeling et al., 2010; Ma et al., 2013). 
Recently, cannabinoids have received extensive research interest due to their roles in increasing 
sleep and fat storage while attenuating inflammatory response and stress-induced behaviours 
(Pacher et al., 2006). The two major endogenous cannabinoids, N-arachidonoylethanolamine (AEA; 
commonly known as anandamide) and 2-arachidonoylglycerol (2-AG), are produced on demand 
post-synaptically as a neuromodulator in response to stress and generally function in opposition to 
the HPA response. For example, selective cannabinoid receptor type 1 (CB1R) antagonist has been 
reported to modulate corticosterone release and possess anxiogenic effects (Wade et al., 2006). Hill 
and colleagues (2011) demonstrated that endocannabinoid signalling played an important role in 
suppressing corticosteroid secretion following stress through inhibition of GABAergic 
neurotransmission. Pharmacological inhibition of fatty acid amide hydrolase (FAAH), an enzyme 
responsible for rapid physiological degradation of anandamide, robustly blocked stress-induced 
corticosterone release (Patel et al., 2004). In addition to its critical involvement in stress 
modulation, endocannabinoids have demonstrated anti-inflammatory properties as FAAH knock out 
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mice have a reduced lipopolysaccharide-induced hyperalgesia and edema, an effect mediated 
mainly through the cannabinoid receptor type 2 (CB2R) (Naidu et al., 2010). Studies have reported 
AEA and other cannabinoid-like fatty acid amides, including N-palmitoylethanolamine (PEA) and 
N-oleoylethanolamine (OEA), exert their anti-inflammatory effects by acting on the peroxisome 
proliferator-activated receptors to induce expression of anti-inflammatory proteins such as nuclear 
factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (IkB-α) while repressing 
expression of TNF (D'Agostino et al., 2007; Rettori et al., 2012; Paterniti et al., 2013; Alhouayek 
and Muccioli, 2014). Interestingly, Tchantchou and colleagues (2014) have recently demonstrated 
effective suppression of traumatic brain injury-induced neuroinflammation, including iNOS and 
COX-2 expression, in microglia/ macrophages by PF-3845, a novel FAAH inhibitor with high 
sensitivity and long duration. However, this represents modulation occurring in a condition of 
chronic injury, while the effects of endocannabinoid modulation by FAAH inhibitor on the nitrergic 
and inflammatory indicators following short term stress remains unclear. Therefore, the present 
study will examined the effects of systemic injection of PF-3845 on the nitrergic and inflammatory-
related genes following acute stress. 
5.3 Materials and Methods  
5.3.1 Ethical approval and experimental animals  
All experimental procedures were in accordance with regulations and policies outlined by The 
University of Queensland Animal Ethics Committee with AEC approval numbers 
SBS/456/14/URG. Outbred male Wistar rats (Rattus norvegicus) aged 5-6 weeks postnatal, 
weighing 206.6 ± 2.04 g were sourced from The University of Queensland Biological Resources 
breeding colony. Rats were housed individually under controlled laboratory conditions (22 ± 2°C; 
55 ± 5% humidity) with a 12:12h light-dark cycle (lights off at 12.30h). Standard rat chow and 
water were available ad libitum. 
5.3.2 Experimental protocol 
Rats were habituated to human handling for 10 minutes per day 6 days prior to experimentation. On 
each experimental day, rats were transported in individual home cages from the colony room to an 
experimental room within the same animal facility. Rats were randomly allocated to 8 treatment 
groups with control, or restraint stress for 60, 240, and 360 minutes with either vehicle or PF-3845 
injection. Rats were subjected to acute restraint stress using adjustable wire mesh restrainers within 
individual home cages (stress treatment starting at 13:45h). The FAAH inhibitor, PF-3845 (5 
mg/kg; Sigma, St. Louis, MO), dissolved in 2% DMSO in normal saline (0.9% sodium chloride) 
was injected 60 minutes before stress treatment with an injection volume of 10 mL/kg (i.p.). During 
this period, rats were acclimatised to the novel experimental room under low light and noise. To 
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isolate the effects of restraint stress, all rats were deprived of food and water during the one hour 
habituation and stress treatment period. Following each allocated treatment, a blood sample was 
collected in sodium heparin (20 IU/mL blood) via tail-tipping. Heparinised blood samples were 
centrifuged at 200 x g for 5 minutes immediately after collection with the resulting plasma 
supernatant stored at -80 for later determination of corticosterone concentrations. Rats were then 
overdosed with 100 mg/kg of sodium pentobarbital (i.p. injection; Lethabarb, Virbac, Peakhurst, 
Australia). Whole brain were rapidly removed and frozen on powdered dry ice for storage at -80
o
C. 
Frozen brains were sectioned on a cryostat and the hippocampus was cryo-dissected from sections 
according to a rat brain atlas (Paxinos and Watson, 2007) on a dry ice-embedded metal platform. 
Regionalised hippocampus was stored at -80
o
C for later relative gene expression analysis. 
5.3.3 Plasma corticosterone assay 
Corticosterone concentrations were measured by an in-house radioimmunoassay using  anti-rat 
corticosterone polyclonal antibody (Sapphire Bioscience Pty. Ltd.) and tritiated [1, 2, 6, 7- 
3
H]-
corticosterone tracer as previously described in Spiers and colleagues (2013). Radioactivity was 
counted in liquid scintillation cocktail (Ultima Gold
TM
, Perkin Elmer) using a Liquid Scintillation 
Spectrometer (Tri-Carb 3100 TR, Perkin Elmer). Dichloromethane extraction recovery was 79.14% 
and intra- and inter-assay coefficients of variation were 5.79% and 2.12% respectively.  
5.3.4 Real-time PCR 
Total RNA was extracted from the hippocampus using a RNeasy mini kit (Qiagen, Doncaster, 
Australia) treated with deoxyribonuclease I and reversed transcribed into cDNA using iScript™ 
Reverse Transcription Supermix (Bio-Rad Laboratories, Gladesville, Australia) according to the 
manufacturer’s instructions. Taqman gene expression ‘assay-on-demandTM’ kits (Life Technologies, 
Mulgrave, Australia) with optimised primers and FAM-labelled probes were used to detect gene 
expression of Nos2 (inducible nitric oxide synthase; Rn00561646_m1), Nos1 (neuronal nitric oxide 
synthase; Rn00583793_m1), Tnf (tumor necrosis factor; Rn01525859_g1), Il1b (interleukin 1 beta; 
Rn00580432_m1), Il6 (interleukin 6; Rn01410330_m1), Nfkbia (nuclear factor of kappa light 
polypeptide gene enhancer in B-cells inhibitor, alpha; Rn01473657_g1), and Ptgs2 (prostaglandin-
endoperoxide synthase 2; Rn01483828_m1). The ∆∆CT method was used for all expression assays 
which were run in a multiplex reaction with VIC-labelled GAPDH as endogenous control using the 
QuantStudio
TM
 6 Flex Real-Time PCR System (Applied Biosystems, Foster City, CA). 
5.3.5 Statistical analysis 
Data were analysed using statistical software GraphPad Prism (Version 6.07, GraphPad Software 
Inc., San Diego, CA, USA). Two-way repeated measure ANOVAs with Fisher’s Least Significant 
Difference (LSD) test were used to compare vehicle and PF-3845 data for all time course analyses. 
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Results were expressed as mean ± standard error of the mean (± SEM) and p-values less than 0.05 
were considered statistically significant.  
5.4 Results  
5.4.1 Inhibition of FAAH dampens acute stress-induced corticosterone release 
This study examined the effects of pharmacological enhancement in endocannabinoid contents by 
administration of selective FAAH inhibitor on inducible nitric oxide synthase and several other 
inflammatory-related genes in the hippocampus following acute stress. To determine whether 
increased endocannabinoid signalling modulates HPA output, we determined concentrations of the 
plasma stress hormone, corticosterone. Pre-treatment with the FAAH inhibitor, PF-3845, 
significantly inhibited restraint-induced corticosterone release [F(1, 40) = 5.863, p=0.0201] in a time-
dependent manner [F(3, 40) = 24.42, p<0.0001]. A comparison of group means demonstrated 
significantly lower corticosterone concentrations in the PF-3845 treated group [472.27 ± 27.2 
ng/mL, p<0.01] at 60 minutes of stress compared to the vehicle-treated group [638.22 ± 66.71 




Figure 5.1. The effect of the fatty acid amide hydrolase inhibitor, PF-3845 (5 mg/kg, i.p. injection), 
on plasma corticosterone levels from control and stressed rats (n=5-7 per group). Plasma 
corticosterone concentration was determined in blood samples collected via tail-tipping from rats 
exposed to 0 (control), 60, 240, and 360 minutes of acute restraint stress. Data are presented as 





5.4.2 Acute stress-induced upregulation of inducible nitric oxide synthase was attenuated by PF-3845 
There was a progressive increase in inducible NOS (Nos2) in the hippocampus of vehicle-treated 
animals as the duration of stress exposure prolonged which was highly significant at 360 minutes of 
stress [5.48 ± 1.25, p<0.001] compared to controls [1.14 ± 0.2]. Figure 5.2A demonstrates a time-
dependent [F(3, 40) = 10.17, p<0.0001] inhibition of hippocampal inducible NOS mRNA levels in the 
PF-384-treated group [F(1, 40) = 4.191, p=0.047]. Post-test analysis revealed a significantly lower 
inducible NOS mRNA expression at 360 minutes of stress exposure following PF-3845 treatment 
[3.25 ± 0.91, p<0.05] compared to vehicle [5.48 ± 1.25]. No significant changes were observed in 
hippocampal neuronal NOS (Nos1) mRNA levels between vehicle- and PF-3845-treated groups 
(Fig. 5.2B).   
 
A 
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Figure 5.2. The effect of the fatty acid amide hydrolase inhibitor, PF-3845 (5 mg/kg, i.p. injection), 
on hippocampal (A) inducible nitric oxide synthase (Nos2), and (B) neuronal nitric oxide synthase 
(Nos1) mRNA expression from control and stressed rats (n=5-6 per group). The relative expression 
was determined in isolated hippocampus collected from rats exposed to 0 (control), 60, 240, and 
360 minutes of acute restraint stress. Data are presented as mean ± SEM, *p<0.05.  
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5.4.3 Dampening of HPA activity by PF-3845 prevents TNF downregulation and TACE upregulation 
Glucocorticoid is known to suppress TNF synthesis contributing to an anti-inflammatory action.  
Treatment with FAAH inhibitor significantly prevented hippocampal TNF downregulation at the 
mRNA level [F(1, 36) = 6.963, p=0.0122] at 60 and 240 [p<0.05] minutes of stress exposure when 




Figure 5.3. The effect of the fatty acid amide hydrolase inhibitor, PF-3845 (5 mg/kg, i.p. injection), 
on hippocampal tumor necrosis factor (Tnf) mRNA expression from control and stressed rats (n=5-
6 per group). The relative mRNA expression was determined in isolated hippocampal tissue from 
rats exposed to 0 (control), 60, 240, and 360 minutes of acute restraint stress. Data are presented as 













The pro-inflammatory cytokine, TNF, is synthesised as a 32 kDa transmembrane anchored 
precursor that is cleaved by TACE, encoded by the gene a disintegrin and metalloprotease 17 
(Adam17), yielding a non-glycosylated soluble 17 kDa protein. Stress significantly increases 
Adam17 mRNA levels at 360 minutes [1.42 ± 0.25, p<0.05] above values of unrestrained controls 
[1.03 ± 0.12] in the vehicle group. Administration of PF-3845 significantly reduced Adam17 
mRNA levels [F(1, 36) = 15.21, p=0.0004] in the hippocampus. The Fisher’s LSD test revealed 
significant reduction in Adam17 mRNA levels by PF-3845 at 60 [p<0.05], 240, and 360 [p<0.01] 




Figure 5.4. The effect of the fatty acid amide hydrolase inhibitor, PF-3845 (5 mg/kg, i.p. injection), 
on hippocampal a disintegrin and metalloprotease 17 (Adam17) mRNA expression from control and 
stressed rats (n=5-6 per group). The relative mRNA expression was determined in isolated 
hippocampal tissue from rats exposed to 0 (control), 60, 240, and 360 minutes of acute restraint 











5.4.4 Inhibition of FAAH constrains inflammatory cytokines including IL-1β and IL-6 upregulation 
following acute stress 
Inflammatory cytokines are rapidly upregulated following activation of immune cells that reside in 
the CNS including microglia, CNS macrophages, and astrocytes. We found that following acute 
psychological stress there was an upregulation of Il-1β expression at 240 [p<0.05] and 360 
[p<0.001] minutes, while Il-6 expression was upregulated at 60 [p<0.05], 240, and 360 [p<0.001] 
minutes of stress exposure in the hippocampus. Previous studies have revealed the anti-
inflammatory properties exerted by endocannabinoids are partly through attenuation of microglial 
activation. In the present study, there was a significant time-dependent [F(3, 36) = 17.21, p<0.0001] 
and PF-3845 treatment [F(1, 36) = 4.358, p=0.044] effects on Il-1β gene expression following stress 
exposure. Post-test analysis showed a transient reduction in Il-1β mRNA levels at 60 minutes of 
stress exposure following PF-3845 treatment [0.67 ± 0.03, p<0.05] compared to the vehicle group 
[1.18 ± 0.15]. Furthermore, the FAAH inhibitor [F(1, 36) = 18.95, p=0.0001] also inhibited the stress-
induced upregulation of Il-6 mRNA in a time-dependent manner [F(3, 36) = 6.049, p=0.002] at 60 





























Figure 5.5. The effect of the fatty acid amide hydrolase inhibitor, PF-3845 (5 mg/kg, i.p. injection), 
on hippocampal (A) interleukin-1β (Il1b) and (B) interleukin-6 (Il6) mRNA expression from 
control and stressed rats (n=5-6 per group). The relative mRNA expression was determined in 
isolated hippocampal tissue from rats exposed to 0 (control), 60, 240, and 360 minutes of acute 






5.4.5 PF-3845 acutely suppressed inflammatory COX-2 mRNA expression in the hippocampus   
It has been demonstrated that COX-2 is constitutively expressed in the brain and is primarily 
responsible for the production of prostanoids including prostaglandin E2 which is involved in 
pathological inflammatory conditions. Notably, PF-3845 treatment [F(1, 36) = 4.476, p=0.041] 
resulted in decreased prostaglandin-endoperoxide synthase 2 (or COX-2) mRNA levels in animals 




Figure 5.7. The effect of the fatty acid amide hydrolase inhibitor, PF-3845 (5 mg/kg, i.p. injection), 
on hippocampal prostaglandin-endoperoxide synthase 2 (Ptgs2; also known as cyclooxygenase-2 or 
COX-2) mRNA expression from control and stressed rats (n=5-6 per group). The relative mRNA 
expression was determined in isolated hippocampal tissue from rats exposed to 0 (control), 60, 240, 









5.4.6 The FAAH inhibitor reduces the potential of NF-кB transactivation monitored by Nfkbia 
mRNA expression 
The transcription factor, NF-КB, plays a central role in the pro-inflammatory signalling pathway by 
regulating the expressions of proteins involved in oxidative stress/damage and inflammation 
including iNOS, pro-inflammatory cytokines, and COX-2. To examine the NF-кB transactivation 
potential, expression of the inhibitory subunit, Nfkbia (or IκB-α), were monitored following stress 
exposure in vehicle and PF-3845-treated animals (Fig. 5.5). In the vehicle-treated group, restraint 
stress significantly increases the expression of IκB-α across all stress time points examined 
[p<0.001] when compared to unstressed controls. Two-way ANOVA demonstrated PF-3845 was 
highly effective [F(1, 36) = 19.16, p<0.001] in blunting IκB-α mRNA expression over the time course 
of the experiment [F(3, 36) = 15.05, p<0001]. Post-test analysis revealed significant reduction at 60 




Figure 5.6. The effect of the fatty acid amide hydrolase inhibitor, PF-3845 (5 mg/kg, i.p. injection), 
on hippocampal nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha 
(Nfkbia) mRNA expression from control and stressed rats (n=5-6 per group). The relative mRNA 
expression was determined in isolated hippocampal tissue from rats exposed to 0 (control), 60, 240, 








This study demonstrated that administration of the FAAH inhibitor, PF-3845, robustly suppresses 
acute stress-induced upregulation of nitrergic and neuroinflammatory responses due to an increased 
endocannabinoid tone within the hippocampus. The results show that pretreatment with PF-3845 
rapidly dampens restraint stress-induced plasma corticosterone release. This was accompanied by a 
reduction in stress-induced iNOS, TACE, IL-1β, IL-6, and COX-2 mRNA upregulation in the 
hippocampus. Furthermore, transcriptional potential of NF-κB was inhibited by PF-3845 suggesting 
that an enhanced endocannabinoid levels in the hippocampus have an overall immunosuppressive 
effect following acute stress exposure.  
In the present study, treatment with PF-3845 negatively modulates HPA axis activation which is in 
agreement with previous literature using an alternative selective FAAH inhibitor, URB597. Patel 
and colleagues (2004) demonstrated that URB597 dose-dependently inhibited corticosterone release 
following a 30 minute restraint stress in mice. Several studies have also demonstrated the 
importance of endocannabinoid in stress system regulation, for example, modulation of CB1R 
signalling by genetic modification or pharmacological blockade of the receptor results in an 
increased HPA activity under basal or stressful conditions (Wade et al., 2006; Cota et al., 2007; 
Steiner et al., 2008). Furthermore, Steiner and colleagues (2008) reported that CB1R receptors are 
localised on the glutamatergic neurons and via dendritic release and the retrograde actions of 
endocannabinoids, the excitatory synaptic drive to corticotropin-releasing hormone neurons are 
suppressed within the paraventricular nucleus of the hypothalamus thereby restraining activation of 
the HPA axis. Interestingly, following acute stress, it has been demonstrated that FAAH-mediated 
AEA hydrolysis was enhanced in response to acute stress and therefore the rapid loss of AEA levels 
in the basolateral amygdala may play an important role in the disinhibition of HPA axis following 
stress (Hill et al., 2009). 
The expression of the calcium-independent NOS isoform is generally restricted but can become 
rapidly and significantly elevated through stimulation of a variety of factors including pro-
inflammatory cytokines (Aktan, 2004). We have previously demonstrated a significant 10.5-fold 
increase in hippocampal iNOS mRNA levels following 240 minutes of restraint stress which 
corresponds well with the 2-fold increase in iNOS activity (Chapter IV). Based on an interesting 
study by Tchantchou and colleagues (2014) where an enhanced endocannabinoid by PF-3845 
successfully suppressed the expression of iNOS following traumatic brain injury, the present study 
aim to test the effect of PF-3845 on acute stress-induced iNOS mRNA upregulation. The FAAH 
inhibitor significantly alleviated stress-induced hippocampal iNOS mRNA upregulation at 360 
minutes of restraint when compared to the vehicle group. This may be an indirect consequence of 
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the early reduction in corticosterone secretion, indicating the initial response to restraint stress was 
buffered following PF-3845 administration. In contrast, we observed no significant changes in 
expression of the constitutive calcium-dependent isoform, nNOS, following PF-3845 
administration. You and colleagues (2009) demonstrated the overall oxidative status in the 
hippocampus, measured using the non-selective and NO-reactive fluorescent probe, 2’, 7’-
dichlorofluorescin diacetate, is both time-dependent and dose-responsive to glucocorticoid receptor 
agonists. Although the relative contribution of NO to the fluorescence of dichlorofluorescein is 
unknown, data from our laboratory indicate that NO-induced activation of the NO-selective 
fluorescent probe, 4-amino-5-methylamino-2′, 7′-difluorofluorescein diacetate (DAF-FM DA), and 
the metabolites of NO, nitrate/nitrite, are increased rapidly following restraint stress exposure over a 
similar timeframe used by You and colleagues (2009). However, it has also been suggested that 
microglia are the principle cell type responsible for expressing iNOS in the CNS following stress 
exposure and these cells are known to express low levels of functional FAAH (Heneka et al., 2000; 
Tham et al., 2007). Tham and colleagues (2007) demonstrated that the FAAH inhibitor, URB597, 
reduced expression of both COX-2 and iNOS in addition to their corresponding products 
prostaglandin E2 and NO following lipopolysaccharide stimulation in cultured cortical microglia. 
Recent data from our laboratory suggests that the acute stress used in the present study does induce 
alterations in the essential glial co-activator of class II major histocompatibility complex, Ciita, 
associated with antigen presentation over a similar timeframe to the changes observed in iNOS 
expression (Chapter IV). This indicates that acute stress induces glial cells to change from a state of 
quiescence to surveillance, with increases in major histocompatibility complex monitoring the 
hippocampus for foreign antigens.  
The transcriptional activation of iNOS has previously been shown to rely heavily on TNF-induced 
NF-κB transactivation. Madrigal and colleagues (2002) demonstrated that one hour of 
immobilisation stress caused an increase in cortical TACE activity and TNF, leading to 
translocation of NF-κB into the nucleus by 4 hours and a subsequent increase in iNOS activity by 6 
hours of stress exposure. Pharmacological inhibition of TACE activity or NMDA receptor 
antagonism strongly attenuated these changes, indicating that glutamatergic transmission and TNF 
production are involved in NF-κB activation prior to iNOS transcription. In the present study, one 
hour of stress exposure increased expression of Adam17 mRNA, the gene responsible for TACE 
translation. This was mirrored by a corresponding decrease in TNF mRNA. Although this may 
seem paradoxical in comparison to the results obtained by Madrigal and colleagues (2002) in the 
cortex, it is likely that the hippocampus does undergo a constrained but significant increase in TNF. 
The potent immunosuppressive effects of glucocorticoids on TNF mRNA have been documented 
previously (Steer et al., 2000). However, pro-TNF protein present in the cytosol would still be 
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subject to cleavage by TACE, and this initial increase in TNF would subsequently potentiate 
Adam17 mRNA transcription (Gooz, 2010). Interestingly, PF-3845 prevented the stress-induced 
decrease in hippocampal TNF mRNA and effectively decreased Adam17 mRNA, resulting in 
significant differences between vehicle and drug treated animals. This is likely due in part to the 
reduction in corticosterone observed early during stress exposure. However, there is also a 
likelihood that enhanced endocannabinoids are acting as anti-inflammatory agents as there is also a 
subtle but significant reduction in hippocampal COX-2 expression. In addition to the TACE/TNF 
system, stress exposure also altered hippocampal IL1-β and IL-6 mRNA in a time-dependent 
manner. Both IL1-β and IL-6 mRNA were increased in the hippocampus following stress exposure 
in vehicle-treated animals. Administration of PF-3845 caused an early inhibition of this increase in 
IL-1β that was only significantly different to vehicle treatment following 60 minutes of stress. 
Microglia were the most likely cellular source of this increase in pro-inflammatory IL-1β based on 
the study by Blandino and colleagues (2006) which evaluated the effects of minocycline on acute 
foot shock-induced increase in central IL-1β. The results from the study demonstrated that 
minocycline, a tetracycline derivative which selectively restrict pro-inflammatory cytokine release 
from microglia by inhibiting its activation and proliferation, abolished the foot shock-induced 
increase in hypothalamic IL-1β mRNA. PF-3845 markedly prevented stress-induced increases in 
hippocampal IL-6 mRNA at all stress durations. The magnitude of these changes may indicate that 
the endocannabinoid system preferentially interacts with IL-6 during a normal response to stress. 
However, IL-6 also exhibits a positive feed-forward expression, meaning reductions in 
corticosterone by PF-3845 may prevent transcription and further potentiation of IL-6 mRNA in the 
hippocampus (Bethin et al., 2000; Spooren et al., 2011). 
Together, the hippocampal stress response exhibits a significant expression profile of pro-
inflammatory cytokines. Increases in the protein products of these genes, particularly within the 
TACE/TNF system, would cause the transactivation of NF-κB and result in activation of several 
downstream targets including transcription of iNOS. In the present study, the status of NF-κB 
following stress exposure was determined by monitoring the inhibitory subunit IκB-α, responsible 
for binding and inactivating NF-κB in the cytoplasm. Bottero and colleagues (2003) validated the 
use of IκB-α mRNA quantification as a simple method of monitoring NF-κB in place of more 
difficult techniques such as electrophoretic mobility shift assays. This inhibitory subunit is rapidly 
transcriptionally activated during increased NF-κB signalling to remove the pro-inflammatory 
transcription factor from the nucleus and restore cellular homeostasis. Although NF-κB can be 
activated by a number of different upstream pathways, Madrigal and colleagues (2002) 
demonstrated that nuclear translocation of this transcription factor was required for stress-induced 
upregulation of iNOS. In the present study, IκB-α levels indicative of NF-κB activity show early 
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and persistent increases following exposure to stress. This increase is strongly attenuated by 
inhibition of FAAH at all time points used in this experiment and likely reflects the combined 
action of decreased corticosterone output, which would rapidly and non-genomically reduce NDMA 
receptor-dependent calcium currents via a GR-independent mechanism, and reductions in pro-
inflammatory cytokines observed in the hippocampus.  
In conclusion, psychological stress produces a distinct pro-inflammatory profile in a number of 
cytokines at different durations of stress exposure in the hippocampus. These exhibit a hierarchy of 
production, with IL-6 appearing to be the primary cytokine in response to this type of stressor in 
this region. Inhibition of the enzyme responsible for endocannabinoid degradation, and hence 
increased endocannabinoid signalling, greatly changes this stress profile both at the peripheral 
hormone and hippocampal transcriptional level. Overall, this results in decreased indicators of 
neuroinflammation following psychological stress exposure for up to 6 hours and, with reductions 
in iNOS transcription, likely prevents the development of stress-induced nitrosative stress on a 
biochemical level. Neuroinflammation is a key pathogenic mechanism in many disease states 
including chronic stress-induced depression. The present study highlights the importance of the 
endogenous endocannabinoid system in the neuroinflammatory response to stress and may offer a 
useful therapeutic target for conditions exacerbated or caused by prolonged stress exposure. 
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6.0 Thesis Summary 
This thesis has focused on establishing an acute profile of stress-induced peripheral and central 
nitrergic activation (Fig. 6.1). In Chapter III, peripheral tissue was demonstrated to be particularly 
susceptible to early oxidative and nitrosative changes following a single episode of psychological 
stress, sufficient to induce oxidative damage. The follow up study, Chapter IV, found that short 
term stress are capable of initiating rapid and time-dependent changes in hippocampal nitrergic 
activity. Specifically, there was a rapid increase in hippocampal NO levels due to an initial increase 
in the constitutive NOS activity. Following transcriptional activation of the inflammatory related-
iNOS and the resultant increases in iNOS enzymatic activity withstand the elevation in NO within 
the hippocampus. In comparison, no change was observed in striatal constitutive NOS, however, the 
delayed stress-induced increase in striatal NO was utmost driven by the inducible isoform. 
Furthermore, an increased NF-κB transactivation potential is accountable for iNOS activation in 
both neural regions examined. Chapter V employed an enzyme inhibitor, PF-3845, to 
pharmacologically enhanced endocannabinoid content which demonstrated anti-inflammatory 
properties by decreasing the expression of iNOS and other inflammatory genes following acute 




















Fig. 6.1. Schematic thesis summary.   
Experiment one demonstrated that a single episode of stress causes early and marked changes of 
both oxidative (reactive oxygen species, ROS; glutathione/glutathione disulfide, GSH/GSSG) and 
nitrosative status (nitric oxide, NO; nitrite and nitrate, NOx) likely contributing to the observed 
increase in oxidative damage (lipid peroxidation, LPO) in peripheral blood. The second experiment 
showed that short term stress rapidly increases hippocampal nitrergic activity through a switch from 
calcium dependent nitric oxide synthase (NOS) to NF-κB-induced calcium independent NOS 
signalling. This was observed concurrently with a primed pro-inflammatory response involving 
major histocompatibility complex (CIITA), macrophage migration inhibitory factor (MIF), 
interleukins (IL-6 and IL-1β), tumor necrosis factor-α (TNF-α) and the converting enzyme (TACE). 
The results from the third experiment demonstrate that pretreatment with the fatty acid amide 
hydrolase inhibitor, PF-3845, dampens the release of corticosterone (CORT) and the hippocampal 
pro-inflammatory response including a decrease in inducible NOS following stress. This experiment 
highlights the importance of endocannabinoid signalling in regulation of the hypothalamic-







6.1 Acute Psychological Stress and the Endocrine System 
The experiments performed throughout this thesis have relied on the generation of a relatively 
strong stress response in order to induce sufficient cellular changes in the nitrergic system. To 
achieve this, we have utilised two well established models of psychological stress, immobilisation 
and restraint. Several indicators of endocrine activity were initially assessed in Chapter III to verify 
the stress models. Plasma prolactin has been used previously in our laboratory as a highly sensitive 
pituitary-derived hormone that exhibits exquisite stress responsiveness while remaining 
unresponsive to glucocorticoid-mediated negative feedback (Weiser et al., 2011). The 
immobilisation stress used in Chapter III was highly effective in producing increased plasma 
prolactin levels to similar, if not higher than those observed in our previous model of restraint stress 
(Spiers et al., 2013). Jaroenporn and colleagues (2009) have shown that prolactin acts as an adrenal 
sensitiser and facilitates the release of corticosterone. In this thesis, stress exposure reliably 
produced 2-3 fold increases in plasma corticosterone concentration across the time points used in 
these experiments. The intra-individual blood sample collection using the tail-tipping method in 
Chapter III produced consistently low corticosterone values for pre-stress and control samples that 
were well within the expected range for rats sampled in the first three hours of the dark cycle 
(Ulrich-Lai et al., 2006). Furthermore, peak corticosterone values were in good agreement with 
previous levels observed in our laboratory using jugular catheter sample collection (Spiers et al., 
2013). Tail tipping was also used in Chapter V for collection of endpoint samples. Although basal 
levels were slightly higher than those observed in Chapter III and likely reflect the addition of the 
intraperitoneal PF-3845 injection, they were still well within the expected range for rats at the 
beginning of the dark cycle (Tab. 6.1).  
 
Table 6.1.  The effects of blood sampling method on the baseline/pre-stress corticosterone 
concentrations. 
 Baseline/Control corticosterone concentrations 
Chapter III: Tail-tip sampling  
140.80 ± 41.57 ng/mL 
Chapter IV: Cardiac puncture 
288.6 ± 21.01 ng/mL 
Chapter V: Intraperitoneal 
injection prior to tail-tip sampling 
227.84 ± 36.60 ng/mL 




Expectedly, animals sampled in Chapter IV demonstrated the highest basal corticosterone levels. 
These samples were collected using the cardiac puncture sampling method following an 
intraperitoneal injection of sodium pentobarbital. Vahl and colleagues (2005) have shown that this 
method of anaesthesia/euthanasia produces the highest concentrations of corticosterone in blood 
collected from the trunk following decapitation. This is likely due to the close proximity of the 
adrenal venous vessels to the inferior vena cava and heart in comparison to the relative distance of 
the tail. However, as the cardiac puncture sampling method also requires loss of reflexive activity, 
the increase in time and physical stress associated with this sampling method undoubtedly plays a 
role in the increased levels of corticosterone observed in Chapter IV. In spite of this, concentrations 
of control samples collected were still in the acceptable range for this part of the light cycle (Ulrich-
Lai et al., 2006; Spiers et al., 2013; Spiers et al., 2014b). This experimental chapter also included an 
assessment of hippocampal GR and MR which are known to be stress responsive. Interestingly, 
hippocampal GR demonstrated expected downregulation as a result of negative feedback in 
response to stress exposure while MR was not changed. A similar phenomenon was observed by 
Paskitti and colleagues (2000) who demonstrated that only the intronic mRNA of MR is responsive 
to acute stress while full length MR is unaffected. Interestingly, using the same model of restraint 
used in Chapter IV and V, we have recently demonstrated that both GR and MR are robustly 
downregulated following 6 hours of acute stress applied in the opposite part of the light cycle (Fig. 
6.2A & 6.2B). This may be due to the relative low levels of corticosterone present prior to restraint 
allowing the MR to remain in the cytosol. In comparison, the high levels of corticosterone observed 
in the dark cycle would occupy the MR and cause nuclear translocation prior to application of the 
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Figure 6.2. The effect of acute restraint stress during the light cycle on (A) hippocampal 
glucocorticoid receptor (Nr3c1) and (B) hippocampal mineralocorticoid receptor (Nr3c2) mRNA 
expression in control and stressed rats (n=8 per group). The relative mRNA expression was 
determined in isolated hippocampal tissue from rats exposed to no stress (control), 1 day, 2 day, or 





















In Chapter V, the administration of PF-3845 produced a significant decrease in stress-induced 
corticosterone secretion at 60 minutes of stress exposure when tissue concentrations of hormone are 
expected to peak (Qian et al., 2011). This was anticipated due to the regulatory influence of 
increased cannabinoids on the activity of the HPA axis (Crowe et al., 2014). Furthermore, similar 
inhibitors of FAAH have demonstrated an inhibitory influence on HPA output (Patel et al., 2004). 
Although this effect was only present in the initial stress period measured, it was hypothesised that 
the decrease in peak HPA activity would effectively blunt the upregulation of inducible NOS in the 
hippocampus observed in Chapter IV.  
Finally, stress was also shown to decrease plasma insulin levels in Chapter III. This decrease 
facilitates the catecholamine and glucocorticoid-mediated hyperglycaemia observed following 
stress exposure (Yamada et al., 1993; Amrani et al., 1994). This hyperglycaemic response was 
observed in Chapter III with an approximately 20% increase in circulating glucose concentrations 
occurring at 60 minutes of immobilisation stress exposure. Interestingly, this peak response 
diminished quickly in comparison to our previous observations using restraint stress (Spiers et al., 
2013). Although the models are quite similar, there is a significant degree more struggling 
behaviour observed in immobilised animals in comparison to those restrained in wire mesh tubes. 
This behaviour likely facilitates the utilisation of glucose and contributes to the greater physical 
demand of immobilisation over restraint. These transient elevations in circulating glucose have been 
observed in previously reported immobilisation experiments on rodents (Sanchez et al., 2002).  
6.2 Acute Psychological Stress and the Redox Response 
One of the major functions of glucocorticoids is increasing cellular energy via the generation of 
ATP in the mitochondrial oxidative phosphorylation pathway (Teague et al., 2007; Du et al., 2009). 
The by-product ROS produced in this process can either: 1) be neutralised by the endogenous 
antioxidant system; 2) induce cellular compartmental oxidative stress; or 3) cross the cell membrane 
via passive diffusion (uncharged ROS such as hydrogen peroxide) or through specialised anion 
channels (charged molecules such as superoxide) (Reyes et al., 2012). The ROS traversing the cell 
membrane to the extracellular space are sequestered by cells and plasma of the circulation which 
have an enormous reducing capacity in comparison to most tissues (Richards et al., 1998; Valko et 
al., 2007). The circulation is so well equipped at neutralising ROS, it has been proposed that this is 
the major secondary function following gas/nutrient exchange (Richards et al., 1998). Markers of 
oxidative stress in peripheral blood have been observed in several neurodegenerative conditions 
such as Alzheimer’s, Amyotrophic Lateral Sclerosis, Huntington’s, and Parkinson’s diseases 
(McGrath et al., 2001; Sohmiya et al., 2004; Klepac et al., 2007; Babu et al., 2008). Chronic 
administration of corticosterone has also been shown to increase circulating oxidative stress 
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indicators (Sato et al., 2010). However, we have recently demonstrated that these indicators are 
responsive to acute stress, with 10-20% increases in oxidative state occurring within 2 hours of 
stress onset and continual increases in the immediate period following stress cessation (Spiers et al., 
2013). Interestingly, the plasma oxidative state reported in Chapter III correlated very highly with 
the oxidative state reported in red blood cells. There are several distinct advantages to assaying 
plasma in place of erythrocytes: 1) plasma can be stored and assayed together to reduce inter-assay 
variability; 2) plasma has very little impact on fluorescence quenching in comparison to the intact 
membranes of erythrocytes; 3) plasma is easier to pipette and does not require normalisation to 
haematocrit or haemoglobin. However, care must be taken in sampling as lysed blood can give false 
positive high results due to the interaction between the DCFH dye and free iron released from 
damaged haemoglobin (Kalyanaraman et al., 2012). The 25% reduction in GSH/GSSG ratio 
observed using immobilisation stress in Chapter III is also in good agreement with our previous 
restraint model (Spiers et al., 2013). This was observed alongside a 10-15% increase in plasma lipid 
peroxidation, indicative of oxidative damage. As the time-course of this experiment was only two 
hours, this level of increase was quite surprising given that the increase in plasma lipid peroxidation 
in rats chronically stressed for 40 days only reaches 30% (Tagliari et al., 2010). However, this 
increase of approximately 15% within two hours of stress exposure is in good agreement with 
previous experiments using restraint stress within our laboratory (Spiers et al., 2014b).  
6.3 Stress-Induced Activation of the Nitrergic System 
6.3.1 Peripheral tissue 
One of the major aims of this thesis was determining if acute psychological stress is capable of 
inducing a response in peripheral nitrergic markers. This was assessed in Chapter III using an 
established method measuring the NO metabolites, NOx, and an experimental method using a 
fluorescent probe quite specific for nitric oxide detection. Assay of plasma NOx from intra-
individual samples indicated that stress is highly effective at inducing an increase in nitrergic 
system activity with nearly a 50% increase observed by two hours of stress exposure. Although the 
increase was more modest, the results seen in the experimental fluorescent method agreed very well 
with the increase seen in NO metabolites. Kojima and colleagues (1998) have demonstrated that 
this fluorescent probe exhibits a stable non-fluorescent profile against other RNS including 
peroxynitrite. The diacetate form is membrane permeable where, once inside the cell, it is 
subsequently cleaved by intracellular esterases to non-fluorescent DAF-FM which reacts 
specifically with nitric oxide to produce the highly fluorescent triazole, DAF-FM T. This 
fluorescent method offers a number of advantages over the measurement of NOx metabolites: 1) the 
direct interaction of the probe with sample NO simplifies the measurement procedure and removes 
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the requirement of utilising the enzyme nitrate reductase; 2) the time required for the fluorometric 
measurement is less than two hours compared to 6-7 hours for NOx determination; and 3) the cost is 
reduced as samples do not require ultrafiltration. However, the disadvantage of this system is the 
current lack of a suitable internal standard, rendering the output semi-quantitative relative to 
controls or baseline samples.  
The results from these two measures clearly indicate that stress is capable of rapidly mobilising the 
nitrergic system. In the case of NOx metabolites, circulating levels can be influenced by dietary 
intake and metabolism of NO from the ʟ-arginine-NO synthase pathway (Lundberg et al., 2008). 
However, as food and water are removed prior to experimentation, it is not likely that dietary NOx 
is heavily contributing to the increases observed. The next likeliest candidate would seem to be 
metabolism of NO produced from the endothelial isoform. However, using human and rat 
endothelial cells, Liu and colleagues (2009) demonstrated that the eNOS promotor region contains a 
suppressive GRE sensitive to 2-3 fold increases in glucocorticoid similar to those observed during a 
stress response. This decrease in eNOS expression is suggested to contribute to the hypertensive 
effect of increased glucocorticoids. Moreover, the increase in struggling behaviour observed in 
Chapter III may indicate increased muscular activity and hence, requirement for nitric oxide-
induced vasodilation. Even with decreasing eNOS, this could be achieved directly by skeletal 
muscular tissue which creates a temporary ‘hypoxic’ state due to the increased oxygen demand. The 
skeletal muscle can derive NO independent of NOS activity by utilising deoxygenated myoglobin to 
reduce nitrate to NO, a process that can also occur in blood via haemoglobin, and plasma via 
xanthine oxidoreductase (Lundberg et al., 2008). However, this would deplete the local nitrite pool 
in favour of NO production. While this may contribute to the observed DAF-FM T formation, this 
would be in opposition to the increases observed in NOx. This indicates that the increases in plasma 
markers of DAF-FM T and NOx ultimately reflect an increased flux of NO metabolism through the 
ʟ-arginine-NO synthase pathway, signalling activation of the nitrergic system. Furthermore, the 
observation of a generalised increase in peripheral nitrergic system activity following stress 
exposure was good evidence that this system is capable of responding to acute challenges and may 
utilise the circulation as a clearance mechanism. However, the large number of redox active 
enzymes present in circulation and the enormous NO quenching activity of haemoglobin would 
make it very difficult to ascertain the originating source of NO production. For example, 
caeruloplasmin, a major copper-carrying ferroxidase enzyme present in circulation under normoxic 
conditions acts as a NO oxidase/nitrite synthase by oxidizing NO. Conversely, a number of 
mechanisms, including reduction by xanthine oxidoreductase are capable of regenerating NO from 
nitrite. This complex and ubiquitous redox cycle limits the conclusions in terms of originating 
tissues that can be drawn from peripheral measures of NO. 
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6.3.2 Central tissue 
Utilising the standard Griess NOx determination and a modified protocol of the fluorescent DAF-
FM T assay, Chapter IV investigated if psychological stress of up to four hours could induce 
changes in these nitrosative markers in both hippocampal and striatal tissue. These two regions have 
previously been shown to exhibit a differential redox response in markers of oxidative damage (Liu 
et al., 1996). Furthermore, recent studies in our laboratory have shown that the hippocampus 
exhibits an initial induction of oxidative protection through upregulation of antioxidative enzyme, 
glutathione peroxidase 1 and 4, an effect not seen in the striatum (Fig. 6.3). This may be the result 
of the high expression of GR in the hippocampus in comparison to striatal tissue. Interestingly, the 
hippocampus demonstrated early changes in both DAF-FM T and NOx formation. However, NOx 
formation exhibited a progressive decline with extended stress exposure. This may indicate that 
increased NO formation in the hippocampus may initially require NOS activation for NO 
production and metabolism after which increased levels of NO may be maintained by the alternative 
NOS-independent pathway utilising nitrite as a substrate for NO production. However, examination 
of enzymatic activity of the Ca
2+
-dependent and independent isoforms indicated that following a 
transient increase in Ca
2+
-dependent activity, there was a steady increase in Ca
2+
-independent 
activity indicative of iNOS activation. This was further supported at the mRNA level with sustained 
declines in hippocampal nNOS mRNA indicative of transcriptional negative feedback while 
hippocampal iNOS mRNA increased exponentially over the short time-course of the experiment. 
This rapid induction has been reported previously in cortical tissue and may indicate the recruitment 
and activation of microglia (Madrigal et al., 2002). Interestingly, in comparison to the hippocampus, 
striatal nitrergic activity demonstrated delayed activation with no change in NOx and slight 
elevations in DAF-FM T formation only appearing after four hours of stress exposure. Enzymatic 
activity in this region indicated that there was a slight insignificant increase in Ca
2+
-dependent 
activity after stress, but the majority of the stress-induced nitrergic activation appeared to be driven 
by the inducible NOS. This was supported by increases in iNOS mRNA. Interestingly, both regions 
displayed robust increases in Nfkbia, one of the inhibitory subunits of NFkB. Bottero and 
colleagues (2003) demonstrated that monitoring the mRNA levels of this subunit directly correlated 
to NF-кB transactivation as this tightly regulated molecule is quickly recruited to inhibit activated 
NF-кB. This very useful observation allows the employment of relatively simple and clean PCR 
techniques in comparison to the more technical electrophoretic mobility shift assays that require use 
of antibodies and radioligands. However, the electrophoretic mobility shift assays was utilised by 
Madrigal and colleagues (2002) to demonstrate that the increase in cortical iNOS was highly 
dependent on transactivation of NF-кB signalling, and this also involved neuroinflammatory 
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Figure 6.3. The effect of acute restraint stress on neural glutathione peroxidase 1 (Gpx1) and 
glutathione peroxidase 4 (Gpx4) mRNA levels in the hippocampus (A & B) and striatum (C & D) 
of control and stressed rats (n=6 per group). Hippocampal and striatal mRNA were determined in 
isolated neural tissue collected from animals exposed to 0 (control), 60, 120, and 240 minutes of 
restraint stress during the dark cycle. Data are expressed as mean ± SEM. Data were analysed using 










6.4 Acute Psychological Stress and the Inflammatory Response 
The observation of increased hippocampal iNOS expression in Chapter IV indicated that 
neuroinflammation may be playing an important role in stress responsiveness and recovery in this 
region. Therefore, the final chapter of this thesis examined if this indicator of nitrergic-mediated 
inflammation could be pharmacologically attenuated using novel modulators of the 
endocannabinoid system that have anti-inflammatory activity towards the iNOS system. This was 
chosen over modulators of HPA activity as these often exert differing effects on glucocorticoids that 
may result in off target effects. For example, as psychological stress does not induce a physical 
trauma and is routinely used to induce anxiety, the common anxiolytic compound diazepam was 
initially considered. However, Kalman and colleagues (1997) demonstrated that diazepam increases 
basal corticosterone markedly to peak stress-induced concentrations following intraperitoneal 
injection of 6 mg/kg. Furthermore, only this dose was effective at alleviating stress responsiveness 
to restraint. While still acting as a behavioural anxiolytic, this basal increase and inability to inhibit 
adrenal output would undoubtedly be sufficient to potentiate iNOS expression, perhaps even in the 
absence of restraint. The next consideration was the corticosterone synthesis inhibitor, metyrapone, 
a compound used in the diagnosis of adrenal insufficiency. However, the nature of this inhibition 
includes decreasing mineralocorticoid production while increasing upstream stress hormones 
ACTH and CRH via the reduction in negative feedback. This imbalance in HPA dynamics, 
particularly in the hippocampus, hypothalamus, and pituitary made this an undesirable option as the 
effect of increased central stress hormones does not wholly represent a reduction in HPA 
responsiveness. As the stress and inflammatory systems are intrinsically linked, with each playing a 
modulatory role on the other, a novel enzyme inhibitor, PF-3845, capable of increasing endogenous 
cannabinoids was selected. Endogenous endocannabinoid signalling has been shown to transiently 
reduce HPA output via direct feedback onto hypothalamic neurons (Steiner and Wotjak, 2008). In 
the present study, administration of this compound effectively blocked stress-induced hippocampal 
inflammatory indicators at the transcriptional including expression of IL-1β, IL-6, COX-2, and 
iNOS. There was also a decreased induction of IκB-α, indicating reduced NF-кB signalling. It is 
interesting to note that the anti-inflammatory effects of PF-3845 were most evident on IL-6 and 
TACE when compared to IL-1β, TNF, and COX-2 expression. In combination with the direct 
effects of increased endocannabinoids on hypothalamic neurons, the reduction in IL-6 may also 






6.5 Future Directions 
The results presented in this thesis have identified acute activation of the nitrergic system in 
response to psychological stress. While the aims of the experiments have been fairly rudimentary in 
nature, mechanistically, the mediators initiating this response have not been identified. Chapter III 
and IV presented some preliminary findings suggesting that glucocorticoids were involved in 
nitrergic activation. However, the next principle test in this line of experiments needs to 
pharmacologically validate the involvement of glucocorticoids using receptor blockade with RU-
486/spironolactone, and corticosterone synthesis inhibition with metyrapone. This can allow a more 
confidant claim towards involvement of glucocorticoids in nitrergic activation. This will need to be 
further validated to ascertain that nitrergic activation is directly associated rather than acting 
through secondary/tertiary mechanisms that are not directly related to glucocorticoid signalling. 
Conversely, as noted in Chapters IV and V above, a single acute psychological stress induces a 
rapid hippocampal pro-inflammatory response even in the presence of high concentrations of anti-
inflammatory glucocorticoids. Moreover, the anti-inflammatory effects of PF-3845 were 
preferentially observed on IL-6 and IκB-α which are known to be resistant to glucocorticoid-
induced suppression in comparison to other cytokines. However, given the relative energy-intensive 
requirements of cytokine production in general, the physiological rationale for negating 
glucocorticoid anti-inflammatory effects during an acute stress response where energy demand in 
other tissues is also high seems counter-intuitive. Furthermore, the oxidative and nitrosative stress 
placed on tissues immediately following acute stress exposure also cause generalised damage to 
lipid membranes, proteins, and DNA, which each require energy in the form of endogenous 
antioxidants and repair mechanisms to reinstate normal cellular function. Frank and colleagues 
(2013) suggested that an additional function of stress-induced glucocorticoids is to prime the 
immune system for subsequent activation as glucocorticoids decrease following peak pulse 
concentrations. While this may be based on specific increases in cytokine mRNA (not necessarily 
translated to protein) and alterations in the activation state of microglia, observed as hyper-ramified 
in post-stress surveillance, little is known of the functional purpose of increasing short-lived 
radicals. While these have traditionally been labelled as by-products of increased metabolism, 
Lundberg and colleagues (2008) proposed that preferential oxidation of NO, to nitrite in particular, 
creates a reservoir of NO accessible in the absence of oxygen required for synthesis. Interestingly, 
recent experiments in our laboratory have demonstrated that the initial hippocampal oxidative 
response to stress causes a sharp decrease in the reduced form of glutathione that coincides with 
increased oxidative status and lipid peroxidation. However, this effect rebounds quickly to restore 
reduced glutathione. This is an important observation as activation of nitric oxide from nitrite 
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requires an abundant cellular reducing agent in order to be an effective reservoir. In spite of this, 
although activation of the nitrergic system and creation of a NO reserve appears to be tethered to 
the pro-inflammatory immune mediators, the functional role of this response in an acute stress 
response has not been established. To address this, experiments using psychological stress coupled 
with a lipopolysaccharide-induced immune challenge should be performed to identify the protective 
or deleterious nature of acute stress-induced nitrergic activation. This should include an 
immunohistochemical component to identify preferential protection/destruction in neurons/glial 
cells expressing the different NOS isoforms. 
6.6 Conclusions 
Psychological stress is a powerful causative factor in a myriad of chronic disease states. Detailed 
knowledge about the regulation of HPA axis activity during physiological conditions is important 
for the development of novel therapeutic strategies for the treatment of prolonged 
psychopathologies. While there is a considerable link between altered nitrergic activity and many 
prevalent neurodegenerative diseases, this thesis has established an acute profile of stress-induced 
peripheral nitrergic activation. Furthermore, the rapid involvement of nitrergic activity within the 
CNS following acute stress displayed regional specificity. This observed nitrergic activation within 
the brain following acute stress is predominately inflammatory-related while an enhanced 
endocannabinoid signalling has the capability of modulating these responses. Further understanding 
the role of the nitrergic system is important in identifying early players in the stress-induced 
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Figure A1. The effect of acute restraint stress on neuronal nitric oxide synthase (Nos1) mRNA 
expression in the medial prefrontal cortex (mPFC) of control and stressed rats (n=5-6 per group). 
The relative expression was determined in isolated medial prefrontal cortex collected from rats 





































Figure A2. The effect of acute restraint stress on inducible nitric oxide synthase (Nos2) mRNA 
expression in the medial prefrontal cortex (mPFC) of control and stressed rats (n=5-6 per group). 
The relative expression was determined in isolated medial prefrontal cortex collected from rats 




































Figure A3. The effect of acute restraint stress on nuclear factor of kappa light polypeptide gene 
enhancer in B-cells inhibitor, alpha (Nfkbia) mRNA expression in the medial prefrontal cortex 
(mPFC) of control and stressed rats (n=5-6 per group). The relative expression was determined in 
isolated medial prefrontal cortex collected from rats exposed to 0 (control), 60, 120, and 240 
minutes of restraint stress. Data are expressed as mean ± SEM, **p<0.01. 
 
 
